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Abstract 
 
Epidemiological studies have shown that a diet high in fruit and vegetables has an 
inverse association with the occurrence of various degenerative diseases such as 
cancer, cardiovascular disease, neuro-degenerative disease and diabetes. Clinical and 
animal studies using fruit and vegetable extracts have shown that polyphenols 
abundant in plants may account for the beneficial effect of diets high in fruit and 
vegetables. Following these findings, laboratories worldwide are investigating the 
mechanisms underlying the health effects exerted by polyphenols. Although many 
studies have investigated the effect of various polyphenols on cancer cells, such as 
inhibition of cell growth, induction of apoptosis, tumorigenesis, few studies have 
been carried out to examine their effect on normal cells and whether they could 
prevent the initiation of cancer. DNA damage, one of the early steps in the 
tumorigenic process, may be caused by toxicants and oxidative stress either from the 
environment or from endogenous sources. Therefore, to prevent such damage, 
multiple mechanisms are deployed by cells to combat the toxic insult and reduce 
oxidative stress. The CNC-bZIP transcription factor, Nrf2, is known to regulate the 
expression of many of the genes involved in these processes.  
 
Under homeostatic conditions, the Nrf2 protein is targeted by its inhibitor Keap1 for 
ubiquitination in the cytosol. Upon redox stress, induced by low molecular weight 
electrophiles, Nrf2 can evade ubiquitination and translocate into the nucleus, where it 
heterodimerizes with members of the small Maf family of transcription factors and 
 XVIII 
bind to the antioxidant response element (ARE) in the promoter region of many 
cellular defence genes, leading to the up-regulation of their transcription. 
 
In our study, we examined whether polyphenols could affect the Nrf2-ARE 
signalling pathway. Preliminary screening was first carried out using AREc32 cells to 
find flavonoids which have ARE-inducing ability. Flavonoids, which are present in 
relatively high concentration in fruits and vegetables and consumed most commonly, 
were chosen for screening. Quercetin and kaempferol showed the highest 
ARE-inducing ability and these two compounds were subsequently were used to 
examine their effect on Nrf2 and its target gene Nqo1 in rat liver RL-34 and mouse 
embryonic fibroblast MEF cells. By Nqo1 enzyme activity assay, Western blotting, 
and Taqman experiments, our study showed that these two flavonoids increased the 
enzyme activity, protein expression and mRNA level of Nqo1. By using Nrf2
+/+
 and 
Nrf2
-/-
 MEFs, we found that such increases are Nrf2-dependent. The effect of 
quercetin and kaempferol on Nrf2 was therefore examined. Nrf2 protein, but not 
mRNA, was found to be elevated by quercetin and kaempferol. By 
cycloheximide-chase experiment, quercetin and kaempferol were shown to stabilize 
the Nrf2 protein by decreasing its turnover time. Furthermore, results from cellular 
fractionation and immunocytochemistry experiments showed that Nrf2 
predominantly resides in nucleus under both normal and stressed conditions; the two 
flavonoids increased the accumulation of Nrf2 in both cytosol and nucleus, although 
the increase of Nrf2 protein in the nucleus was more pronounced. In addition, it was 
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found that the flavonoids inhibited the ubiquitination of Nrf2. To address how the 
flavonoids inhibit the ubiquitination, we carried out mutagenesis experiments with 
quercetin and found Cys151 in Keap1 is required for stabilization of Nrf2, which 
indicates that quercetin may act as an electrophile and modify the Cys151 in Keap1, 
ultimately leading to the disruption of the association between Keap1 and Nrf2. The 
involvement of ARE in the regulation of Nqo1 by quercetin and kaempferol were 
examined by mutagenesis experiments, the results of which showed that the ARE 
was involved in both the basal expression of Nqo1 and its induction by quercetin and 
kaempferol.  
 
Besides the ARE, the promoter region of Nqo1 contains a xenobiotic responsive 
element (XRE) which can mediate gene regulation by AhR. With the evidence from 
previous research showing that Nqo1 can be up-regulated by the AhR agonist TCDD, 
we examined the involvement of XRE in the induction of Nqo1 by the flavonoids in 
mutagenesis experiments. The absence of XRE only affected the basal level but not 
the inducible level of Nqo1. However, by immunocytochemistry experiments, we 
showed that quercetin and kaempferol can act as AhR agonists. This was confirmed 
by Taqman experiments showing these two flavonoids can increase the mRNA level 
of Cyp1a1. 
 
Lastly, the effect of quercetin and kaempferol in vivo was also examined in animals 
by using C57BL/6 male mice. Only quercetin showed up-regulation of Cyp1a1 
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mRNA in the small intestine. An effect on Nqo1 and Nrf2 by the flavonoids observed 
in cells was not seen in the tissues.  
 
Taken together, the data presented in this thesis shows that the flavonols quercetin 
and kaempferol up-regulate the Nrf2-ARE signalling pathway by stabilizing the 
CNC-bZIP protein; such up-regulation also leads to the trans-activation of Nqo1. In 
addition, the two flavonoids are AhR agonists and increase the mRNA level of 
Cyp1a1 which is also observed in the mouse small intestine. Such increase of 
Cyp1a1 may indicate their implication in the prevention of gastrointestinal cancer.  
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1 Introduction 
 
1.1 Phytochemicals and their preventive effect 
1.1.1 Phytochemicals and its subclasses 
Phytochemicals are non-nutritive constituents produced by secondary metabolism in 
plants. They defend plants against predators, microbial infections and ultraviolet 
light, regulate metabolic pathways in plants and provide color, flavor and smell to the 
plants. Phytochemicals can be classified as carotenoids, polyphenols, alkaloid, 
nitrogen-containing compounds, and organosulfur compounds. Polyphenols are 
compounds possessing one or more aromatic rings with one or more hydroxyl group 
and are generally categorized as phenolic acids, flavonoids, stilbenes, coumarins, and 
tannins (Liu, 2004).  
1.1.2 Polypheonols 
Polyphenols are abundant components in our diet and evidence for their role in the 
prevention of degenerative diseases such as cancer, cardiovascular and Parkinson‟s 
or Alzheimer‟s disease is emerging. In edible plants, several hundred molecules 
possessing polyphenol structure (i.e. several hydroxyl groups on aromatic rings) have 
been identified. In non-edible plants, even more of these related molecules have been 
identified, numbering several hundreds of them. Depending on the number of phenol 
rings and different types of connection between these rings, several groups of 
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polyphenols can be distinguished, including the phenolic acids, flavonoids, stilbenes, 
and lignans (Manach et al., 2004). 
1.1.3 Subclasses of flavonoids and their distribution in food 
More than 4000 distinct flavonoids have been identified and approximately 900 of 
them are consumed in the human diet. As shown in Figure 1.1, flavonoids share a 
generic structure, consisting of two aromatic rings (A and B rings) linked by 3 
carbons atoms that are usually contained in an oxygenated heterocycle ring, or C ring. 
The flavonoids can be further classified as flavonols, flavones, catechin-tanins, 
anthocyanidins, and isoflavones, according to structural differences in their C-ring 
(Table 1.1). Flavonoids are found in nearly all fruit and vegetables and are frequently 
found in nature as conjugates in gycosylated or esterified forms. A large number of 
different sugars, of which more than 80 kinds exist, also contribute to the chemical 
variety of flavonoids. However, flavonoids can occur as aglycones in nature and food 
processing can assist the conversion of conjugates to their aglycones. (Liu, 2004) 
 
 
Figure 1.1 General structures of common food flavanoids. 
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Flavonoids 
class 
Flavonols Flavones Isoflavones Catechins Anthocyanins 
Carbon atom 
in ring C to 
which B is 
attacthed 
2 2 3 2 2 
C-ring 
unsaturation 
2-3 double 
bond 
2-3 double 
bond 
2-3 double 
bond 
None 1-2, 3-4 double 
bond 
C-ring 
functional 
groups 
3-hydroxy, 
4-Oxo 
4-Oxo 4-Oxo 3-hydroxy; 
4-gallate 
3-hydroxy 
Table 1.1 Chemical characteristics of each flavonoid subclasses. 
 
1.1.3.1 Flavonols 
Flavonols are present in various foods, the structures of which are characterized by 
the presence of a double bond between C2 and C3 and a hydroxyl group in the C3 
position (Figure 1.2). They are generally present at relatively low concentrations of 
around 15-30 mg/kg fresh weight and the richest sources are onions (up to 1.2 g/kg 
fresh wt), curly kale, leeks, broccoli, and blueberries. Amongst beverages, the 
amount of flavonols in red wine and tea can also be as great as 45 and 30 mg/L, 
respectively (D'Archivio et al., 2007). 
 
 
Figure 1.2 Structures of the main representatives of flavonols quercetin and kaempferol 
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1.1.3.2 Flavones  
Flavones are much less abundant than flavonols in fruit and vegetables and they 
characteristically possess a double bond between C2 and C3 as shown in Figure 1.3 
and Table 1.1. Flavones consist chiefly of glycosides of luteolin and apigenin. 
Amongst edible plants, parsley and celery are important sources of flavones. 
However, polymethoxylated flavones can be found in large quantities in the skin of 
citrus fruits (D'Archivio et al., 2007). 
 
 
Figure 1.3 Structures of typical flavones luteolin and apigenin. 
 
1.1.3.3 Flavanones 
High concentrations of flavanones are mainly found in citrus fruit, though they can 
also be found in tomatoes and aromatic plants such as mint. Their structures are 
characterized by the presence of a saturated three-carbon chain and an oxygen atom 
attached to the C4 atom (Figure 1.4 and Table 1.1). They are also present in the plant 
in their glycosylated form. The representative flavanones are naringenin, hesperetin 
and eriodictyol (D'Archivio et al., 2007). 
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Figure 1.4 Structure of the typical flavanone narigenin. 
 
1.1.3.4 Isoflavones 
With the hydroxyl group in the C7 and C4 position, isoflavones share structural 
similarities to estrogen. Due to this property, the metabolites of isoflavones have 
been found to be able to bind to estrogen receptors and therefore have been classified 
as phytoestrogen (Reinli & Block, 1996). Soya and its processed products are the 
main source of isoflavones in the human diet. Like other flavonoids, they mostly 
exist in a glycosylated form. They are represented in plants as three main molecules: 
genistein, daidzein and glycitein (D'Archivio et al., 2007). 
 
Figure 1.5 Structure of genistein, one of the typical isoflavones 
 
1.1.3.5 Catechins 
Catechins are found in many types of fruit such as apricot and cherry. However, 
green tea and chocolate are much greater sources of catechins. Unlike the flavonoids 
mentioned above, the catechins have a saturated three-carbon chain with a hydroxyl 
group in the C3 atom (Figure 1.6). Another distinguishing property of this family is 
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that they exist as aglycones in foods. Catechin and epicatechin are the main flavanols 
in fruit (D'Archivio et al., 2007). Gallocatechin, epigallocatechin, and 
epigallocatechin gallate are found in certain seeds of leguminous plants, in grapes 
and more importantly in tea (Manach et al., 2004).  
 
Figure 1.6 Structures of typical catechins. 
 
1.1.3.6 Anthocyanins 
Anthocyanins are water soluble and exist primarily in glycosytes which are called 
anthocyanidins. They serve as pigments that give rise to the red and blue colors in 
some fruits and vegetables. In human diet, anthocyanins are found in red wine, 
certain varieties of cereals, and certain leafy and root vegetables (aubergines, 
cabbage, beans, onions, radishes), but they are most abundant in fruit. Cyanidin is the 
most common anthocyanidin in foods (Manach et al., 2004).  
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Figure 1.7 The structure of cyanidin. 
 
Human intake of all flavonoids is estimated at a few hundred milligrams to a 
maximum of about 650 mg/day. The total average intake of flavonols (quercetin, 
myricetin , and kaempferol ) and flavones (luteolin and apigenin) was estimated as 
23 mg/day in the United States, Denmark and Hollond (Manach et al., 2004). In 
Holland, quercetin contributed to ~70%; kaempferol, 17%; myricetin, 6%; luteolin, 
4%; and apigenin 3% (Hertog et al., 1993). However, this can vary a lot due to 
different areas. 
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Table 1.2 Sources content of flavonoids in common foods.  
The amount of representative flavonoids, from different family, present in different fruit and 
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vegetables are shown in table. Data are adapted from Manach et al. (2004) 
 
1.1.4 Bioavailability of flavonoids  
Bioavailability of flavonoids varies amongst different chemicals depending on their 
chemical structure, sugar groups attached and their molecular weight. For instance, 
the aglycone is more easily absorbed than their glycosides; proanthocyanidins 
existing as polymers and having high molecular weight are poorly absorbed in the 
small intestine and are rapidly metabolized and eliminated (Manach et al., 2005). 
Direct evidence on the bioavailability of phenolic compounds has been obtained by 
measuring their concentration in plasma (Marrugat et al., 2004 ) and urine (Tian et 
al., 2006) after ingestion of either pure compounds or food stuffs in which the 
content of interested polyphenols have been determined (Fito et al., 2007). Data have 
been reported showing that the maximal plasma concentrations of flavonoids are low, 
usually less than 1 μmol/L, reaching to a maximum level 1-2 h after ingestion. 
Therefore, the maintenance of a high concentration in plasma requires repeated 
ingestion of the polyphenols over time. (D'Archivio et al., 2007). Studies 
investigating the extent of polyphenol absorption in humans, after the ingestion of a 
single dose of polyphenols provided as a pure compound, plant extract or whole 
food/beverage, showed that the quantities of intact polyphenols found in urine vary 
form one flavonoid to another. Inter-individual variations have also been observed, 
probably due to the different composition of the colonic microflora which can affect 
their metabolism (Manach et al., 2005).  
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1.1.5 Absorption of polyphenols 
To explore whether flavonoids can exert chemopreventive effects, it is more 
important to understand how they are absorbed by the body and whether they are 
further metabolized to biologically active or inactive metabolites. There are 
numerous sites important for the metabolism of dietary polyphenols, including the 
gastrointestinal tract, the liver, and various other tissues such as the skin and brain. In 
addition, flavonoids are able to penetrate tissues, particularly those in which they are 
metabolized such as liver and intestine. However, not many data are available in 
either humans or animals. In one study tea polyphenols were measured in human 
prostate tissue and showed that after consumption of 1.42 L of green tea or black tea 
for 5 days, catechins from the beverage were bioavailable in prostate tissue samples 
ranging from 21-107 pmol/g tissue (Henning et al., 2006).  
 
The route of absorption and metabolism of polyphenols is stomach, gastrointestinal 
tract and liver. After crossing these barriers, polyphenols will be circulated in the 
plasma and transported to various target tissues or excreted in either the urine or bile. 
Though the aglycones can be absorbed by small intestine, the most abundant forms 
of flavonoids in foods are esters, glycosides, or polymers which are poorly absorbed 
(Scalbert & Williamson, 2000). However, these conjugates of aglycones can be 
hydrolyzed by enzymes such as glycosidases which can occur in food itself 
(endogenous or during processing) or in the cells of the gastrointestinal mucosa or 
can be secreted by the colon microflora. Such reactions do not occur under the acidic 
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conditions in the stomach. The converted polyphenols are readily bioavailable to the 
body. After hydrolysis in the gastrointestinal tract, the aglycones are absorbed by the 
intestinal enterocyts where they undergo different conjugation reactions including 
glucuronidation by UDP-glucuronyl transferase (UDP-GT), methylation by 
catechol-O-methyltransferase (COMT). Once flavonoids reach the liver, any 
remaining aglycone will undergo glucuronidation or sulfation and methylated 
polyphenolics may undergo demethylation (Singh et al., 2008). In addition, as 
flavonoids have a planar aromatic structure, they may undergo oxidation in their role 
as antioxidants to form quinone-like structures that are detoxified by conjugation 
with glutathione or are broken down to smaller phenolic compounds (Corona et al., 
2006).  
 
Polyphenol metabolites circulate in the blood bound to proteins, and albumin 
represents the primary protein responsible for binding and transporting polyphenols. 
The affinity of polyphenols for albumin varies according to their chemical structure 
and it is not clear whether binding to albumin affects their biological activity 
(D'Archivio et al., 2007).  
 
1.1.6 Beneficial properties of flavonoids 
Various potentially beneficial properties of dietary flavonoids have been proposed 
including antioxidant properties, chelation of metals, anti-viral activity, anti-bacterial 
activity, anti-inflammatory properties, oestrogenic activity, anti-mutagenic activity, 
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and either the activation or inhibition of various enzymes. Some flavonoids show 
strong antioxidant activity, such as quercetin and the anthocyanin aglycone, cyanidin, 
which was reported to have antioxidant potentials 4-fold higher than that of the 
vitamin E analogue, trolox (Rice-Evans et al., 1995). There are basically three 
requirements for possessing antioxidant activity by flavonoids: firstly, the presence 
of ortho-dihydoxyl (catechol) groups on the B ring; secondly, the presence of a 
2,3-double bond in the C ring; thirdly, free hydroxyl groups on the 5 and 7 position 
of the A ring (Apak et al., 2007; Zhang, 2005). Their antioxidant activities have been 
suggested to be responsible for their cancer prevention property (Akira et al., 2008; 
Padhye et al., 2010). Some flavonoids, such as quercetin (Ferrali et al., 1997), 
cyanidin and procyanidin (Quesada et al., 2010) are good chelators of metals like 
iron, zinc and copper and therefore could inhibit platelet aggregation and therefore 
contribute to the prevention of cardiovascular disease (Mladěnka et al., 2010). 
Furthermore, some flavonoids are able to affect the expression or activity of various 
enzymes. For example, quercetin and kaempferol have been reported to increase the 
activity of thioredoxin reductase in normal human keratinocytes (Sugahara et al., 
2010). 
 
1.1.7 Flavonoids and disease 
Epidemiological studies have shown that there is an inverse relationship between 
intake of flavonoids and the risk of developing cardiovascular disease, and 
age-related disease such as Alzheimer‟s disease, and various types of cancer (Singh 
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et al., 2008). However, the mechanisms responsible for their beneficial effect is still 
unclear and under intensive investigation. One of the suggested mechanisms is that 
flavonoids are protective through their antioxidant property. As sustained elevated 
levels of reactive oxygen species have been found to be associated with various 
neoplastic diseases, the antioxidant property and ability of flavonoids to induce 
cytoprotective enzymes may contribute to their chemopreventive effect. 
  
Anti-inflammatory activity is another possible chemopreventive mechanism, as 
inflammation contributes to the initiation and progression of various neoplastic 
diseases (Pierini et al., 2008). It has been reported that flavonoids extracted from 
fruit and vegetables can inhibit the NF-кB signalling pathway, which is involved in 
the initiation of inflammation (Prasad et al., 2010). Furthermore, modulation of 
critical cell activities of cellular responses, by flavonoids,  such as regulation of cell 
cycle (Ong et al., 2010), cell proliferation and cell apoptosis (Zhong et al., 2010), 
may also account for the chemopreventive effect of flavonoids.  
 
1.1.8 Flavonoids and cancer 
Although carcinogenesis is a complex multistep process, in which numerous 
molecular mechanisms play different roles (Hanahan & Weinberg, 2000) and six 
general  steps are involved. These include initiation, promotion, progression, 
angiogenesis, invasion and metastasis. Flavonoids may reduce the cancer risk both 
by blocking initiation of carcinogenesis and by suppressing the later promotion and 
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/or suppression stages.  
  
Regarding the initiation of carcinogenesis, it always starts with genetic alterations. 
To avoid this, direct and indirect strategies can be taken, i.e. preventing DNA attack 
by reactive oxygen species, reducing the toxicity of procarcinogens by enhancing 
their conjugation and excretion, inhibition of carcinogen uptake into cells, increased 
efflux of carcinogen from cells, and enhancing DNA repair (Manson et al., 2007). 
For example, quercetin has been reported to protect DNA damage by hydrogen 
peroxide and benzo[a]pyrene (Duthie et al., 1997; Wilms et al., 2005).  
The progression of cancer could also be halted by activation of cell cycle arrest or 
apoptosis.  A number of flavonoids alone, or in combination, have been found to 
suppress cell proliferation or induce apoptosis in carcinoma cells including quercetin 
(Hsieh & Wu, 2009), EGCG, resveratrol (Hsieh & Wu, 2008), kaempferol (Leung et 
al., 2007), procyanidin and pomegranate extracted ellagitannins (Syed et al., 2007). 
EGCG has also been shown to inhibit cell growth by inducing cell cycle arrest in the 
G0/G1 phase (Chen et al., 2004). Another flavonol found in rice bran, tricin, was 
shown to inhibit the growth of breast tumour cells by causing G2/M arrest in vitro 
and in vivo (Cai et al., 2004). Therefore, different flavonoids may exert their 
chemopreventive effect through distinct mechanisms.   
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1.2 Drug-metabolizing enzymes 
1.2.1 The Drug-metabolizing enzyme system 
Drug-metabolizing enzymes, also called xenobiotic transformation enzymes, provide 
the defence against foreign chemicals, to which humans are constantly exposed. 
Xenobiotics include a broad spectrum of chemicals, either manufactured or natural, 
such as drugs, pollutants, alkaloids and pyrolysis products found in cooked food. 
Many xenobiotics are toxic and if they accumulate in the body, they may cause cell 
damage and eventually kill an organism. Therefore, a large number of enzymes with 
various specificities are required for the biotransformation and elimination of these 
toxicants. Examples of reactions and enzymes involved in detoxification include: 
oxidation reaction catalyzed by cytochromes P450, alcohol dehydrogenase (ADH), 
aldehyde dehydrogenase and glutathione peroxidase; reduction reaction catalyzed by 
aldo-keto reductase (AKR), short chain dehydrogenase/reductase (SDR), and 
NAD(P)H dehydrogenase, quinone 1 (NQO1); hydrolysis catalyzed by epoxide 
hydrolase; conjugation reactions catalyzed by UDP-glucuronosyltransferase (UGT), 
sulfotransferase (SULT), methyltransferase, acetyltransferase, and glutathione 
transferase (GST) (Zimniak, 2008). Generally, the first three reactions mentioned 
above can introduce a functional group to the substrate such as –OH, -NH2, -SH or 
–COOH leading to a modest increase in the hydrophilicity in the end-product. 
Conjugation reactions include glucuronidation, sulfonation, acetylation, methylation, 
conjugation with glutathione, and conjugation with amino acids. Cofactors are also 
required for these reactions; they react with functional groups originally present in 
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the substrate or introduced through the other types of detoxification reactions. 
Compared with oxidation and reduction, conjugation reactions can result in a 
significant increase in the hydrophilicity of the substrates, therefore promoting the 
excretion of foreign chemicals (Klaassen, 2008). In the 1970‟s the concept of Phase I 
and Phase II drug metabolism was proposed, in which the Phase I enzymes included 
those responsible for hydrolysis, oxidation, and reduction of xenobiotics while Phase 
II enzymes catalyze the conjugation of xenobiotics with sugars and amino acids 
(Williams, 1971). 
 
In addition to phase I and II enzymes, transporters that can facilitate drug 
metabolizing have been classified as the phase III drug-metabolizing enzymes. The 
phase III transporters include a large family of proteins such as P-glycoprotein (P-gp), 
multidrug resistance associated protein (MRP) and organic anion transporting 
polypeptide. They are present in various tissues including liver, intestine, kidney and 
brain. The transporters play a crucial role in the absorption, distribution and excretion 
of xenobiotic (Xu et al., 2005). 
   
Besides toxicity, xenobiotics can also be therapeutic beneficial as in the case of drugs. 
Thus modification of therapeutic agents by drug-metabolizing enzymes can also 
change their biological effects. Therefore, drug-metabolizing enzymes play a vital 
role in determining the intensity and duration of action of drugs and chemical 
toxicity and chemical tumorigenesis (Klaassen, 2008).   
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1.2.2 Monofunctional and bifunctional inducers  
Although most of the drug-metabolizing enzymes are constitutively expressed, their 
synthesis can be induced by some xenobiotics. The existence of mono- and 
bifunctional inducers was proposed by Talalay (Prochaska et al., 1985; Prochaska & 
Talalay, 1988). Mono-functional inducers selectively increase the expression of 
genes encoding NQO1 and GSTs that are regulated through the presence of an 
antioxidant response element (ARE) in their promoter regions. Such induction is 
mediated by transcription factor, the nuclear factor erythroid 2-related factor 2 (Nrf2), 
as a consequence of inhibition of its repressor Kelch-like ECH-associated protein 1 
(Keap1). Bifunctional inducers increase the expression of NQO1 or GSTs as well as 
proteins from P450 family, such as CYP1A1. They can bind with high affinity to the 
aryl hydrocarbon (Ah) receptor and lead to its activation which upon translocation to 
the nucleus in turn binds to the xenobiotic responsive element (XRE) and 
transactivates genes responsible for some enzymes in the P450 family such as 
Cyp1a1, Cyp1a2 and Cyp1b1.  
 
1.2.3 Induction and regulation of Nqo1  
Inducers of Nqo1 can be classified into nine structurally diverse classes (Figure 1.8): 
1. Oxidizable diphenols, phenylenediamines and quinones; 2. Michael reaction 
acceptors; 3. Isothiocyanates, dithiocarbamates and related sulfur compounds; 4. 
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1,2-Dithiole-3-thiones, oxathiolene oxides, and other organosulfur compounds; 5. 
Hydroperoxide; 6. Trivalent arsenicals; 7. Heavy metals; 8. Vicinal dimercaptans; 
and 9. Carotenoids and related polyenes. (Dinkova-Kostova et al., 2005; Russo, 
2007). Although structurally distinct, these chemicals share common properties of 
electrophilicity and capacity to modify sulfhydryl groups. Blocking the initiation of 
tumours by administration of certain of these inducers has been seen in various 
tissues, such as liver, colon, mammary gland and pancreas (Myzak & Dashwood, 2006). 
There is substantial and mounting evidence that drug metabolizing enzymes, e.g., 
N-acetyltransferase (NAT), GST, SULT, and UGT, and NQO1, play important roles 
in the detoxification of electrophilic toxicants and their induction protects against 
carcinogenesis and mutagenesis. Induction of certain drug-metabolizing enzymes is 
regulated at the transcriptional level through AREs in the promoter region of their 
genes. The transcription factor Nrf2 is principally responsible for mediating basal 
and inducible expression of ARE-driven genes; Nrf2 binds the ARE as a heterodimer 
with small Maf proteins. The most compelling evidence that Nrf2 makes a major 
contribution to the regulation of ARE-driven genes comes from the study of Nrf2 
knockout mice. In particular, the basal and inducible expression of Gst and Nqo1 is 
substantially reduced in Nrf2
-/-
 mice when compared with their wild-type 
counterparts (Itoh et al., 1997; McMahon et al., 2001). Besides Nrf2 and small Maf 
proteins, other transcription factors may influence ARE-driven gene expression. In 
vitro DNA binding studies using antibody supershift assays have shown that Nrf1 
and members of the AP-1 family can bind the ARE (Nguyen et al., 2003). Besides 
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these transcription factors, several intracellular and signal transduction pathways are 
involved in the activation of Phase II enzymes. These pathways include the 
mitogen-activated protein kinase (MAPK) pathway, the protein kinase C (PKC) 
pathway, and the phosphatidylinositol 3-kinase (PI3K) pathway (Huang et al., 2002; 
Lee et al., 2001; Yu et al., 1999) 
  
Figure 1.8 Structures of typical Nqo1 inducers.  
Typical inducers from each class are selected and presented. The names in the brackets are the classes 
they belong to.  
 
1.2.4 Antioxidant responsive element  
The ARE is a cis-acting enhancer sequence that mediates transcriptional activation of 
genes in cells exposed to oxidative stress. Proteins that are members of the 
ARE-gene battery include those associated with glutathione biosynthesis, redox 
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proteins with active sulfydryl moieties and drug-metabolizing enzymes. The 
cis-acting element was first identified within the 5‟ flanking region of a 41bp DNA 
sequence in the rat GSTA2 gene containing 41-bp DNA and was later designated as 
the ARE due to its responsiveness to phenolic antioxidants (Rushmore et al., 1991). 
The core DNA sequence essential for the response to these chemicals was 
determined through deletion and mutational analysis and was firstly defined as 
5‟-TGACnnnGC-3‟ (Favreau & Pickett, 1991). However, the same study also 
showed that nucleotides situated immediately 5‟ to the „core‟ ARE were also required 
for basal and inducible expression of the gene. Consistent with this finding, research 
from another group proposed the extended ARE core sequence as 
5‟-TMAnnRTGAYnnnnGCRwwww-3‟ (M=A/C; R-A/G; Y=C/T; and W=A/T), 
demonstrating the importance of flanking sequence for the context-specific 
regulation of gene transcription (Wasserman & Fahl, 1997). In 2003, through point 
mutations across the whole ARE in the mouse Nqo1 promoter, Nioi et al. found that 
the 3‟tetra-nucleotide „wwww‟ is required for neither basal nor inducible gene 
expression. The same study also revealed that nucleotides previously suggested to be 
redundant (which are shown as „n‟ in the sequence mentioned above) are required for 
gene induction, and on the other hand, the core sequence that had been reported 
previously to be essential before was found to be dispensable in the case of mouse 
Nqo1 (Nioi et al., 2003). Take together, these studies indicated that the sequence of 
ARE in the promoter of different genes may be distinct.  In addition to the genes 
that encode the rat GSTA2 and mouse Gsta1 proteins, genes encoding the rat and 
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human NQO1 proteins (Favreau & Pickett, 1991; Jaiswal, 1991), glutamate cysteine 
ligase catalytic subunit (GCLC) and modulatory (GCLM) subunits (Moinova & 
Mulcahy, 1998; Mulcahy et al., 1997; Wild et al., 1998), and HO-1 (Inamdar et al., 
1996) were also found to be transcriptionally regulated via the ARE. Table 1.3 shows 
the ARE sequence present in the promoter region of different ARE-driven genes.  
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Table 1.3 ARE sequences in the promoter of different genes from different species.  
The sequences shown are from the genes for antioxidant, metal-binding, and detoxication proteins 
from human, mouse and rat. As Ap-1binding site share some similarities in the sequence of ARE, the 
sequence of AP-1 binding site in the genes, and its core sequence were also shown in the table. The 
nucleotides in bold capital letters are those that share identity with the extended 16-bp ARE consensus 
sequences (5 ´TMAnnRTGAYnnnGCR´). M=A/C; R=A/G; Y=C/G/T. Data are adapted from Hayes 
et al. (2010)  
 
  23 
1.2.5 Induction of drug-metabolizing enzymes and cancer 
chemoprevention 
Carcinogenesis is a complex and protracted multistage process, yet the entire course 
can be initiated by a single event wherein a cellular macromolecule is damaged by an 
endogenous or exogenous agent. Strategies for protecting cells from these initiating 
events include increasing drug-metabolizing enzymes which are involved in 
promoting the conjugation and excretion to reduce their toxicity. Reduction of 
electrophilic quinones by NQO1 is an important detoxification pathway, which 
converts quinones to hydroquinones and reduces oxidative cycling. Therefore, 
chemicals which can increase the expression or activity of NQO1 may help to 
prevent the initiation of cancer.  
 
1.2.6 Induction and regulation of P450s  
Cytochromes P450 play important roles in drug, carcinogen, and steroid hormone 
metabolism (Estabrook, 1996). There are 18 CYP mammalian gene families , and 
four of these families (1, 2, 3, and 4) principally metabolize foreign compounds 
including drugs, food additives and environmental pollutants (Nebert & Dalton, 
2006). Some cytochrome P450 enzymes are substrate inducible, a property that 
allows the cell to adapt to changes in its chemical environment. Induction of CYP 
enzymes has both advantage and disadvantages. On one hand, enzyme induction 
inhibits chemical carcinogenesis because it increases the rate of carcinogen 
detoxification which will prevent the accumulation of lipophilic compounds to 
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harmful levels. On the other hand, as cytochrome P450 enzymes have broad 
substrate specificities, enzyme induction by one compound may lead to increased 
metabolism of a second compound, producing loss of drug effect. In addition, 
cytochrome P450 induction can produce an imbalance between detoxification and 
activation reactions, leading to adverse effects. In the case of polycyclic aromatic 
hydrocarbons (PAHs), found in cigarette smoke, metabolism by cytochromes P450 
can generate arene oxides which are electrophiles that bind covalently to cellular 
components. At high concentrations, where detoxification pathways may become 
saturated, induction can increase the production of reactive metabolites beyond the 
capacity of cellular defences, thereby producing toxicity or neoplasia (Conney, 1982; 
Weisburger, 1978).  
 
The CYP superfamily contains up to 18 families of mammalian genes and they are 
regulated through different mechanisms. The induction of the CYP1 family is 
regulated by a heterodimer composed of the (AhR) and the aryl hydrocarbon receptor 
nuclear translocator (Arnt) (Hankinson, 1995), while the expression of CYP2, 3, 4 
family members is regulated by the nuclear factor constitutive androstane receptor 
(CAR), pregnane X receptor (PXR) and peroxisome proliferator-activated receptor 
(PPAR), respectively (Kawajiri & Fujii-Kuriyama, 2007). It is also noteworthy that 
some P450s such as Cyp2c55 andCyp2u1 can also be regulated by Nrf2 (Hu et al., 
2006).  
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1.2.7 Regulation of CYP1A1 through the XRE 
Typical inducers of CYP1A1 include halogenated aromatic hydrocarbons (HAH) and 
polycyclic aromatic hydrocarbons (PAH), and the environmental contaminant 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Studies into the mechanism of 
CYP1A1 induction have employed TCDD as the xenobiotic inducer. Understanding 
the basis of CYP1A1 induction is important because it is involved in the metabolism 
of PAHs and the production of reactive genotoxic metabolites that may initiate 
carcinogenesis. Studies using AhR-defective or Arnt-defective cells showed that 
induction of CYP1A1 is AhR/Arnt dependent (Jones et al., 1986). Later work 
revealed the protein-DNA interaction between AhR/Arnt complex and the 
cis-element 5‟-TNGcGTG-3‟, which is present in multiple copies within the 
enhancer of CYP1A1 (Denison et al., 1988). This element was designated the XRE, 
but has also been called the dioxin responsive element, or the Ah-responsive element 
(Whitlock, 1999). In this thesis it is referred to as the XRE. Further investigations 
using mutational analysis indicated the core sequence essential for the functional 
XRE is 5‟-CGTG-3‟ (Shen & Whitlock, 1992).  
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1.3 The CNC-bZIP Nrf2 transcription factor 
1.3.1 CNC-bZIP family of transcription factors 
The CNC-basic leucine zipper (CNC-bZIP) family, a subfamily of bZIP proteins, 
play important roles in mammalian development and the regulation of expression of 
genes involved in various biological processes, including proliferation, apoptosis, 
differentiation, and stress responses. The first isolated CNC-bZIP protein was the 
nuclear factor-erythroid 2 p45-subunit (NF-E2 p45) (Chang et al., 1993). 
Subsequently, another three closely related transcription factors Nrf1 (Chan et al., 
1993), Nrf2 (Moi et al., 1994) and Nrf3 (Derjuga et al., 2004) were cloned. In 
addition, two distantly related proteins were also isolated and named Bach1 and 
Bach2 (Oyake et al., 1996). The CNC-bZIP transcription factors are composed of 
two conserved structural domains, named the „CNC‟ domain and bZIP domain, with 
the CNC domain situated just N-terminal to the bZIP domain (Chan et al., 1993; 
Chan et al., 1998; Moi et al., 1994). Members of the CNC-bZIP family form 
heterodimers with the bZIP small Maf proteins, composed of MafK, MafF and MafG, 
to bind to DNA sequences with different specificity (Motohashi et al., 1997). Both 
the CNC and the bZIP domains are responsible for the DNA binding property and 
binding specificity of the transcription factors. 
 
1.3.2 Stucture of Nrf2  
The CNC bZIP transcription factor Nrf2 contains six domains, namely Neh1-Neh6 
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(Figure 1.8), which are conserved amongst species (Itoh et al., 1995; Itoh et al., 
1999). The Neh1 domain comprises a bZIP region fused to a CNC region and is 
responsible for its ability to dimerize with small Maf proteins and its ability to bind 
DNA as an obligate heterodimer. The N-terminal Neh2 domain is required for 
redox-sensitive negative control of the CNC-bZIP factor (Itoh et al., 1999). The 
C-terminal Neh3 domain interacts with chromodomain helicase DNA-binding 
protein 6 (CHD6) and therefore might associate with the transcriptional apparatus 
(Nioi et al., 2005).  Both Neh4 and Neh5 are transactivation domains that interact 
with CREB-binding protein (CBP) (Katoh et al., 2001). The central Neh6 domain 
contributes to redox-independent negative control of Nrf2 (McMahon et al., 2004). 
 
Figure 1.9 Schematic representation of the structural domains of Nrf2, Nrf1, Nrf3 and Keap1. 
Location of the Neh1-Neh6 domains in rat Nrf2 was shown in the cartoon. The conserved CNC and 
bZIP domains were compared amongst Nrf1, Nrf2 and Nrf3. Structure of the Keap1, the negative 
regulator of Nrf2 was also shown. Cartoons were adapted from Hayes & McMahon et al. (2009). CTR, 
C-terminal region; KR, kelch repeat. 
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1.3.3 Function of Nrf2 in normal cells 
In mammalian cells, Nrf2 enables adaptation to oxidants and electrophiles by 
stimulating the transcriptional activation of around 100 cytoprotective genes (Hayes 
& McMahon, 2009) each containing at least one ARE in their promoters (Favreau & 
Pickett, 1991; Nioi et al., 2003). Genes whose expression is controlled by Nrf2 
include those encoding antioxidant proteins, enzymes involved in NADPH 
regeneration, drug-metabolizing enzymes (Table 1.4), drug-efflux pumps, heat shock 
proteins, α- and β-subunits of the 26S proteasome, growth factors, growth factor 
receptors, and various transcription factors (Hayes & McMahon, 2009). The elevated 
expression of cytoprotective genes can lead to increased capacity of cells to scavenge 
ROS which can cause lipid, DNA and RNA oxidation that can initiate tumour 
formation. In addition, the increased level of drug-metabolizing enzymes and 
drug-efflux pumps enables the detoxification of  a wide range of toxic compounds 
including those containing α,β-unsaturated carbonyl, epoxide, halide, hydroperoxide 
and quinone moieties, and the removal of their inactive conjugated metabolites from 
cells (Klaassen, 2008). Overall, the upregulation of ARE-driven genes by activation 
of Nrf2 enables cells to adapt to increased concentrations of ROS, reactive nitrogen 
species, and numerous electrophiles. Furthermore, studies using transgenic Nrf2 
knock out mice revealed that disruption of Nrf2 is associated with a marked 
increased susceptibility to hyperoxia (Cho et al., 2002), and various forms of chronic 
lung disease produced by exposure to cigarette smoke (Cho et al., 2002). In addition, 
Nrf2 can also protect against the formation of DNA adducts or mutations produced 
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by aflatoxin B1, benzo[a]pyrene and diesel exhaust fumes (Aoki et al., 2007; Aoki et 
al., 2001; Ramos-Gomez et al., 2003). 
 
Table 1.4 Nrf2 regulated drug-metabolizing enzymes from different species.  
Drug metabolizing enzymes from different species which are regulated by Nrf2 are shown in the table. 
Selected inducers of each drug metabolizing enzymes are also shown (Shen & Kong, 2009).  
 
1.3.4 Negative regulation of Nrf2 by Keap1 
The activity of Nrf2 is primarily regulated by Keap1 by binding to its Neh2 domain 
(Itoh et al., 1999). Nrf2 is a highly unstable protein (t1/2 ~15 min), subject to 
proteolytic degradation catalyzed by the 26S proteasome via the ubiquitin-dependent 
pathway (Nguyen et al., 2003; Stewart et al., 2003). Studies by different groups 
showed that the association of Keap1 with Nrf2 promotes Nrf2 ubiquitination in a 
constitutive manner (McMahon et al., 2003; Zhang & Hannink, 2003) through the 
cullin 3-dependent pathway (Kobayashi et al., 2004; Zhang et al., 2004). Moreover, 
study by genetic knockdown of the cellular Keap1 protein or using Keap1
-/-
 animals 
indicated that upon interaction with Keap1, Nrf2 is targeted directly for 
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ubiquitination and degradation.  
 
Mammalian KEAP1 proteins are metalloproteins that contain a Broad-complex, 
Tramtrack, Bric-à-brac (BTB) dimerization domain, an intervening region (IVR) 
enriched with Cys residues, and a protein docking site, a domain comprising six 
Kelch repeats (Adams et al., 2000; Dinkova-Kostova et al., 2005; Li et al., 2004; 
Zipper & Mulcahy, 2002). Most significantly, the cysteines play an important role in 
regulating the substrate adaptor function of Keap1. Mouse and human KEAP1 
proteins contain 25 and 27 cysteines, respectively, around half of which are likely to 
be highly reactive, able to form thiolate anion under normal physiological conditions 
(Hayes & McMahon, 2009). These Cys residues thus present Keap1 as an attractive 
target for potential regulation by thiol-reactive chemical species and, hence, 
inhibitory modulation of its activity was suggested to be an important mechanism for 
Nrf2 activation (Dinkova-Kostova et al., 2002; Dinkova-Kostova et al., 2001; Itoh et 
al., 1999; Wakabayashi et al., 2004; Zhang & Hannink, 2003). Overexpression of 
recombinant KEAP1 in various cell lines has shown that Cys23, Cys273 and Cys288 
(Kobayashi et al., 2004; Nioi & Nguyen, 2007; Zhang & Hannink, 2003) are 
required for its repression of Nrf2. In addition, Cys151 appeared to be required for 
inhibition of the substrate adaptor activity of Keap1 by inducing agents (Zhang & 
Hannink, 2003).  
 
Very recently, a two-site substrate recognition model, also called the hinge and latch 
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model, was presented to explain how Keap1 recruits Nrf2 and assists in 
ubiquitination of the CNC-bZIP protein by Cul3-Rbx1 (McMahon et al., 2006; Tong 
et al., 2006). In this model, each Kelch-repeat domain from a Keap1 homodimer 
binds to one Nrf2 protein through a weak-binding DLG motif (residues 29-31) or a 
strong binding ETGE motif (residues 76-84) located in the N-terminal Neh2 domain 
of Nrf2. The binding affinity of Kelch to the ETGE motif is approximately 100-fold 
higher than that of Kelch to the DLG motif. Several studies suggest that the Keap1 
homodimer binds both the DLG and ETGE motifs in Nrf2 to align the seven 
ubiquitin-accepting lysine residues between these two motifs into a conformation 
suitable for ubiquitin conjugation. Upon oxidative stress, modification of the cysteine 
residues on Keap1, such as C151, C273, or C288 in the BTB or linker domain, 
imposes a conformational change that disrupts the weak Kelch-DLG binding, 
resulting in diminished Nrf2 ubiquitination without dissociation of Nrf2 from Keap1. 
Such dissociation will lead to increased level of Nrf2 protein resulting in the 
activated Nrf2 signalling pathway (Itoh et al., 1999; Kobayashi et al., 2004; 
McMahon et al., 2003; Zhang & Hannink, 2003; Zhang et al., 2004). 
 
Another model also exists to explain the stabilization of Nrf2 which is to induce the 
ubiquitination of Keap1. In this model, the triggering of ubiquitination of Keap1 is 
by modification of Cys residues in it and it has been reported that treatment with 
certain xenobiotics can trigger the ubiquitination of Keap1 (Hong et al., 2005; Zhang 
et al., 2005).  
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Figure 1.10 Negative regulation of Nrf2 by Keap1 and its activation upon redox stress. 
Under homeostatic condition, Nrf2 is targeted for ubiquitination by Keap1. Upon redox stress, the 
Nrf2 will be released from keap1, translocated into nucleus, heterodimerize with small Maf, and bind 
to ARE in the gene promoter region, leading to its activation. 
 
1.3.5 Other regulators of Nrf2 
As Keap1 targets Nrf2 for ubiquitination, it has been suggested that any mechanism 
that can disrupt the interaction between the two proteins would lead to the activation 
of Nrf2. Several protein kinases have been implicated directly or indirectly in the 
modification of Nrf2, resulting in its activation, including PKC, ERK, MAPK, p38, 
and PERK. Upon oxidative stress, phosphorylation of Nrf2 at serine 40 by PKC has 
been reported to release it from Keap1 (Huang et al., 2002). A study by Cullinan et al. 
also suggested that PERK-dependent phosphorylation followed by endoplasmic 
reticulum (ER) stress triggers dissociation of Nrf2/Keap1 complexes and inhibits 
re-association of Nrf2/Keap1 complexes in vitro (Cullinan et al., 2003). Besides, 
activation of several upstream kinases, such as extracelluar signal-regulated kinases 2 
and 5 (ERK2 and ERK5), c-Jun NH2-terminal kinase 1 (JNK1) can lead to the 
phosphorylation of Nrf2 resulting in its transcriptional activation (Xu et al., 2006). 
Recently, a research group found that several MAPKs including p38, JNK1/2 and 
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ERK2 could phosphorylate Nrf2 at Serine 215, 408, 558, 577 and T559. However, 
such phosphorylation only affect the activity of Nrf2 moderately. Therefore, the 
author proposed that direct phosphorylations of Nrf2 contribute only a little to the 
regulation of Nrf2 activity (Sun et al., 2009). 
 
A recent study showed that in response to oxidative stress, p21 is regulated and the 
154
KRR motif in p21 directly interacts with the DLG and ETGE motifs in Nrf2 and 
thus competes with Keap1 for Nrf2 binding, compromising ubiquitination of Nrf2. In 
addition, using p21-deficient mice, this study also demonstrated that p21 mediated 
upregulation of Nrf2 protein under both basal and induced conditions (Chen et al., 
2009). On the other hand, glycogen synthase kinase-3β (GSK3β) negatively regulates 
Nrf2 signalling via phosphorylation of Nrf2 at tyrosine or serine residues. 
Furthermore, the p38 MAP Kinase can phosphorylate Nrf2 protein, causing an 
increased interaction between Nrf2 and Keap1 which in turn attenuates constitutive 
and inducible Nrf2 activity (Keum et al., 2006; Xu et al., 2006).  
 
1.3.6 Nrf2 gene induction 
Besides its regulation by Keap1, ubiquitination and various signalling pathway, there 
is also possibility that Nrf2 may be regulated at transcriptional level on the basis that 
the Nrf2 promoter contains two ARE sequences, -579 5´-TGACTCCGC-3´ and -317 
5´-TGACTCCGC-3´ (Kwak et al., 2003) and also XRE or XRE-like sequences -712 
5´-GCGTG-3´, 755 5´-CACGC-3´, and 870 5´-CACGC-3´(Miao et al., 2005). It has 
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been shown that Nrf2 mRNA is modestly increased in mouse keratinocytes by 
3H-1,2-dithiole-3-thione treatment (Kwak et al., 2003) and the isothiocyanate 
sulforaphane. Regarding to the presence of XRE in the promoter region, the mRNA 
of Nrf2 was shown to be increased by TCDD in mouse hepatoma 1c1c7 cells (Miao 
et al., 2005). Furthermore, multiple single nucleotide polymorphisms exist in the 
promoter of human NRF2, and one of these (-617 C/A) significantly reduces gene 
expression (Marzec et al., 2007). However, it is not known whether such 
polymorphisms prevent the variant allele from being transcriptionally activated by 
thiol-active agents.  
 
1.3.7 Nrf2 in cancer promotion and drug resistance 
In the previous sections the beneficial sides of Nrf2 were described; however, this 
bZIP transcription factor also possesses potentially harmful activities. Several studies 
have shown that Nrf2 can promote tumourigenesis and chemoresistance. The first 
evidence suggesting that Nrf2 is involved in cancer promotion was from the finding 
that Nrf2 and GSTP1 were upregulated during development of heptatocellular 
carcinoma (Ikeda et al., 2004). Later studies identified the existence of the Keap1 
mutation or loss of heterozygosity in the Keap1 locus in lung cancer cell lines or 
cancer tissues. The ultimate result of Keap1 mutation is the increase Nrf2 activity 
and transactivation of its downstream genes (Padmanabhan et al., 2006; Singh et al., 
2006). An investigation in 65 Japanese patients with lung cancer suggested that there 
was a high incidence of Keap1 somatic mutations with lung adenocarcinoma (Ohta et 
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al., 2008). Consistently, another report indicated that Keap1 expression was reduced 
in lung cancer cell lines and tissues, compared to that in normal bronchial epithelial 
cell line (Wang et al., 2008). Moreover, Nrf2 was found to be overexpressed at later 
stage of cancer in lung tissue (Wang et al., 2008). In addition, a mutation of Keap1 
(C23Y), leading to its inability to repress Nrf2, was found in breast cancer (Nioi & 
Nguyen, 2007).  
  
Collectively these results suggest that loss of function of Keap1 may result in 
prolonged activation of Nrf2 prompting the survival of cancer cells. Such 
consequence may be due to the up-regulation of some of the downstream genes 
regulated by Nrf2 which can prevent cells from apoptosis. 
 
Besides cancer promotion, Nrf2 also contributes to the resistance of cancer cells to 
chemotherapy which was indicated in a study showing that prognosis in patients with 
lung cancer that contain mutant Keap1 or Nrf2 was worse than that in patients with 
lung tumours lacking such mutations (Shibata et al., 2008). As activation of Nrf2 
protects normal cells against cytotoxic agents, it is possible that they protect 
malignant cells in human tumours against chemotherapeutic drugs. Thus the in vitro 
study by Wang et al. investigated the role of Nrf2 in determining drug response in 
lung carcinoma, breast adenocarcinoma and neuroblastoma. The results showed that 
up regulation of Nrf2 enhanced cells resistance, whereas down regulation sensitizes 
cells to chemotherapeutic agents (capsulation, doxorubicin and etoposide) (Wang et 
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al., 2008). Therefore, strategies to overcome drug resistance caused by upregulation 
of Nrf2 are desirable. Hayes, et al. have reviewed the means to solve this problem, 
either by antagonizing Nrf2 directly or by exploiting upregulated ARE-drive genes to 
activate cytotoxic pro-drugs (Hayes & McMahon, 2009).  
 
1.3.8 Nrf2 and other diseases 
In addition to cancer prevention, activation of Nrf2 and its downstream ARE-driven 
genes may also prevent neurodegenerative disease (Chen et al., 2009; Shih et al., 
2005), neovascular disease (Cano et al.), cardiovascular disease (Li et al., 2009) and 
diabetes. It is noteworthy that common factor in the pathogenesis of all these 
diseases is oxidative stress. Many studies have proved that the protection exerted by 
up-regulation of Nrf2 is ultimately due to the increased expression of antioxidant 
response, which can combat the oxidative insults, followed by activation of Nrf2.   
  
 
1.4 The aryl hydrocarbon receptor 
1.4.1 The structure of AhR protein 
The Aryl hydrocarbon receptor (AhR) belongs to the eukaryotic Per-ARNT-Sim 
(PAS) domain protein family that function as sensors of extracellular signals and 
environmental stresses affecting growth and development (Gu et al., 2003). Amongst 
them, AhR regulates adaptive and toxic responses to a variety of chemical pollutants, 
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including polycyclic aromatic hydrocarbons and polychlorinated dioxins with TCDD 
as a classic inducer of AhR. The AhR cDNA was first cloned from mouse in 1992 
(Burbach et al., 1992; Ema et al., 1992). Subsequently, the human (Dolwick et al., 
1993) and rat (Carver et al., 1994) AhR cDNA were also cloned. Though the cDNA 
of AhR has been cloned in other species such as birds, fish, amphibians, studies on 
the rodent and human AhR have been the most extensive (Hahn, 2002). In addition, 
comparative study by Hahn suggested that AhR is highly evolutionarily conserved. 
Structural analysis of the AhR cDNA in the early study revealed that AhR protein has 
two structural domains, the basic helix-loop-helix (bHLH) and PAS domains in the 
N-terminal half of the molecule (Burbach et al., 1992; Ema et al., 1992). The bHLH 
region contributes to DNA binding and the HLH region to protein-protein 
dimerization; a nuclear localization signal is contained in this region while nuclear 
export signals are present in both bHLH and PAS domain. The PAS domain is 
sub-divided into PAS A and PAS B domains. A study using the yeast Gal4 fusion 
system provided evidence that the C termini of the AhR harbours a potent 
transactivation domain (TAD) consisting of proline/serine/thereonine-rich (P/S/T), 
glutamine (Q-rich) and acidic subdomains, each of which function independently and 
exhibits varying levels of activation (Jain et al., 1994; Korkalainen et al., 2000; 
Rowlands et al., 1996). In addition, the AhR shares structural similarity with its 
nucleus dimerization partner Arnt and its repressor AhRR. Structures of these three 
proteins are schematically presented in Figure 1.11.  
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Figure 1.11 Schematic representation of the full-length of mouse AhR, Arnt and AhRR.  
The characterized domains represented are the basic helix-loop-helix (bHLH), Per-Arnt-sim (PAS), 
transactivation or repression domain. Figures are adapted from Fuji-kuriyama & Kawajiri (2010) 
 
1.4.2 Transformation of AhR  
The AhR is a soluble ligand-activated transcription factor that is held in the 
cytoplasm as an inactive protein in a complex with the chaperones Heat shock 
proteins HSP90, HSP23, and an immunophilin-like protein XAP and p23. HSP90 
binding is essential to retain AhR in the cytoplasm and this interaction is thought to 
mask the nuclear localization signal of AhR. Upon ligand binding, HSP90-bound 
AhR translocates into the nucleus, and this is followed by dissociation of AhR from 
the HSP90 complex, whereupon it heterodimerizes with Arnt, another bHLH-PAS 
protein. This heterodimer subsequently binds to XREs, in the regulatory region of 
target genes (Hankinson, 1995). A number of other coactivators and various 
components have been reported to form the transcription complex on the AhR/ Arnt 
heterodimer, and the interaction and order of the complex formation still needs to be 
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fully elucidated (Fujii-Kuriyama & Kawajiri, 2010).  
 
After ligand binding, phosphorylation of both AhR itself and the HSP90 complex on 
several sites are required for the transformation of AhR to the fully functional 
receptor (Puga et al., 2009). Subsequently, the fully functional AhR can induce the 
expression of many detoxification genes which have XRE in their promoter region.  
These genes (table 1.5)  include cytochromes P450 such as CYP1A1, CYP1A2, 
CYP1B1, and CYP2S1, and other drug-metabolizing enzymes such as UGT1A6, 
NQO1, and ALDH3A1, along with several GST isoenzymes (Puga et al., 2009).   
 
 
Figure 1.12 Activation of AhR 
AhR is kept inactive in cytoplasm by binding to a complex of proteins. Upon ligand binding, it will be 
released from that complex and translocated into nucleus, where it heterodimerizes with Arnt. The 
dimer will subsequently bind to XRE in the promoter region of genes and lead to the gene activation.  
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Table 1.5 Genes encoding for the drug-metabolizing enzyme that are regulated by AhR 
Gene encoding drug-metabolizing enzymes in mouse and rat that are regulated by AhR are 
summarized in the table (Beischlag et al., 2008; Sun et al., 2004). However, the list of such genes is 
still growing.  
 
 
1.4.3 Down regulation of AhR activity 
AhR activity can be down regulated either before or after its activation by different 
mechanisms, including proteasomal degradation of AhR, competitive inhibition of 
AhR by the AhR repressor (AhRR) and binding to its antagonists.  
 
It was found by in vitro experiment that AhR can be rapidly depleted after exposure 
to its ligand. This event most likely occurs after the activation of its target genes and 
can be blocked by the proteasome inhibitor MG-132. Such degradation can occur in 
both cytoplasm and nucleus (Davarinos & Pollenz, 1999; Lees et al., 2003; Pollenz 
& Dougherty, 2005). Besides proteasomes, degradation of AhR by itself can occur 
after the receptor translocates into the nucleus and forms an E3 ubiquitin ligase 
complex with Cullin-4B (CUL4B), damaged-DNA-binding 1 (DDB1), ransducin 
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β-like 3 (TBL3) and ring box protein 1 (Rbx1). This ubiquitin ligase complex can 
then catalyze the ubiquitination of several proteins including estrogen receptor (ER) 
α and β, androgen receptor (AR) and AhR itself (Ohtake et al., 2007).  
 
In addition, a negative feedback exists in AhR signalling implying that AhRR which 
can be transcriptionally induced by activated AhR (Mimura et al., 1999). The 
promoter region of AhRR contains a functional XRE sequence enabling the 
activation of AhRR gene expression upon ligand activation of AhR. As AhRR 
contains a bHLH-PASA region that is structurally similar with AhR, followed by a 
C-terminal transcription repression domain, AhRR also forms a heterodimer with 
Arnt (Mimura et al., 1999). This heterodimer binds competitively to the XRE 
sequence with the AhR/Arnt heterodimer and subsequently recruits co-repressors 
(Oshima et al., 2007). Therefore, the activation of AhRR ultimately leads to the 
inhibition of AhR (Baba et al., 2001; Mimura et al., 1999). 
 
1.4.4 Ligands of AhR 
AhR ligands include exogenous and endogenous compounds and exhibit structural 
diversity, though their binding affinities differ to a great extent. Exogenous ligands 
consist of not only synthetic xenobiotics but also normal dietary components. 
Amongst AhR ligands that have been identified and characterized, exogenous 
synthetic ones which show the highest affinity which include planar, hydrophobic 
HAHs (e.g. polyhalogeneated dibenzo-p-dioxins, dibenzofurans, and biphenyls) and 
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PAHs (such as 3-methylcholanthrene, benzo(a)pyrene, benzanthracenes, and 
benzoflavones). Between HAHs and PAHs, the former is more metabolically stable 
and act as the most potent class of AhR ligands, with binding affinities in the pM to 
nM range, whereas PAHs, the more metabolically labile ones, bind with relatively 
lower affinity in the nM to μM range (Denison & Nagy, 2003).  
 
Dietary chemicals acting as ligands of AhR have been described in numerous studies 
which showed that those chemicals can either activate or inhibit the AhR signalling 
pathway. In 1978, Watternberg and Loub showed that indoles occurring in edible 
cruciferous vegetables can inhibit the formation of neoplasia induced by AhR in mice 
indicating they can inhibit the activity of AhR (Wattenberg & Loub, 1978).  
However, in 1991, another group showed that one of the indoles Indole-3-carbinol 
(I3C) can increases the CYP1A1 activity and act as an AhR agonist (Bjeldanes et al., 
1991). Besides I3C, more dietary plant compounds have been reported to 
competitively bind to the AhR, such as curcumin (Ciolino et al., 1998), quercetin and 
kaempferol (Ciolino et al., 1999). On the other hand, some dietary plant chemicals 
have been identified as inhibitors of AhR, such as resveratrol (Ciolino et al., 1998). It 
is noteworthy that many dietary chemicals themselves have little or no AhR ligand 
activity; however, once they entered the mammalian digestive tract, they may 
undergo conversion and become significantly more potent AhR ligands. Examples of 
such chemicals include I3C which itself is a weak inducer of gene expression, 
whereas, ICZ, an acidic condensation product formed from I3C has very high affinity 
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of AhR (~0.2-3.6 nM) (Denison & Nagy, 2003).  
 
In addition to exogenous ligands, a number of endogenous ligands of AhR also exist. 
Evidence for the presence of endogenous ligands has been found in various studies.  
Firstly, the identification of nuclear AhR complexes in unexposed cells in culture and 
tissue slices indicated the existence of endogenous ligands. Secondly, the fact that 
AhR deficient cells had altered cell cycle progression (Ma & Whitlock, 1996; Wei et 
al., 1996) suggested the effect of endogenous ligands. Thirdly, the AhR knockout 
animals exhibited numerous physiological changes and developmental abnormalities 
suggesting AhR can be activated by endogenous ligands (Lahvis et al., 2000; 
Schmidt et al., 1996). A number of the candidates for endogenous ligands of AhR, 
bearing various structures have been suggested. These include: indigoids, 
2-(1‟H-indole-3‟-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE), equilenin, 
arachidonic acid metabolites, haem metabolites, tryptophan metabolites, and 
ultraviolet photoproducts of tryptophan (Nguyen & Bradfield, 2007).  
 
Taken together, these studies indicate that AhR can bind many different chemicals 
including environmental contaminants, therapeutics, naturally occurring chemicals 
and small molecules isolated from tissues. These chemicals have diverse structures 
and can bind to the AhR with various affinities.   
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1.4.5 Physiological functions of AhR 
Some of the AhR inducers as discussed before are PAHs, PCBs, and dioxins. They 
are environmental pollutants causing acute and chronic toxicity and some of them are 
carcinogens. A number of them induce the expression of genes for 
xenobiotic-metabolizing enzymes such as P450 through the AhR. Besides its 
involvement in metabolism of xenobiotics, AhR plays a crucial role in various 
physiological processes (Henklová et al., 2008). Constitutive AhR levels are 
generally high in liver but AhR is also abundant in diverse mammalian tissues such 
as placenta, thymus, lung, kidney, small intestine, heart and pancreas (Harper et al., 
2006). They have various biological functions ranging from reproduction, 
developmental function, immunity, cell cycle and cell proliferation, cell adhesion and 
migration (Barouki et al., 2007). 
 
Indications that AhR is involved in normal physiological processes came from 
studies showing that AhR can be activated in a xenobiotic-independent way (Allan & 
Sherr, 2005; Chang & Puga, 1998; Richter et al., 2001; Singh et al., 1996). 
Furthermore, AhR-null mice provided a deeper insight into the physiological process 
requiring AhR activity. These animal models not only demonstrated that this receptor 
is essential for dioxin-induced toxicity (Fernandez-Salguero et al., 1996) and 
carcinogenesis (Shimizu et al., 2000), but they also revealed the existence of an 
AhR-deficient phenotype. Different studies showed that genetic deletion of the AhR 
in mouse caused early death or pathological changes by 13 months and was 
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accompanied by a wide variety of phenotypic alteration in major organ systems 
including cardiovascular system, characterized by progressive cardiac hypertrophy, 
gastric hyperplasia that progressed into polyps with age, T cell deficiency in spleens, 
and abnormalities in skin such as hyperkeratosis, and marked dermal fibrosis 
(Fernandez-Salguero et al., 1997; Lund et al., 2006).  
 
Besides its effect on the cardiovascular system, the immune system and skin, 
AhR-null females showed difficulties in maintaining pregnancy and their pups 
showed poor survival during lactation and weaning (Abbott et al., 1999). In addition, 
AhR has a significant impact on the development of liver. The livers of AhR null 
mice are smaller in size and show portal fibrosis and early lipid accumulation 
(Fernandez-Salguero et al., 1995; Schmidt et al., 1996). Comparing liver mRNA 
profiles between wild- type and AhR-null mice showed that the expression patterns 
of 392 genes were changed due to the absence of AhR. The mechanisms that underlie 
these physiological functions of AhR include its effect on the cell cycle which in turn 
can affect the progress of cell proliferation, either inhibiting or promoting it 
depending on the cell phenotype (Barouki et al., 2007) which will be discussed later. 
The AhR is also involved in developmental processes and cell adhesion and 
migration (Barouki et al., 2007).  
 
1.4.6 Involvement of AhR in the progress of tumourigenesis 
As the AhR can both promote and inhibit cell proliferation, there has been some 
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discussion about whether it is a tumour promoter or tumour suppressor.  
 
The AhR cooperates with signalling molecules involved in survival pathways that 
sustain cell proliferation. An example is NF-кB, with which AhR can physically 
interact, leading to its activation in human breast cancer MCF-7 cells. Activation of 
NF-кB causes the transactivation of the c-myc proto-oncongene, thus by this 
mechanism the AhR may contribute to increased proliferation and carcinogenesis in 
the breast (Dong et al., 2000). Another study also showed that AhR can induce cell 
proliferation in human lung carcinoma A549 cells due to the over-expression of the 
receptor. Mice expressing a constitutively active AhR also showed increased 
frequency of the formation of induced hepatocarcinomas by N-ntrosodiethyl 
(Moennikes et al., 2004) and spontaneous tumours in the glandular stomach 
(Andersson et al., 2002). As activation or over-expression of AhR can stimulate cell 
proliferation and even carcinogenesis, the receptor appears to have oncogenic 
activity.  
 
On the other hand, several studies found that activation of AhR can halt the cell cycle 
at different stages and thus inhibit cell proliferation. In non-proliferating 5L-heptoma 
cells, activation of AhR by exogenous ligands can trancriptionally activate the 
tumour suppressor p27
kip1
. Consistent with this observation was that induction of 
p27
kip1
 by dioxin in fatal thymus was accompanied by inhibition of cell proliferation 
(Kolluri et al., 1999). As mentioned earlier, the AhR can stimulate cell proliferation 
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in MCF-7 cells without exogenous ligand. By contrast, in the presence of exogenous 
ligands, AhR can synergize and interact with the pRb tumour suppresser resulting in 
the inhibition of pRb-mediated E2F-dependent transcription and ultimately leading to 
cell cycle arrest (Puga et al., 2000). Another study also showed that cell cycle was 
blocked at G1 by dioxin in MCF-7 and mouse hepatoma Hepa-1 cells. Such blockage 
was due to the interaction between activated AhR and the p300 co-activator, leading 
to displacement of p300 from E2F-dependent promoter and proliferation arrest 
(Marlowe et al., 2004). Cell cycle arrest by constitutively activated AhR has also 
been found in a few other cell lines, transgenic mice, and mouse thymus in organ 
culture through different mechanism (Barouki et al., 2007). Taken together, these 
findings suggest that constitutive or induced activation of AhR by exogenous ligands 
may act like a tumour suppressor by inhibiting cell proliferation.  
 
Therefore, depending on the phenotype of cells and inducers, AhR can either inhibit 
or promote cell proliferation and thus have tumour suppressor or oncogenic activity.  
 
1.4.7 Cross talk between AhR and other signalling pathways 
As discussed earlier, besides mediated dioxin-induced toxicity, AhR also influences 
many physiological functions. The mechanisms that underlie the wide diversity of 
AhR activity is its cross talk with multiple signalling transduction pathways 
including mitogen-activated protein kinases (MAPKs), cell cycle progression and 
apoptosis, and transcriptional factors such as hypoxia induced factor (HIF1) and 
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Nrf2.   
 
The MAPKs, mediating important intracellular transduction, include three families: 
extracellular signal kinases (ERK1/2), c-Jun N-terminal/stress-activated protein 
kinases (JNK/SAPK), and the p38s. MAPKs or their down-stream MAPK-activated 
protein kinases can phosphorylate a large panel of substrates on serine and threonine 
residues, which enable them to regulate gene expression and protein functions (Cobb 
& Goldsmith, 2000).  
 
In general, ERK1 and 2 are involved in regulating mitogenic and developmental 
events and the four p38 kinases isoforms play important roles in the inflammatory 
response, apoptosis and the cell cycle. The three JNK isoforms play important roles 
in cellular signalling, the immune system, stress-induced and developmentally 
programmed apoptosis, carcinogenesis and in the pathogenesis of diabetes (Weston 
& Davis, 2002).  
 
Although TCDD, the well known AhR ligand, activates ERK and JNK, such 
activation occurred equally in both AhR-positive and AhR-negative cells, suggesting 
induction of MAPK by AhR ligand in an AhR-independent manner. However, 
TCDD-stimulated MAPKs appear critical for the induction of AhR-dependent gene 
transcription and CYP1A1 expression (Tan et al., 2002). A recent study has shown 
that, in MCF-7 cells, TCDD and another ligand 3-methylcholanthrene induced 
  49 
morphological changes that modulate epithelial cell plasticity in MCF-7 cells. Such 
dioxin-induced events were mimicked by constitutive expression and activation of 
AhR. In addition, a correlated event was the activation of JNK which is reversible 
using a JNK inhibitor indicating the effects of AhR on cell plasticity is in a JNK 
dependent pathway. Therefore, these novel effects on cell plasticity support a 
mechanistic role for the AhR in cancer progression as mediated by many of its 
ligands (Diry et al., 2006).  
 
Activation of p38 by AhR ligands seems to be a cell-specific consequence. For 
example, p38 can be activated by TCDD in RAW 264.7 murine macrophages in an 
AhR-independent mechanism (Park et al., 2005) but not in mouse embryonic 
fibroblasts. 
 
Another signalling pathway AhR interacts with is the RB-E2F axis which is 
responsible for several cell cycle check points such as G1 and S check points. Direct 
interactions have been found between ligand activated AhR and either the 
hypophosphorylated RB protein or E2F. Interaction between AhR and RB blocks the 
phosphorylation of RB leading to the repression of S-phase specific gene 
transcription. Alternatively, AhR activation can induce CDK inhibitors that arrest the 
cell cycle in G1. In addition, one study using Ahr
+/+
 and Ahr
-/- 
fibroblasts showed that 
the proliferation rate is faster in Ahr
+/+
 fibroblasts compared with that in Ahr
-/- 
fibroblast in a ligand independent manner. Growth-promoting genes were 
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significantly down-regulated in Ahr
-/- 
fibroblast, whereas growth-arresting genes 
were up-regulated. These results suggested that the Ah receptor may play an intrinsic 
role in regulating cell proliferation independent of either exogenous of endogenous 
ligands (Chang et al., 2007). In contrast, AhR-dependent promotion of cell 
proliferation through induction of JUN-D and cyclin A was also observed (Andrysík 
et al., 2007). 
 
Activation of E2F1 can activate apoptosis and there is evidence suggesting that E2F1 
can act as a tumour suppressor due to its ability to initiate apoptosis in cells that lose 
normal cell cycle control (DeGregori & Johnson, 2006). It has been found that AhR 
and E2F1 can physically interact both in vitro and in vivo resulting in the repression 
of the transcriptional activity of E2F, and ultimately the inhibition of apoptosis.  
 
Besides physical interaction, AhR can modulate several genes which contain the 
XRE sequences in their promoter region at the transcriptional level. For instance, the 
promoter region erythoropoietin (Epo), which is transcriptional regulated by HIF1α, 
contains five functional XRE which can be bound by AhR/Arnt complex and 
regulate the gene expression of Epo (Chan et al., 1999). In addition, AhR has been 
shown to be able to bind directly to the promoter region of Nrf2 through the XRE 
sequence (Miao et al., 2005).  
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1.5 Aim of this thesis 
Initially, we carried out screening on a panel of flavonoids using the human 
mammary AREc32 reporter cell line. Quercetin and kaempferol were found the 
potent inducers of ARE-driven gene expression. Subsequently, the mechanisms by 
which these two flavonoids exert their chemopreventive effects, presumably through 
Nrf2/ARE and/or AhR/XRE, was examined. Experiments were therefore carried out 
to: 
1. Identify whether flavonoids can induce cytoprotective genes. 
2. Determine whether flavonoids activate ARE-driven gene expression and whether        
this involves induction of Nrf2 or inactivation of Keap1.  
3. Determine whether flavonoids activate XRE-driven gene expression and whether 
this involves ligand activation of AhR. 
4. Determine whether cross talk occurs between Nrf2 and AhR. 
5. Examine whether flavonoids can confer protection against genotoxic compounds. 
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2  Materials and Methods 
2.1 Chemicals and reagent 
2.1.1 Chemicals 
All chemicals were of the analytic grade, All chemicals were of the highest quality 
grade and readily available commercially. Dimethyl sulfoxide (DMSO), SUL (>98% 
pure), 3-MC, 4‟-6-diamidino-2-phenylindole (DAPI), 2-nitrophenyl 
β-D-galactopyranoside (β-gal), 4-hydroxycinnamic acid (p-Coumaric acid), 
3-aminophytahydroaxide (luminol), cycloheximide (CHX) and digitonin were 
purchased from Sigma-Aldrich Company Ltd (Dorset, UK). NADPH was supplied 
by Melford laboratories Ltd. (Ipswich, UK). All polyphones were obtained from 
Extrasynthese (Genay Cedex, France). (Table 2.1)  
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Table 2.1 Name, formula and molecular weight of different phytochemicals.  
 
2.1.2 Antibodies 
NQO1, AKR1C1 and GST antibodies, raised in rabbit were from the Hayes Lab. 
Rabbit anti-Nrf2 antibody was generously provided by Dr. Michael McMahon. 
Monoclonal CYP1A1 antibody was a gift from Dr. Colin Henderson (BRI, 
University of Dundee). Polyclonal antibody against AhR (M-19 and M-20), protein 
A/G plus-agarose immunoprecipitation reagent (sc-2003), normal goat IgG (sc-2028) 
and mouse monoclonal Anti-actin antibody were purchased from Santa Cruz 
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Biotechnology Inc. (Santa Cruz, CA, USA). Monoclonal antibody against AhR was 
purchased from Abcam PLC. (Cambridge, UK). Alexa-Fluor 488 (FITC, fluorescein 
isothiocyante)-Goat anti-rabbit IgG and Alexa-Fluor 594 (Rhodamine) donkey 
anti-sheep IgG were from Invitrogen Ltd. (Paisley, UK). Horseradish 
peroxidase-conjugated secondary antibodies against the mouse or rabbit IgG were 
purchased from Bio-Rad laboratories. The antibody against 
glyceraldehye-3-phosphate dehydrogenase (GAPDH) was from Amino Bioproducts 
Ltd. (Frellstedt, Germany). Lamin A/C was from Upstate Co. (Dundee, UK).  
 
2.1.3 Enzymes 
Restriction enzymes were obtained from Promega Corp. (Madison, WI, USA), New 
England Biolabs (Ipswich, MA, USA) and F. Hoffmann-La Roche Ltd. (Basel, 
Switzerland). Klenow enzyme, T4 DNA ligase and deoxynucleotide triphosphates 
(dNTPs) were bought from Promega (Southampton, UK). DNA polymerase was 
obtained from Stratagene (La Jolla, CA, USA). Reverse transcriptase was from 
Qiagen (Crawley, UK). 
 
2.1.4 Oligonucleotide primers and DNA plasmids  
All oligonucleotide primers for PCR amplification were synthesized by MWG 
Biotech CO. (Ebersberg, Germany). TaqMan® Gene Expression Assays (Table 2) 
and TaqMan® Master Mix were supplied by Applied Biosystems (Foster City, CA, 
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USA). All DNA plasmids were obtained from Invitrogen or Promega. 
 
2.1.5 Cell line, cell culture media and reagents 
Name, species and tissue origins of each cell line are listed in table 2.2. 
Dulbecco‟s modification of Eagle‟s medium (DMEM), Isocoves modified 
Dulbecco‟s medium (IMDM), Opti-MEM medium, heat-inactivated foetal bovine 
serum (FBS), L-glutamine, penicillin/streptomycin, insulin-transferin-selenium (ITS), 
human epidermal growth factor (EGF) and trypsin, were all purchased from Life 
Technologies Ltd (Paisley, Scotland, UK). 
 
Name Species Tissue origins Cell type 
AREc32 Homo Sapiens 
Mammary 
gland 
Epithelial 
RL-34 Rattus norvegicus Liver Epithelial 
MEF Mus musculus Embryo Fibroblast 
COS1 Cercopithecus aethipos Kidney Epithelial 
HEC116 Homo Sapiens Endometrium Epithelial 
HT29 Homo Sapiens Colon Epithelial 
Caco-2 Homo sapiens Colon Epithelial 
 
Table 2.2 Name, species, tissue origins and cell type of all the cell lines used in this study. 
 
2.1.6 Animals 
7 week old C57BL/6J male mice were purchased from Charles River laboratories 
(Charles River UK Ltd. Manston Road, Margate, Kent, England) 
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2.1.7 Other chemicals and reagents 
Bradford assay reagent, Bio-Rad DC protein assay kit, polyacrylamide and agarose 
gel kits were purchased from Bio-Rad Laboratories (Hemel Hempstead, UK). Protein 
molecular mass standards, DNA size ladders for electrophoresis and 
Lipofectamine
TM
 2000 were purchased from Invitrogen Ltd. (Paisley, UK). 
Immobilon-P membrane was obtained from Millipore (Watford, UK). Steady-Glo
®
 
Luciferase Assay System and Luciferase Reporter Assay System were from Promega. 
BCA Protein Assay Reagent (bicinchoninic acid) was from Thermo Scientific Inc. 
(Rockford, IL, USA). 
 
 
2.2 Molecular Biology Methods 
  
2.2.1 Basic methods for DNA manipulation 
2.2.1.1 Agarose-gel electrophoresis 
DNA was resolved on the basis of size by agarose-gel electrophoresis. Gels 
contained 0.8 – 1.2 % (w/v) agarose with 0.3 µg/ml ethidium bromide in TAE buffer 
(40 mM Tris, 20 mM acetic acid, 2 mM EDTA, pH 8.0). Samples were mixed with 
DNA sample buffer (12% (v/v) glycerol, 60 mM EDTA, 0.6 % (w/v) SDS, 0.003% 
bromophenol blue) and loaded onto gels, alongside size markers (Invitrogen), before 
being subjected to electrophoresis at 70 V for 60 minutes. DNA was visualized on a 
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UV translluminator at 320 nm. 
  
2.2.1.2 Ligation 
Plasmid vector and insert DNA molecules were ligated with the ratio of 1:5 after 
restriction enzyme digestion. 1 U of T4 DNA ligase (Promega) was used in every 10 
µl of the total volume of reaction. The mixture was incubated at 4°C overnight. 
 
2.2.1.3 Transformation 
TOP 10 E.coli strain was used for propagation of all the plasmid DNA. An aliquot 
(90 μl) of Top 10 cells and 1 μl of DNA plasmid were used for each reaction. 
Plasmid DNA was mixed with bacteria and incubated on ice for 30 min. Thereafter 
they were subjected to heat shock at 42°C for 45 sec before being replaced on ice 
for 2 min. Subsequently, 800 μl of LB medium was added to the cell mixture and 
incubated in an orbital shaker incubator (225 rpm) at 37°C for 1 h. Finally, the 
bacteria were plated onto LB agar containing appropriate antibiotics and incubated 
at 37°C for 16 h.  
 
2.2.1.4 Small-scale isolation of plasmid DNA 
A single colony was picked from the LB agar plate from the transformation 
procedure and inoculated into a 3.5 ml LB liquid culture containing the same 
antibiotic and grown for 16 h in an orbital shaker incubator (225 rpm) at 37°C. 
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Plasmid DNA was isolated using QIAprep Spin Miniprep kit (Qiagen) as 
recommended by the manufacturer. 
 
2.2.1.5 Large-scale isolation of plasmid DNA 
A single colony was picked from the LB agar plate from the transformation 
procedure, inoculated into a 3.5 ml LB liquid culture that also contained the 
appropriate antibiotic, and grown in an orbital shaker incubator (225 rpm) for 8 h at 
37°C. A 0.4 ml aliquot of this culture was then added to 200 ml of fresh LB with 
antibiotic and grown for 16 hs at 37°C. Plasmid DNA was isolated using QIAfilter 
Maxiprep Kit (Qiagen) according to manufacturer‟s instructions. 
 
2.2.1.6 Quantification of DNA 
Plasmid DNA was diluted 1:200 in sterile ddH2O and quantified by optical 
diffraction (OD) at 260 nm on an Ultrospec 2100 pro UV/Vis spectrometer 
(Amersham Biosciences). The OD ratio at 260 nm/280 nm gave an indication of 
DNA purity, where a ratio of 1.8-2.1 represented the highly purified DNA. 
  
2.2.1.7 Gel extraction of DNA  
Isolation of PCR products which represented < 10 μg DNA was achieved following 
an initial agarose electrophoresis step, as described in 2.2.1.1. The DNA fragments in 
agarose-gel were visualized by UV 320 nm. Gel slices containing the DNA fragment 
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of interest were cut out and extracted using QIAquick Gel Extraction Kit (Qiagen) 
according to the manufacturer‟s instruction.  
  
2.2.2  Reporter gene constructs  
2.2.2.1 Introduction of point mutations in the promoter region of mouse Nqo1 
The WT -1016/Nqo1-Luc reporter construct, which contains 1016 bp of the upstream 
region of the mouse Nqo1 gene, has been described previously (Nioi et al., 2003). 
Transversion point mutations were introduced to the ARE consensus sequence in 
which -435 5‟-TGAG-3‟ -432 was mutated to -435 5‟-GTCT-3‟ -434 to generate 
AREmut-1016/Nqo1-Luc, or XRE consensus sequence in which -385 5‟-GCGTC-3‟ 
-380 was mutated to -385 5‟-TATGT-3‟-380 to generate XREmut-1016/Nqo1-Luc. To 
generate AREmut -1016/Nqo1-Luc, the pair of primers used are ARE 5‟: 
5‟-CTTTCAGTCTAGAGTCACAGGTCTTCGGCAAAATTTGAGCCC-3‟ and 
ARE 3‟: 5‟- 
GGGCTCAAATTTTGCCGAAGACCTGTGACTCTAGACTGAAAG-3‟. The pair 
of primers used for generating XREmut-1016/Nqo1-Luc, were XRE 5‟ 5‟- CCC 
CACCCTTCCCCTATATGTCAAAGGTGACTTCCCACGGC-3‟ and XRE 3‟ 5‟- 
GCCGTGGGAAGTCACCTTTGACATATAGGGGAAGGGTGGGG-3‟. The 
simultaneous mutation of both ARE and XRE was generated by using 
AREmut-1016/Nqo1-Luc as the template and XRE 3‟ and XRE 5‟ as the primer pair. 
Point mutagenesis was performed using polymerase chain reaction and Hot start Pfu 
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turbo DNA polymerase (Stratagene, Cheshire, UK) to amplify the target sequence. 
Three steps PCR were used to amplify the DNA. Firstly, template DNA was 
denatured at 95°C for 2 min. Secondly, the DNA template was denatured at 95°C for 
1 min, before the primers were annealed at 55°C for 1 min, and then extended at 
68°C for 12 min; these events were repeated for 25 cycles. Lastly, the DNA was 
extended at 68°C for 15 min for 1 cycle. The components of the reaction mixture are 
listed in table 2.3. After confirming the accuracy of the mutagenesis and whole 
sequence by DNA sequencing the PCR fragments were digested  
 
 
Figure 2.1 Generation of construct containing transversion mutations.  
Strategy for generating construct containing transversion mutations of ARE, XRE or both of these element is 
described in material and methods. White letters indicate the original element sequence, while black letters and 
the sequence in italic either above (ARE) or under the box indicated the mutated sequence. The map of 
pGL-3-Basic vector into which the promoter sequence ligated was shown here as well. 
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2.2.2.2 Deletion of the ARE and XRE sequences in the promoter region of 
mouse NQO1 
Deletion mutations were introduced using P-1016/Nqo1-Luc reporter construct as the 
template to remove either the ARE (-435 5‟-TGAGTCGGC-3‟ -427) or the XRE 
(-387 5‟-TAGCGTG-3‟-380) in the 5‟-upstream region of Nqo1 to generate the 
constructs ∆ARE-1016/Nqo1-Luc and ∆XRE-1016/Nqo1-Luc respectively. Deletion 
mutagenesis was performed using the polymerase chain reaction and Hot start pfu 
turbo DNA polymerase (Stratagene, Cheshire, UK) to amplify the target sequence. 
For ∆ARE-1016/Nqo1-Luc, the pair of primer used are 5‟- 
CAGTCTAGAGTCACAGAAAATTTGAGCCCATCC-3‟ (sense) and 5‟- 
GGATGGGCTCAAATTTTCTGTGACTCTAGACTG (antisense). To generate 
∆XRE-1016/Nqo1-Luc, the primer pair used were 
5‟-GCCCCACCCTTCCCCCAAAGGTGACTTCCCACG-3‟ (sense) and 
5‟-CGTGGGAAGTCACCTTTGGGGGAAGGGTGGGGC-3‟ (antisense).    
Deletion of XRE was introduced within ∆ARE-1016/Nqo1-Luc to make a double 
deletion construct ∆ARE/XRE-1016/Nqo1-Luc by using the same primer pair that was 
employed to generate ∆XRE-1016/Nqo1-Luc. Three steps PCR were used to amplify the 
DNA as describe in 2.2.1.1. The component of the reaction mixture is listed in table 
2.3. 
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Table 2.3 Components and their final concentration the of PCR mix for point and deletion 
mutagenesis of the ARE and XRE sequences.  
 
2.2.2.3 XRE luciferase reporter plasmids 
The XRE-luciferase reporter plasmids were generated using the pGL3-promoter 
vector (Promega) containing an SV40 promoter upstream of the firefly luciferase 
gene. Either two or four copies of the XRE (5‟-GTGCG-3‟) present in the mouse 
Nqo1 promoter were inserted into the vector in a head-to-tail orientation, through 
NheI and XhoI restriction sites upstream of the promoter-luc transcriptional region. A 
linker with the sequence of 5‟-CCC-3‟ and 5‟-GGG-3‟ was placed between 
individual XRE enhancers. Plasmids generated were called pGL_2×XRE-Luc or 
pGL_4×XRE-Luc. Primer pairs used for generating pGL_2×XRE-Luc or 
pGL_4×XRE-Luc were XRE2×_For (5‟-CTAGCGCGTGGGGGCGTGC-3‟) and 
XRE2×_Rev (5‟-TCGAGCACGCCCCACGCG-3‟) or XRE4×_For 
(5‟-CTAGCGCGTGGGGGCGTGGGGGCGTGGGGGCGT) and XRE4×_Rev 
(5‟-TCGAGCACGCCCCCACGCCCCCACGCCCCCACGCG-3‟) respectively. All 
primers have a phosphate modification at the 5‟ end and were diluted in ddH2O to 
100 pmol/l. An alquot of 20 μl of each primer of the primer pair was mixed with 5 μl 
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of 10 × annealing buffer (100mM Tris, pH7.5, 1 M NaCl and 10 mM EDTA) in a 
total volume of 50 μl and incubated at 100°C for 5 mins followed by 1 h incubation 
at 20°C. Annealed primers and the pGL3-promoter vector were digested by XhoI and 
NheI restriction enzymes before being ligated .  
   
2.2.2.4 Expression constructs for AhR, Nrf2, Keap1 and Ubiquitin 
Expression constructs for mouse Nrf2-V5, mKeap1 and his-ubiquitin were 
generously provided by Dr. Michael McMahon.  
Expression construct for mouse AhR was generated as stated below.  A cDNA clone 
containing the entire coding region of mouse AhR (100016223) was obtained from 
Geneservice (Cambridge, UK) and was located in the pENTR223.1 vector between 
two Sfi I sites. The plasmid was first purified from bacteria clone using QIAprep 
Spin Miniprep kit (Qiagen, Sussex, UK). The accuracy of the inserted cDNA 
sequence encoding the whole region of Mouse AhR was verified by sequencing 
using M13F primer.  The cDNA encoding mouse AhR was amplified with hot start 
turbo DNA polymerase using the two oligonucleotides 
5‟-CCCAAGCTTGGCACCATGAGCGGCGCCAACATC-3‟ (sense) and 5‟- 
CCGCTCGAGACTCTGCACCTTGCTTAGGAATGC-3‟ (antisense) to introduce a 
5‟ HindIIIand a 3‟ xhoI restriction sites. A two-step PCR amplification was carried 
out: in the first step, the DNA template was denatured at 95°C for 1 min for 1 cycle; 
in the second step, the DNA template was denatured at 94°C for 1 min, annealed to 
primers at 68°C for 30 sec and extended at 68°C for 3 min (this was repeated for 35 
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cycles). The final PCR product was digested using restriction enzymes HindIII and 
XhoI ( Promega) and ligated into digested pcDNA3.1/V5 his A that had been treated 
with the two restriction enzymes.  
   
2.2.3 DNA sequencing 
The fidelity of the cDNA products and all constructs made in this study were 
sequence-verified by the Human Genome Group, Department of Molecular and 
Cellular Pathology, Medical School University of Dundee, Scotland, UK. 
   
2.2.4 Transient transfection experiments 
Transfection experiments were usually conducted in RL-34 cells or MEFs. Typically, 
6 × 10
5
 cells/well were seeded in 6-well plates and allowed to grow overnight to 
reach the confluence of 70%. Cells were then transfected with 2 μg total amount of 
DNA using lipofectamine
TM
 2000 as the transfection reagent and β-gal construct was 
used as an internal control. The ratio of β-gal construct to target construct was 1:15. 
For over-expressing experiment, pcDNA3.1/A was added to the transfection mixture 
to ensure equal amount of total DNA of every sample. The transfection procedure 
was as follows: 2 μg of plasmid DNA was diluted in 100 μl Opti-MEM and 4 μl 
(RL-34 cells) or 6 μl (MEF cells) lipofectamineTM 2000 reagent was diluted in 100 μl 
Opti-MEM. The mixture was incubated for 5 min at RT. Thereafter diluted DNA was 
added to diluted transfection reagent and incubated for 15 min at RT. Meanwhile, 
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cells were washed with PBS twice and media was replaced with 800 μl Opti-MEM. 
After incubation, 200 μl DNA-lipofectamine complex was added to cells in each well 
and left for 6 h before medium was changed back to growth medium. Cells were then 
recovered in growth medium overnight and used for later experiment.  
 
2.2.5 Luciferase reporter gene assays and statistical analysis 
For AREc32 cells, after treatment, luciferase activity was measured using 
Steady-Glo
®
 Luciferase Assay System (Promega) according to the manufacturer‟s 
instructions. For RL-34 and MEF cells, after transfection and treatment, luciferase 
activity was measured using Luciferase Reporter Assay System (Promega). Cells 
were washed once with RT PBS and lysed in 1 × passive lysis buffer. Lysate was 
then centrifuged using a bench top centrifuge 13000 rpm for 1 min to remove cell 
debris. 20 μl supernatant was used for measuring luciferase activity according to the 
manufacturer‟s protocol.  
 
2.2.6 TaqMan quantitative real-time PCR 
   
2.2.6.1 Isolation of RNA from cultured cells 
The cell monolayer was washed twice with ice-cold PBS and scraped into lysis 
buffer RLT supplied with the RNeasy Mini Kit (Qiagen) (350 µl/60mm dish) 
containing 1% (v/v) β-mercaptoethanol. Isolation of RNA was then achieved using 
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the RNeasy Mini Kit, including the on-column DNA digestion step. 
 
2.2.6.2 Isolation of RNA from animal tissues 
Tissues were pulverized to a fine powder using a pestle and mortar under liquid 
nitrogen. Samples (10 – 30 mg) were placed in an Eppendorf microfuge tube, which 
was pre-chilled on dry-ice, and homogenised in 600 µl ice-cold RLT containing 1% 
(v/v) β-mercaptoethanol using an Ultra-Turrax T8 rotor-stator homogeniser 
(IKA-Werke, 60 sec at 90% power). Homogenised samples were centrifuged at 
16,000 g at 4°C for 10 min to remove debris and the supernatants were loaded onto 
RNeasy spin columns for isolation of RNA using the RNeasy Mini Kit (Qiagen), 
including the on-column DNA digestion step. 
 
2.2.6.3 Quantification of RNA 
RNA was diluted 1:200 in sterile ddH2O and quantified by OD260 on an Ultrospec 
2100 pro UV/Vis spectrometer (Amersham Biosciences). As was the case for DNA, 
the OD ratio at 260 nm/280 nm gave an indication of RNA purity, where 1.8 – 2.0 is 
the ideal range. Quality of RNA was assessed by agarose-gel electrophoresis. Two 
clear visible distinct bands corresponding to 28S and 18S rRNA would indicate that 
the RNA was of good quality. 
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2.2.6.4 Reverse transcription of mRNA to cDNA 
RNA was reverse-transcribed to cDNA using the Omniscript Reverse Transcription 
Kit (Qiagen). At this stage, concentration of RNA of each sample was equalized and 
1.5 µg of RNA was used for each reaction; oligo (dT) 15 primer (Promega) was 
diluted in ddH2O to the final concentration of 10 µM. The component for each 
reaction was listed in Table 2.4. The reaction was preceded for 1 h at 37°C, 
whereupon cDNA was diluted in ddH2O to a final concentration of 10 ng/µl. 
 
 
Table 2.4 Components and their volume and final concentration for reverse-transcription 
reaction.   
 
2.2.6.5 Quantitative Real-Time PCR (TaqMan®) 
TaqMan
®
 Gene Expression Assays (table 2.4) was used to quantify mRNA for NQO1, 
Nrf2, AKR1C1, CYP1A, AhR. All the assays were from Applied Biosystems 
including as assay for actin mRNA, employed as an internal control. All the assays 
were labelled with a 5‟ fluorescent reporter dye (6-carboxyfluorescein (6-FAM)) and 
a 3‟ quenching dye (6-carboxytetramethylrhodamine (6-TAMRA)). 
 
Quantitative Real-Time PCR (qRT-PCR) was performed on the Prism Model 7700 
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Sequence Detector (Perkin Elmer/Applied Biosystems). Samples were analyzed in 
triplicate. Each reaction mixture had a final volume of 15 µl and contained 0.75 µl 
TaqMan
®
 Gene Expression Assay, 4.5 µl master mix, and 20 ng of cDNA. 
 
The TaqMan
®
 reaction conditions comprised an initial cycle of 50°C for 2 min then 
95°C for 10 min, followed by 40 cycles of 95°C for 15 sec then 60°C for 1 min. 
Fluorescence at 518 nm was measured, with excitation at 494 nm. Threshold cycle 
(CT) values, where the PCR product became detectable above the background signal, 
were analyzed using Sequence Detector v1.7 software (Perkin Elmer Biosystems). 
Fold-induction values were normalized against a control treatment and were 
calculated relative to that of actin calibrator in Excel (Microsoft) using the 
comparative CT method. 
 
Table 2.5 Assay ID of the gene expression assays.  
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2.3 Cell biology methods 
2.3.1 Cell lines and culture media 
All cell lines were grown at 37°C in 5% CO2 and 90% relative humidity. AREc32 
cells were generously provided by Dr. XiuJun Wang (Biomedical Research Institute, 
Medical school, University of Dundee, Ninewells Hospital, Dundee). These cells 
were derived from the MCF-7 cell line following stable transfection with a luciferase 
reporter construct driven by 8 copies of the ARE found in mouse Gsta1 that was 
ligated into the pGL3-promoter vector (Wang et al., 2006). The AREc32 cells were 
maintained in DMEM (1 mg/ml glucose) supplemented with 10% FBS, 1% (v/v) 
penicillin/streptomycin and 0.8 mg/ml G418. Cells were passaged upon reaching 
~70% confluence. The cell monolayer was washed with PBS and incubated with 
0.25% (w/v) trypsin in PBS for 5 – 10 mins. Cells were resuspended in growth 
medium and pelleted by centrifugation, resuspended in growth media and split 1:4 or 
1:3. 
Rat Liver RL-34 cells, Monkey kidney COS1 cells, human endometrial 
adenocarcinoma HEC-116 cells, human epithelial colorectal adenocarcinoma cells 
and human colon adenocarcinoma HT29 cells lines were maintained in DMEM (4.5 
mg/ml glucose) supplemented with 10% FBS and 1% (V/V) penicillin/streptomycin. 
Murine hepatoma hepa-1c1c7 cells were maintained in MEM alpha medium without 
nucleoside supplemented with 10% FBS and 1% (v/v) penicillin/streptomycin. The 
cell monolayer was washed with PBS and incubated with 0.25% (w/v) trypsin in 
PBS for 5 – 10 min. Cells were resuspended in growth medium and pelleted by 
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centrifugation, resuspended in growth media and split 1:6 to 1:3. 
 
MEF cells were maintained in IMDM (17.7g powdered IMDM (Invitrogen), 40.4 ml 
7.5% NaHCO3, made up to 1 L in sterile dH2O) supplemented with 10% and 0.001% 
(w/v) EGF (Invitrogen) and 5% (v/v) 100 × ITS (Gibco). MEF cells were maintained 
in flask or dishes coated with 0.1% gelatine (Sigma).  Cells were passaged every 
two or three days. The cell monolayer was washed with PBS and incubated with 
0.05% (w/v) trypsin with 0.2 mM EDTA in PBS for 5 min RT. Cells were 
resuspended in growth medium, pelleted by centrifugation (1500 rpm, 3 min), 
resuspended in growth media and split 1:2. 
 
2.3.2 Treatment of cells with chemicals 
1000 × stock solutions of all compounds were prepared in dimethyl sulphoxide 
(DMSO). For treatment, stocks were diluted 1:1000 into complete media, giving a 
final concentration of DMSO vehicle in the media of 0.1% (v/v). 
 
Once AREc32 cells reached to the confluence of 70%, growth medium was replaced 
with growth medium without serum containing appropriate chemicals and left for 24 
hours. 
For RL34, HT-29, HCT116, Caco2 and MEF cells, growth medium was replaced 
with fresh growth medium with appropriate chemicals. For luciferase assay, cells 
were treated for 24 hours. For Western blot analysis of NQO1 and AKR1C1, cells 
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were treated with chemicals for 24 hours while for the analysis of Nrf2, 2 hours 
treatment was carried out. For Taq-man experiment, cells were treated for 12 hours.  
  
2.3.3 Immunocytochemistry 
RL-34 cells were grown as a monolayer on coverslips that were placed in 60mm dish 
and allowed to reach 40% confluence. Medium was then replaced with growth 
medium containing appropriate chemicals for either 30 min or an hour. After 
chemical treatment, cells were firstly washed with cold 1× PBS (0.01 M phosphate 
buffer (pH6.8), 0.14 M NaCl) twice and then fixed with 1 ml of 4% (w/v) 
paraformaldehyde for 3 min. After the incubation, cells were washed three times in 1 
× PBS each for 5 minutes and subsequently permeabilized with 1 ml of 0.2% Triton 
X-100 for 20 min at RT. Cells were then washed 3 times as described before and 
incubated with 1 ml of blocking buffer (3% BSA in 1 × PBS) for 1 hour at 4°C. In 
succession, the blocking buffer was replaced with primary antibody (1:200 dilution 
for Nrf2 antibody and 1:50 dilution for AhR antibody), and left to react for overnight 
at 4°C. The coverslips were then washed as before and subsequently incubated with 
1 ml blocking buffer containing the fluorescent –labelled secondary antibody. 
Alexa-Fluor 48 (FITC, fluorescein isothiocyante)-Goat anti-rabbit IgG (Invitrogen) 
was used as the secondary antibody for Nrf2.  Alexa-Fluor 594 (Rhodamine) 
donkey anti-sheep IgG was used as the secondary antibody for AhR. 
 
The cellular DNA was stained by incubating the slides in a solution of 
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4‟-6-diamidino-2-phenylindole (DAPI, 10 μg/ml) for 10 min at RT. The coverslips 
were washed 3 times as before and mounted on a glass slide using 10% (w/v) 
Mowiol medium and were allowed to dry at 4°C. The cell-loaded slides were 
examined under a confocal microscope.  
 
2.3.4 Confocal microscopy 
The cells were labelled with appropriate primary and secondary antibodies for 
immunocytochemistry. FITC (excitation/emission = 495/519 nm) or Rhodamin 
(excitation/emission = 594/610 nm)-labelled secondary antibody was used to locate 
the endogenous proteins. Confocal images were obtained using a LSM 510 laser 
scanning microscope system (Carl Zeiss, Germany). The DAPI image represents 
nuclear DNA staining, DIC indicated images from normal light microscopy, and the 
merge signal represents the results obtained when the three images were 
superimposed.  
 
2.3.5 Subcellular fractionation 
2.3.5.1 RL-34 cells 
RL-34 cells were seeded in two 100 mm dishes for each subcellular fraction sample 
to reach the confluence of 100%. Afterwards, cells were treated with appropriate 
chemicals for 2 h and preceded for subcellular fractionation. The procedure is 
described below.  
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Cells were washed once with ice cold PBS, scraped in serum free DMEM and 
centrifuged at 600 × g, 4°C for 5 min. Medium was then removed and the cell pellet 
was homogenized in 4 pellet-volumes of 1× Isotonic buffer (10 mM Hepes, pH7.8, 
containing 250 mM, 1 mM EGTA, 1mM EDTA and 25 mM KCL) supplemented 
with 1% (w/v) complete protease inhibitor cocktail (Roche Applied Science). The 
resuspended cells were gently homogenized by repetitively passing the mixture 
through a 23-gauge needle with 20 strokes. Afterwards, the homogenate was 
centrifuged at 1300 × g at 4°C for 15 min both pellet and supernatant were kept. The 
cell pellet was resuspended in 500 μl STM buffer (250 mM sucrose, 50 mM Tris-Cl 
(pH 7.5), 5 mM MgCl2 and 10 mM iodoactamide) by gently pippeting and layer onto 
200μl of a sucrose cushion (40% (w/v) sucrose, 10 mM HEPES (pH7.5), 10 mM 
KCL, 1.5 mM MgCl2 and 1 mM dithiothreitol). Resuspended cells were 
subsequently spanned at 1000 × g and 4°C for 15 min and the pellet acquired was the 
purified nuclei (N) which was subjected to be lysed in 100 μl RIPA buffer 
supplemented with 1% (w/v) complete protease inhibitor cocktail. Meanwhile, 
supernatant obtained from the 1300 × g centrifugation was centrifuged again at 
17000 × g 4°C for 30 min to remove cell debris. The supernatant was then centrifuge 
at 100, 000 × g 4°C for 1 hour and the pellet is kept as membrane fraction (M) which 
was homogenized in 100 μl RIPA buffer while the protein in the supernatant fraction 
was and kept as the cytosolic fraction (C) and concentrated by acetone precipitation, 
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2.3.5.2 MEF cells  
The procedure of cell fractionation for MEF cells is similar with that for RL-34 cells 
with some modification and the steps are shown below. In addition, only purified 
nuclei and 3000 × g fraction containing membrane and cytosol are separated.  
 
Cells was washed once with ice-cold PBS, scraped in serum free IMDM and 
centrifuged at 1500 × g, 4°C for 5 min. Medium was then removed and cell pellet 
was resuspended in 4 pellet-volumes of 1× hypotonic buffer (10 mM Hepes, pH7.8, 
containing 250 mM, 1 mM EGTA, 1mM EDTA and 25 mM KCL) supplemented 
with 1% (w/v) complete protease inhibitor cocktail (Roche Applied Science). 
Resuspended cells were kept on ice for 30 min and subsequently gently homogenized 
by repetitively passing the mixture through a 25-gauge needle with 25 strokes. The 
homogenate was then centrifuged at 3000 × g at 4°C for 10 min; the supernatant is 
kept as fraction (S) which contains cytosol and membranes. Protein from the 
supernatant was concentrated by acetone precipitation as described previously. 
Meanwhile, the cell pellet was resuspended in 500 μl STM buffer by gently pippeting 
and layer onto 200μl of a sucrose cushion and subsequently spanned at 3000 × g and 
4°C for 10 min. The pellet was the purified nuclei (N) and was lysed in 100 μl RIPA 
buffer supplemented with 1% (w/v) complete protease inhibitor cocktail.  
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2.4 Biochemical methods 
  
2.4.1 Cytotoxicity assay  
The cytotoxicity of phytochemicals to cells was examined by  the 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, as 
modified by (Hansen et al., 1989). This technique exploits the formation of a 
water-insoluble purple formazan product generated from water-soluble yellow MTT 
by functional mitochondria as a means of spectrophotometrically measuring viability 
following dissolution of the cell monolayer in organic solvent. RL-34 or Hepa1c1c7 
cells were seeded in 96-well plates at the density of 8 × 10
3
 cells per well in 100 μl 
growth medium, giving ~80% confluence after 24 h incubation. Media was then 
removed carefully by gentle inversion and replaced with 100 μl of treatment media 
containing different concentration of the phytochemical of interest in growth media. 
After 20 h incubation at 37°C, 25 μl MTT (5 mg/ml in sterile PBS) was added to 
each well, giving final concentration of MTT of 1 mg/ml before the mixture was 
incubated at 37°C for 90 min. A volume of 100 μl lysing buffer (Dissolve 20% (w/v) 
SDS into 50% (v/v) N, N-dimethylformamide DMF in ddH2O and adjust pH to 4.7) 
was added to each well subsequently and incubated at 37°C for 60-90 min to allow 
all the formazon dissolve completely. Plates were then read at 570 nm on a 
Benchmark microplate reader (Bio-Rad) and lysing buffer was used as blank. Data 
were analyzed using Excel software, wherein absorbance was converted to arbitrary 
units of survival.  
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2.4.2 Measurement of NQO1 enzyme activity assay 
 RL-34, MEF Nrf2
+/+
 and MEF Nrf2
-/-
 cells were seeded in 96-well plates with a 
starting density of 1.7×10
4 
 or 2×10
4 
cells per well for RL-34 or MEF cells 
respectively. Thereafter, the cells were incubated for ~24 hs to reach the confluence 
of ~80%. The cell culture media was removed by inverting the plates and was 
replaced with growth media containing appropriate chemicals before being left for 
another 24 h at 37°C, 5% CO2. The media was then removed and the plates were 
washed with PBS twice, after which the cells were lysed in 75 μl/well digitonin (a 
suspension of 0.8 g/L digitonin in PBS containing 2 mM EDTA, pH7.8) at RT for 30 
min. During the last 10 min of lysis, the plates were transferred to the orbital shaker 
at 150 rpm. By the completion of lysis, 20 μl of the cell lysates were transferred to a 
fresh 96-well plate and protein concentration was measured by BCA assay. The 
remaining cell lysates were used for NQO1 enzyme activity assay according to 
“Prochaska” microtiter plate bioassay (Fahey et al., 2004). The procedure of this 
assay is described as follows. A volume of 200 μl MTT buffer (0.025 M Tris-Cl, pH 
7.4, 0.5% BSA (w/v), 0.01% Tween 20, 5 μM FAD, 1mM G-6-P, 30 μM NADP, 20 
U/ml G-6-P-D, 0.3 mg/ml MTT and 4.3 μg/ml Menadione (dissolve menadione in 
AcN at 4.3 mg/ml)) was added to each well and plates were then incubated at RT for 
5 min followed by addition 50 μl dicumarol (5 % DMSO, 5 mM KPO4 and 0.3 mM 
dicumarol). The plate was then immediately read at absorbance of 610 nm using 
SpectraMax (Molecular devices, 1311 Orleans Drive, Sunnywale, CA 94089-1136, 
USA). A every 30 sec Kinetic reading lasting for 5 min was performed at first and 5 
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min endpoint reading was chosen and carried out for the analysis. Absorbance 
obtained was normalized by protein concentrations and the change of NQO1 activity 
was calculated.   
 
2.4.3 Determination of protein concentration 
2.4.3.1 Determination of protein concentration by Bradford assay 
Protein concentration was determined according to the method of Bradford assay 
(Bradford, 1976). Samples were compared to a standard curve of bovine serum 
albumin (BSA) dissolved in water at concentration of 0, 0.0625, 0.125, 0.25 and 0.5 
mg/ml. Bradford reagent (Bio-Rad) was diluted 1:5 with dd H2O. Samples and 
Bradford reagent were then loaded to RX DAYTONA machine (Randox Laboratories 
Ltd., 55 Diamond Road, Crumlin, Co. Antrim, UK) which measured the absorbance 
at 595 nm for calculation of protein concentration within samples.  
 
2.4.3.2 Determination of protein concentration by Bio-Rad DC protein assay 
For each assay, mix 2μl reagent S with 100 μl reagent A which formed the solution 
A‟. Add 4 μl of lysate or standard which is the same as describe in section 2.4.3.3 
into each plastic cuvette. Subsequently add 100 μl of A‟ followed by 800 μl of 
reagent B and incubate at RT for 15 min. Absorbance was read at OD750nm by an 
Ultrospec 2100 pro UV/Vis spectrometer. Protein concentration was calculated 
according to the standard curve.  
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2.4.4 Western blotting 
2.4.4.1 Preparation of protein samples from cells 
Cells were seeded in 60 mm dishes and treated with xenobiotic as described in 2.3.2. 
At the end of each experiment, the cells were washed twice in ice-cold PBS and 
scraped into 400 μl ice-cold Radio-immune Precipitation Buffer (RIPA) (50 mM 
Tris-HCl, pH7.4, 150 mM NaCl, 1% (v/v) NP40, 0.5% (w/v) deoxycholic acid, 0.1% 
(w/v) SDS), supplemented with complete EDTA-free protease inhibitor cocktail (1 
tablet/10 ml). The cell lysates were incubated on ice for 15 min followed by 
centrifugation at 13,000 rpm at 4°C for 20 min to remove insoluble cell debris. The 
protein concentration of the supernatant was measured by Bradford assay. 1:10-1:20 
dilution was made to supernatant for protein concentration analysis.  
 
2.4.4.2 Protein preparation from animal tissues 
10-30 mg tissue powders prepared in section 2.2.6.2was measured out and put into 
an Eppendorf microfuge tube pre-chilled on dry ice. Add 1 ml 1 × SDS buffer (0.125 
M Tris-HCl (pH 6.8), 2% SDS, 10% glycerol) to every 10 mg of sample. Samples 
were homogenized on ice for 1 min using an Ultra-Turrax T8 rotor stator 
homogenizer (IKA-Werke, 90% power).  Homogenized samples were incubated at 
70°C with shaking at 1400 Hertz for 10 min. Any undissolved tissue residual was 
sedimented by centrifugation at 16,000 g at RT for 10 min to remove insoluble debris. 
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Protein concentration of the supernatant was analyzed by Bio-Rad DC protein assay. 
After protein concentration analysis, 0.001% bromophenol blue was added to the 
sample. 
 
2.4.4.3 Polyacrylamide gel electrophoresis (PAGE) 
Protein samples were resolved using the discontinuous electrophoresis method of 
Laemmli (Laemmli, 1970). Cell lysates were adjusted to final concentration of 1 
mg/ml in SDS-PAGE sample buffer (5× solution: 67mM Tris-HCl, pH 6.8, 2.2% 
(w/v) SDS,27% (v/v) glycerol, 0.72M β-mercaptoethanol , 0.1% (w/v) bromophenol 
blue ) and denatured by heating for 4 min at 95°C.  
 
Polyacrylamide gels (0.75 cm thick) were cast in the Mini-Protein II cell (Bio-Rad). 
Separating gel (8-12% (w/v) acrylamide, 375 mM Tris-HCl, pH 8.8, 0.1% (w/v) SDS, 
0.04% (w/v) TEMED and 0.1% (w/v) ammonium persulphate) were poured and 
overlaid with ethanol until polymerisation was complete (10 min). Ethanol was then 
removed and stacking gel (4% (w/v) acrylamide, 125 mM Tris-HCl, pH 6.8, 0.1% 
(w/v) SDS, 0.1% (w/v) TEMED, 0.1% (w/v) ammonium sulphate) pored directly on 
top of the separating gel. Gel combs were inserted into stacking gel to create sample 
wells, and polymerisation was allowed to proceed (15-30 min). Samples were loaded 
into wells for electrophoresis in running buffer (25 mM Tris, 200 mM glycine, 0.1% 
(w/v) SDS) at 200V for 45-60 minutes to achieve good separations of protein.  
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2.4.4.4 Transfer of proteins to Immobilon-PTM membrane 
Proteins from SDS-PAGE acrylamide gels was transferred to Immobilon-P™ 
membrane (Millipore) using the Mini Transblot System (Bio-Rad) and carried out in 
transfer buffer (25 mM Tris, 200 mM glycine, 20% (v/v) methanol), which was kept 
cool by an icepack, at 100V for 1 h. For protein with large molecular mass (i.e. 
ubiquitinated Nrf2 protein), 0.1% SDS (w/v) was included in the transfer buffer. 
 
2.4.4.5 Immunoblotting with primary and secondary antibodies 
All incubations were performed in petri-dish placed on an orbital shaker at 60 rpm. 
Immobilon-PTM membranes were blocked in TBS-T (50 mM Tris-HCl, 150 mM 
NaCl, 0.1% (v/v) Tween-20
®
) with 10% (w/v) powdered fat-free milk (Marvel) 
overnight at 4°C. Primary antibody, appropriately diluted in 10% TBS-T/milk was 
then added, again for incubation either overnight at 4°C or for 1 h at room 
temperature. The membrane was then washed first in 0.25% TBS-T once for 5 min 
and then in 0.1% TBS-T 3 x 5 min at RT before addition of the appropriate 
horseradish peroxidise (HRP)-conjugated secondary antibody in TBST/milk for 
incubation for 1 h at room temperature, followed by a second series of washes as 
described before.  
 
2.4.4.6 Visualization of antibody complex by enhanced chemiluminescence  
Antibody-protein complexes on Immobilon-P™ membranes were visualized by 
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enhanced chemiluminescence (ECL) and autoradiography. Following the final series 
of washes, membranes were incubated for 30 s in equal volumes of ECL solution 1 
(100 mM Tris, pH 8.5, 2.5 mM luminol, 0.4 mM p-coumaric acid) and ECL solution 
2 (100 mM Tris, pH 8.5, 0.02% (w/v) H2O2), then directly exposed to 
autoradiographic film (Super RX, Fuji). Quantitation of the chemiluminescent signal 
intensity required use of a commercial ECL solution (Immobilon Western 
Chemiluminescent HRP Substrate (Millipore)), followed by signal detection in an 
LAS-3000 mini Imager (Fujifilm). Data were analyzed using Quantity One Software 
(Bio-Rad). Intensity of the band for target protein was normalized to that of actin or 
GAPDH.  
 
2.4.4.7 Re-probing western blots 
Some antibody-blotted membranes were washed for 30 min in 0.1% TBS-T followed 
by incubation with a stripping buffer (7 M guanidine hydrochloride, 50 mM glycine, 
0.05 mM EDTA, 0.1 M KCl and 20 mM 2-mercaptoethanol at pH 10.8) for 8-10 min. 
Membranes were then washed under running tap water and 0.1% TBS-T for 20 min 
at RT. The membranes were then re-probed with additional primary antibody. The 
subsequent steps of the immunoblotting procedure were carried out as described 
before.  
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2.4.5 Protein precipitation by acetone 
In order to concentrate proteins in cell lysates, 5 × volume of acetone was added to 
the sample. The mixture was kept on ice for 5-15 min before being spun at 3000 × g 
for 5 min. The supernatant was removed and the pellet was dissolved in an 
appropriate volume of RIPA buffer by sonication (2 × 10 sec pulse at 8 W). 
 
2.4.6 Determination of the half life of Nrf2 protein 
RL-34 cells were treated with quercetin, kaempferol or DMSO for 2 hours prior to 
treatment with cycloheximide (final concentration 1μmol/l) for between 0 and 60 
min. Whole cell lysates were prepared and the amount of Nrf2 protein was examined 
by Western blotting. Densitometry analysis was then carried out using Quantity One 
Software (Bio-Rad) to calculate band intensities. The relative amount of Nrf2 was 
plotted on a semi-log plot with the amount of Nrf2 protein obtained before the 
addition of CHX being set at 1.0.  
 
2.4.7 Protein co-immunoprecipitation experiment 
RL-34 cells were seeded in 100 mm dish and left for ~ 24 hours to reach 100% 
confluence before they were treated with appropriate phytochemicals at various time 
points prior to being harvested at the same time. Cells were then washed twice with 
ice-cold PBS and scraped in 400 μl lysis buffer (50 mM Tris, pH 8.0, 2 mM EDTA, 
pH 8.0, 1 mM NaVO4, 50 mM NaF, 2.5% glycerolphosphate (v/v), 10% Triton 
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X-100 and 0.1 mM PMSF). Once in lysis buffer, cells were incubated on ice for 20 
min, after which, the lysates were centrifuged at 14,000 rpm at 4°C for 20 min. 
Protein concentration was measured using the supernatant. An aliquot of 40 μl of the 
supernatant was added into another eppendorf containing 40 μl H2O and 20 μl 5 × 
reducing Laemmli sample buffer followed by incubating at 95°C for 4 min and this 
was the input. For the rest of the supernatant, 1 mg of protein from each sample was 
mixed with 2 μg immunoprecipitation antibody and was left tumbling en-over-end at 
4°C overnight. After the overnight incubation, the mixture was added to 50 μl of 
protein agrose A/G and left for tumbling for 2h before being washed three times, 5 
minutes each. Finally in lysis buffer 50 μl 2 × reducing Laemmli buffer and boil the 
sample as before.  
 
2.4.8 In-vitro ubiquitin assay 
COS-1 cells were seeded in 60 mm dishes at 1 × 10
6
 cells/dish and left to recover for 
20-24 hours. Cells were then transfected as described before with appropriate 
combinations of plasmids including pcDNA3.1/V5mNrf2, mKeap1 and pHis-Ub. 
The empty pcDNA3.1 plasmid was used to equalize the total amount of DNA 
transfected to cells in each dish. On the third day, cells were treated with various 
phytochemicals for 2 h followed by ubiquitination assay. The procedure of the assay 
is stated as below.  
 
  84 
After removal of medium cells were washed with one volume of ice-cold PBS and 
scraped into 0.4 ml of ice-cold PBS. An aliquot of the suspension (80 l) was 
transferred to a separate eppendorf and the subjected for centrifugation at 500 x g, 
4
0
C for 1 to pellet the cells. The cell pellet was subsequently lysed in 200 l of 2x 
reducing Laemmli sample buffer and sonicated (2 x 10 sec pulses at 8 W) to reduce 
viscosity. Samples were then incubated at 95
0
C for 4 min and this represented the 
input sample. For the remainder of the suspension, cells were pelleted as described 
before and lysed  in 1 ml of Buffer A (6 M Guanidine:Hcl, 10 mM Tris in phosphate 
buffer pH 8.0) supplemented with 5 mM imidazole, 50 mM iodoacetamide and 0.1 % 
(v/v) Triton X-100. After vigorous vortexing, the sample was sonicated as described 
earlier, before being added to 60 l of bead-suspension which had been washed twice 
with 200 l volumes of Buffer A. Thereafter, the mixture was incubated overnight at 
RT with end-over-end tumbling before the resin was pelleted (5000g, 1 min, RT). 
Supernatant was removed and the resin was washed with 0.8 ml of Buffer A 
supplemented with 0.1 % (v/v) Triton X-100, incubating at RT for 5 min with 
end-over-end rotation. Afterwards, three washing steps were carried out sequentially: 
i) 0.85 ml Buffer B (8 M Urea, 10 mM Tris in phosphate buffer pH 8.0) 
supplemented with 0.1 % (v/v) Triton X-100; ii) 0.9 ml Buffer C (8 M Urea, 10 mM 
Tris in phosphate buffer pH 6.5) supplemented with 0.2 % (v/v) Triton X-100 ; and 
iii) 0.95 ml Buffer C supplemented with 0.1 % (v/v) Triton X-100. After the 
completion of washing, to elute the material that remains bound to the resin, 50 l of 
elution buffer was added to the final pellet of resin before being gently vortexed. The 
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mixture was left standing at RT for 20 min prior to incubation at 95
0
C for 4 min. 
Resin was pelleted (16000g, 1 min, RT) and the supernatant was transferred to a new 
eppendorf. This represents the IP and can be stored at -20
0
C for later analysis. 
 
2.4.9 β-Gal activity Assay  
During this thesis, the pcDNA3.1/V5His/LacZ expression plasmid containing the 
β-galactosidase (β-gal) gene was cotransfected, together with a reporter and/or 
expression constructs, into cells in order to control for transfection efficiency. To 
assay for β-gal activity, the cells were disrupted in a lysis buffer, centrifuged at 11, 
000 × g and 4°C for 10 min, before the supernatants were assayed directly for β-gal 
activity using. A substrate mixture was prepared as follows: for every 1.32 ml β-gal 
solution (4mg/ml 0.1 M sodium phosphate buffer pH7.5) add 4.02 ml 0.1 M sodium 
phosphate buffer (0.082 M Na2HPO4 and 0.018 M NaH2PO4) and 60ul 100 × Mg 
solution (0.1 M MgCl2 and 4.2 M β-mercaptoethanol). 
 
2.4.10 Glutathione assay  
Intracellular glutathione (GSH) levels were measured according to the method of 
Tietze{Tietze, 1969 #387}. RL-34 cells were grown in 60 mm dished at the density 
of 1 × 10
6
 cells per dish and trypsinised. Ice-cold complete medium was added to 
inhibit the enzyme, and the single-cell suspension was centrifuged at 400 g for 2 min 
at 4°C. The cell pellet was resuspended in ice-cold PBS and again collected by 
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centrifugation at 400 g for 2 min at 4°C. Cells were resuspended in 200 µl of lysis 
buffer (50 mM Tris, pH 7.8, 150 mM NaCl, 1% NP40) and fractured by 3 
freeze/thaw cycles in liquid nitrogen. Cell debris was removed by centrifugation at 
16,000 g for 3 min at 4°C. Aliquot the soluble fraction and mix in an equal volume 
10% (v/v) ice-cold sulphosalicylic acid (SSA) and incubated on ice for 20 min. The 
precipitated protein was removed by centrifugation at 16,000 g for 3 min at 4°C. 
Supernatant was kept for later analysis. 
 
A GSH standard curve was prepared in 10% (v/v) SSA with concentrations of 6, 12, 
24, 48, 60, 80 and 120 µM. Sample analysis was carried out in triplicate in a 96-well 
plate, with 10 µl of sample or standard added to each well, followed by 150 µl of 
assay mixture (1 mM DTNB, 0.34 mM NADPH in 150 mM NaPO4 buffer, pH 7.5, 
containing 7.5 mM EDTA), and finally GSH reductase solution (10 µl of 10 U/ml in 
150 mM NaPO4 buffer pH 7.5 containing 7.5 mM EDTA). Absorbance of the 
reaction at 415 nm was measured every 15 sec for 5 min in SpectraMax (Molecular 
devices). GSH concentrations were derived from the standard curve. Protein 
concentrations were measured by BCA assay and GSH concentration expressed as 
nmol GSH/mg protein. 
 
2.5 Animal Husbandry 
Health of animals was monitored daily. Mice were kept in the animal unit for four 
weeks to allow them adapt to the environment. By the time the mice were 11 weeks 
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old, they were treated with phytochemicals as appropriate by gavage once a day for 4 
consecutive days. Phytochemicals were dissolved in PBS as a suspension at the 
concentration of 50 mg/ml or 400 mg/ml. A suspension of 200 μl/kg appropriate 
suspension was given to mouse by gavage resulting in the final concentration being 
10/80 mg of chemicals per 1 kg of animal weight. Blood and urine were collected 
every second day 2 hs after the treatment. On the fifth day, 24 h after the last 
treatment, mice were culled and tissues were excised and immediately washed in 
PBS and finally transferred to universals for snap freezing in liquid nitrogen and 
stored at -80°C. 
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3 Induction of NQO1 by polyphones in an Nrf2-ARE 
dependent pathway 
 
3.1 Introduction 
3.1.1 Dietary flavonoids present in the diet as aglycone or glycosides  
As a subclass of polyphones, flavonoids and their polymers constitute a large class of 
food constituents that accounts for approximately two thirds of the polyphones in our 
diet. More than 4000 flavonoids have been identified. They all share a common 
structure, consisting of two aromatic rings (A and B rings) linked by 3 carbon atoms 
that are usually contained within an oxygenated heterocyclic ring (the C ring). The 
generic structure of a typical flavonoid is shown in Figure 3.1. The structural 
requirements for the antioxidant and free radical scavenging functions of flavonoids 
include a hydroxyl group at carbon position 3, a double bond between carbon 
position 2 and 3, a carbonyl group at carbon position 4 and polyhydroxylation of the 
A an B aromatic ring. Most flavonoids are present in nature as glycosides and other 
conjugates. The most ubiquitous flavonoids in fruit and vegetables are flavonols, and 
the two most representative chemicals are quercetin and kaempferol. Flavonols are 
usually present in glycosylated forms and the sugar moieties associated with them 
are often glucose or rhamnose, though other sugars may also be involved such as 
galactose arabinose, xylose or gucuronic acid. Flavones are much less common than 
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flavonols in fruit and vegetables and consist of chiefly glycosides of luteolin and 
apigenin. The group of flavonoids present in high concentration in citrus fruit is the 
flavanones, the main aglycones of which are narigenin, hespertin and eriodictyol. 
They are generally glycosylated by a disaccharide, at carbon atom position 7, with 
either a neohesperidose or a rutinose. In contrast with other flavonoids, flavanols are 
not glycosylated in foods. They exist as both a monomer form (catechins) and a 
polymer form (proanthocyanidins). Catechins are especially rich in tea, while 
procyanidins are present in a wide range of fruit and vegetables. Antocyanins exist in 
different chemical forms and are highly unstable in the aglycone form. While they 
exist in plants, their degradation is prevented by glycosylation and esterification 
(Manach et al., 2004).  
 
 
Figure 3.1 General structure and numbering nomenclature of flavonoids 
 
3.1.2 Quercetin and kaempferol 
The flavonols quercetin and kaempferol, the structures of which are shown in figure 
3.2, are enriched in onions and apples (Miean & Mohamed, 2001). They exist as a 
variety of glycosides or in an aglycone form. Studies have shown that both the 
glycosides and the aglycone form are absorbed by the human gut though at different 
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efficiencies (Hollman & Katan, 1997). The aglycone forms of quercetin and 
kaempferol are similar in structure, differing only by one hydroxyl group in the 
B-ring. However, this one difference appears to account for the much higher free 
radical-scavenging activity of quercetin than kaempferol (Yamamoto et al., 1999). 
The cancer preventive activity of quercetin has been extensively studied. In animal 
models, it has chemopreventive activity against tumourigenesis induced by PAHs 
(Mukhtar et al., 1988). In cell culture models, quercetin exerts multiple biochemical 
effects that are relevant to carcinogenesis, including metal chelation, antioxidant 
properties, inhibition of hepatic enzymes, and the induction of drug-metabolizing 
enzymes. Induction of NQO1 by quercetin has been found in MCF-7 (Valerio et al., 
2001) and HepG2 cells (Tanigawa et al., 2007). Epidemiological studies have shown 
that there is an inverse association between the intake of quercetin and lung cancer 
(Stefani et al., 1999). Limited evidence has also been provided by Nöthlings that 
quercetin, as well as kaempferol, exerts a preventive effect on the development of 
pancreatic cancer in current smokers, but not in former and never smokers (Nothlings 
et al., 2008). Another study showed that intake of kaempferol but not quercetin had 
an inverse association with the risk of ovarian cancer (Gates et al., 2007). Taken 
together, it appears that quercetin and kaempferol can inhibit the initiation of cancers 
in various tissues.  
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Figure 3.2 Structure of quercetin and kaempferol  
 
3.1.3 Characterization of the AREc32 cells 
A stable ARE-driven reporter gene cell line has been generated by Wang et al. (2006) 
that was derived from human breast carcinoma MCF7 cells. The reporter construct 
employed contained eight copies of the cis-element common to the rat GSTA2 and 
mouse Gsta1 gene promoters which had been ligated into the pGL3 promoter vector. 
Luciferase activity in AREc32 cell can be increased significantly by monofunctinal 
and bifunctional inducing agents including sulforaphane, t-BHQ, and 
β-naphthoflavone. Furthermore, the expression of ARE-driven luciferase activity in 
AREc32 cells is mediated by Nrf2. In the reporter cells, endogenous mRNAs for 
NQO1, GCLC, GCLM and AKR1C1 were increase by t-BHQ to various extents 
(Wang et al., 2006).  
 
3.1.4 Regulation of NQO1  
NQO1 is a key enzyme involved in defence against oxygen reactive species and the 
inhibition of neoplasia. It can be induced upon oxidative stress and thus protects cells 
  92 
against certain environmental insults such as benzo[α]pyrene produced from 
cigarette smoke and diesel exhaust. Expression of NQO1 is regulated in an 
Nrf2-ARE dependent fashion. The AREs identified in the regulatory region of the rat, 
mouse and human NQO1 genes show conservation of the nucleotide sequence 
immediately adjacent to the „core‟ enhancer. However, there is an important 
difference, between the ARE enhancers in the mouse, rat and human NQO1, in that 
the human cis-element contains an embedded AP-1 site (Jaiswal, 1991) which is 
absent from the AREs in the rodent genes (Favreau & Pickett, 1991; Nioi et al., 
2003). The Nrf2 CNC-bZIP transcription factor is recruited to the ARE of NQO1 as 
an obligate heterodimer with small Maf proteins (Itoh et al., 1997; McMahon et al., 
2001; Nioi et al., 2003; Thimmulappa et al., 2002). Disruption of the mouse Nrf2 
gene not only abolishes the inducible expression of Nqo1 but also results in a 
reduction in its constitutive expression.  
 
Besides the ARE in NQO1, a xenobiotic responsive element (XRE) has also 
indentified in the promoter region of the mouse, rat and human genes (Favreau & 
Pickett, 1991; Jaiswal, 1991; Nioi & Hayes, 2004). The XRE has the consensus 
sequence 5´-TA/TGCGTG-3´ and the adjacent 3´ nucleotide is often an A or a C, 
thus the „core‟ enhancer is considered as 5´- TA/TGCGTG
A
/c-3´. The core sequence 
of XRE in mouse and rat Nqo1 are closely similar. In mouse Nqo1, the core sequence 
of the XRE in NQO1 is 5´-TAGCGTGC-3´, between -386 and -379 from the 
transcriptional start site, located 41 bp upstream of the „core‟ ARE. In the rat Nqo1 
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gene, a closely similar 5´-TTGCGTGC-3´ sequence is located between -372 and 
-365 nucleotide from the transcriptional start site, 40 bp downstream of the „core‟ 
ARE. By contrast, the XRE in human NQO1, 5´-AGGCGTGA-3´, between -742 
and -735, is located 274 bp upstream of its „core‟ ARE. In addition, the core XRE in 
rodent Nqo1 shared close similiarity with that in rodent Cyp1a1.  Induction of Nqo1 
enzyme activity by TCDD has been observed in Hepa-1c1c7 cells but not in 
Hepa-1c1c7 cells that possess defects in AhR or Arnt (Ma et al., 2004). These findings 
suggest that Nqo1 can be activated by chemicals that are AhR ligands. Furthermore, 
using Nrf2
+/+
 and Nrf2
-/- 
mouse embryonic fibroblasts, it has been found that 
induction of NQO1 mRNA by TCDD is Nrf2-dependent (Ma et al., 2004). These 
findings suggest that NQO1 can be regulated by the AhR through the XRE and by 
Nrf2 through the ARE upon exposure to different chemicals. Moreover, there may be 
some type of cross-talk between the AhR and Nrf2 transcription factors.  
 
3.1.5 Nrf2+/+, Nrf2-/- and DBA/2O MEF cells 
The Nrf2
+/+
 and Nrf2
-/-
 mouse embryonic fibroblasts were derived from mice on a 
C57BL/6 genetic background. The Nrf2
-/-
 MEFs were derived from homozygous 
mutant mice, in which the b-ZIP region of the Nrf2 gene was replaced with a 
recombinant SV40 nuclear localization signal (NLS)-β-galactosidase (lacZ) 
recombinant gene (Itoh et al., 1997). The DBA/2 inbred mice are regarded as being 
genetically “nonresponsive” when compared with “responsive” strains such as the 
C57BL/6 mouse. The later animals exhibit high induction of CYP1A1 enzyme 
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activity in liver when they are treated with nonhalogenated polycyclic aromatic 
hydrocarbons such as MC, BP, or BA. By contrast “nonresponsive” mice do not 
show a significant increase in hepatic P-450 even when treated with very high doses 
of nonhalogenated PAHs. For the highly potent halogenated inducer TCDD, though it 
can induce P-450 in “nonresponsive” strains of mice, the dose required for 
half-maximal induction by TCDD is approximately 15-fold higher in DBA/2 mice 
than in C57BL/6 mice. In addition, though AhR receptors were found to be present in 
the cytosol of liver of DBA/2 mice, they have very low affinity to the ligands (Okey 
et al., 1989). In 1993, Chang et al. found the Ah receptor locus polymorphism of 
C57BL/6 and DBA/2 mice are due to the amino acid changes between the two 
different allelic forms of AhR in C57BL/6 and DBA/2O. This research group 
discovered there were a total of ten nucleotide differences between the two alleles, 
five of which were responsible for amino acid substitutions, leading to the structural 
change. Such structural changes possibly result in the different affinity of AhR in the 
two different mouse strains (Chang et al., 1993).  
 
3.1.6 Aim 
Selected flavonoids, the ones distributed in commonly consumed fruits and 
vegetables, were screened using AREc32 cells to find the most potent ARE-inducers. 
Subsequently, experiments were carried out to see whether these phytochemicals 
increase the expression of NQO1 and whether it is Nrf2 dependent. Furthermore the 
involvement of the ARE and XRE enhancers in the promoter region of mouse Nqo1 
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in gene induction by phytochemicals was also investigated using mutagenesis 
analysis. Finally, the biological consequence of gene induction by flavonoids was 
examined to see whether they could provide protection against cytotoxicity induced 
by acrolein.  
 
3.2 Results 
 
3.2.1 Screen to identify phytochemicals that induce ARE-driven gene 
expression using the AREc32 reporter cells 
3.2.1.1 Determination of the optimal time interval required for ARE-driven 
gene induction.  
The AREc32 reporter cell line was used to screen the ability of polyphenols to induce 
ARE-driven gene expression. To determine the optimal induction of luciferase 
activity, a time course experiment was carried out using the isothiocyanate 
sulforaphane, which is a classic activator of ARE-driven genes. AREc32 cells were 
treated with sulforaphane at a final concentration of 10 μmol/l for various periods of 
time as indicated in Fig 3.3. It was found that upon treatment with sulforaphane, 
luciferase activity increased with time, reaching a maximum of around 13-fold at 24 
hours. Though we tried 48 hours as well, the medium dried out and this is not 
technically applicable for 96-well plate format.  Thus AREc32 cells were treated for 
24 hours with the test polyphenols in the luciferase reporter activity screening 
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experiment. In addition, sulforaphane was included as a positive control in every 
plate of each experiment. 
 
Figure 3.3 Time dependent induction of luciferase activity in AREc32 cells by sulforaphane 
AREc32 cells were treated with sulforaphane (10 μmol/l) for different periods of time before being 
harvested simultaneously and luciferase activity measured. Experiments were performed on at least 
three independent occasions. Data represent mean ± standard deviation.  
 
3.2.1.2  Screening of polyphenols to identify ARE-inducers 
The flavonoids selected for study include flavonols, flavanones, catechin tannins and 
anthocyans. The flavonol group contained: quercetin and its glycosides quercitrin, 
rutin and quercetin-3-O-glucopyranoside; kaempferol and its glycosides 
kaempferol-3-O-glucoside and kaempferol-3-O-rutinoside; the flavanone group 
consisted of narigenin, its glycoside narigenin-7-O-glucoside, and the glycoside 
hesperitin; the catechin tannin group included (-)-epicatechin and 
(-)-epigallocatechin gallate; the anthocyan group included cyanidin chloride and its 
glycosides kuromanin chloride and keracyanin chloride; callistephin chloride, oenin 
chloride and myritillin chloride. The AREc32 cells were treated with the 
phytochemicals at a concentration of 20 μmol/l for 24 hours before luciferase activity 
was measured. Each treatment was carried out in triplicate and every experiment was 
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performed on at least three separate occasions. The results are shown in Figure 3.4. 
Amongst these compounds, quercetin and kaempferol from the flavonoid family 
stimulated the highest induction, producing increases of 4.5-fold and 3.8-fold, 
respectively (p < 0.001). It is interesting to note that the glycosides of quercetin and 
kaempferol did not produce comparable increases in luciferase activity, though rutin 
gave a 10% induction (p < 0.05). Besides quercetin and kaempferol, narigenin, a 
flavanone gave a 30% (p < 0.05) increase in luciferase activity. From the anthocyan 
family, aglycone caynidin chloride increased reporter gene activity 17% while its 
glycosides did not appear to stimulate any significant induction; another two 
glycosides keracyanin chloride and oenin chloride gave inductions of 34% and 26% 
respectively. No effect on the luciferase activity was observed for the chemicals from 
the catechin tannin family. As these chemicals were used at a concentration of 20 
μmol/l, which is much higher than the physiological concentration, a 2-fold induction 
was considered worth pursuing. On this basis, the two most potent phytochemicals 
quercetin and kaempferol from the flavonol family were used for further studies. 
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Figure 3.4  Preliminary screening using AREc32 cells.  
All chemicals were used at a final concentration of 20 μmol/l. Cells were treated with these chemicals 
for 24 h before luciferase activity was measured. Experiments were performed on at least three 
independent occasions. Data represent mean ± standard deviation. 
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3.2.1.3  Dose-response of gene induction by quercetin and kaempferol 
A dose-response experiment was carried out for quercetin and kaempferol to 
determine the maximal concentration of polyphenol required to induce ARE-drive 
gene expression. As shown in Figure 3.5, both quercetin and kaempferol were able to 
induce ARE-driven luciferase activity in a dose-dependent manner. Their ability to 
induce luciferase activity reached a plateau at concentrations of between 10 and 20 
μmol/l. Thus a final concentration of 20 μM quercetin and 20 μM kaempferol was 
chosen for subsequent experiments.  
 
 
Figure 3.5 Dose-dependent induction of reporter gene activity in AREc32 cells by quercetin and 
kaempferol. 
AREc32 cells were treated with either quercetin or kaempferol at various concentrations for 24 h 
before luciferase activity was measured. Experiments were performed on at least three independent 
occasions. Data represent mean ± standard deviation. 
 
 
3.2.2 Design and use of XRE luciferase reporter plasmids  
A pGL_4×XRE-Luc luciferase reporter construct was generated as described in 
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2.2.2.3. It was transfected into RL-34 cells along with β-Gal. After 18 h recovery 
from transfection, the cells were treated for 24 h with 1 μM β-NF or 1 μM ICZ. 
Thereafter, luciferase activity was measured as described in section 2.2.5. The result 
in Figure 3.6 showed that even treatment with the typical XRE inducers β-NF or ICZ 
gave increase in reporter activity of only 1.4- and 1.5-fold, respectively, which 
suggests that this construct is not responsive enough in RL-34 cells. It therefore was 
not used to screen XRE inducers.  
 
Figure 3.6 Performance of the pGL_4×XRE-Luc reporter plasmid.  
RL-34 cells were transfected with pGL_4×XRE-Luc along with β-Gal. After transfection, cells were 
treated with β-NF (1 μmol/l) or ICZ (1 μmol/l) for 24 h before luciferase activity was measured. 
Experiments were performed for at least three independent occasions. Data represent mean ± standard 
deviation. 
 
 
3.2.3 Phytochemicals have no effect on the expression of GSTP1 protein in 
RL-34 cells  
Having shown that quercetin and kaempferol can induce ARE-driven gene 
expression, we examined their effect on the expression of GSTP1 because its gene is 
thought to contain a functional ARE. Non-transformed rat liver RL-34 cells were 
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seeded in 60 mm dishes. After they reached 80% confluence, they were treated with 
phytochemicals for 24 h. Whole cell lysates were analysed for the level of GSTP1 
protein in the cells. As shown in Figure 3.7, neither quercetin nor kaempferol had any 
effect on the expression of GSTP1 protein.  
 
 
Figure 3.7 No effect by quercetin or kaempferol on the expression of GSTP1. 
RL-34 cells were treated with quercetin or kaempferol at the final concentration of 20 μmol/l and 
sulforaphane of 5 μmol/l. The same blot was stripped and re-probed with anti-actin antibody.  
 
 
3.2.4 Quercetin and kaempferol increase NQO1 enzyme activity in a 
dose-dependent manner 
Having shown that quercetin and kaempferol induce reporter gene expression in the 
AREc32 cells, we examined their effect on NQO1. For this purpose, 
non-transformed rat liver RL-34 cells and primary MEF cells were used. Firstly the 
effect of quercetin and kaempferol on NQO1 enzyme activity was examined. Cells 
were treated for 24 h with quercetin, kaempferol or DMSO before NQO1 activity 
was measured. Both quercetin and kaempferol increased the oxidoreductase activity 
in a dose-dependent manner in both cell lines (Figure 3.8). In RL-34 cells, quercetin 
increased NQO1 activity 4.5-fold at the highest concentration used, which was 20 
μmol/l. By contrast, kaempferol increased NQO1 activity 2.8-fold at the same 
 GST-pi 
 Actin 
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concentration. In Nrf2
+/+
 MEF cells, quercetin and kaempferol increased the NQO1 
activity 2.2-fold and 1.3-fold, respectively, at a concentration of 20 μmol/l. When the 
experiment was performed in Nrf2
-/-  
fibroblasts cells, the basal NQO1 enzyme 
activity was substantially lower than was observed in Nrf2
+/+  
fibroblasts, and no 
increase was observed upon treatment with either quercetin or kaempferol. These 
results suggest that Nrf2 regulates both basal NQO1 activity and its induction by 
quercetin and kaempferol.  
 
 
A 
B 
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Figure 3.8 Quercetin and kaempferol increase NQO1 enzyme activity in a dose-dependent and 
Nrf2-dependent manner.  
RL-34 (A), Nrf2
+/+ 
and Nrf2
-/- 
MEF cells (B) were treated with various concentrations of quercetin or 
kaempferol for 24 h before the enzyme activity was measured as described in Materials and Methods. 
The value of enzyme activity was normalized to that of protein concentration and treated cells were 
compared with untreated cells. 
 
 
3.2.5 Induction of NQO1 by phytochemicals  
As treatment with quercetin or kaempferol increased NQO1 enzyme activity, we 
examined whether they could increase the level of the oxidoreductase protein. Thus 
endogenous NQO1 protein in RL-34 and MEF cells was measured by Western 
blotting following treatment with quercetin or kaempferol at a concentration of 20 
μmol/l for 24 hours; in addition, sulforaphane (5 μmol/l), a typical activator of Nrf2, 
and 3-MC (1 μmol/l), a typical AhR agonist, were used as positive controls. Western 
blotting showed that both quercetin and kaempferol increased the endogenous NQO1 
protein in RL-34 and Nrf2
+/+
 MEF cells (Figure 3.9). Densitometry analysis in 
Figure 3.9 A showed that quercetin increased NQO1 protein approximately 30-fold 
in RL-34 cells whereas kaempferol increased NQO1 protein levels about 25-fold in 
the same cell line. Both flavonoids increased Nqo1 protein in MEF cells, as shown in 
Figure 3.9B, to a much lesser extent than was observed in RL34 cells; quercetin 
increased the amount of Nqo1 protein around 3-fold while kaempferol produced a 
1.5-fold increase. Furthermore, the basal level of Nqo1 protein and its level of 
induction were substantially lower in Nrf2
-/- 
MEF cells than in wild-type fibroblasts. 
It was also found that treatment with 3-MC produced a moderate increase in Nqo1 
protein of about 10-fold in RL-34 cells, but this was not observed in either wild-type 
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or Nrf2 knockout MEF cells.  
A 
 
 
B 
 
 
Figure 3.9 Phytochemicals increase the level of Nqo1 protein in rodent cells in an 
Nrf2-dependent manner. 
RL-34 (A), Nrf2
+/+ 
and Nrf2
-/- 
MEF cells (B) were seed in 60 mm dishes. After ~ 24 h recovery, when 
cells reached ~80% confluence, they were exposed to vehicle DMSO (0.1%, v/v), quercetin (20 
μmol/l), kaempferol (20 μmol/l), sulforaphane (5 μmol/l) or 3-MC (1 μmol/l). Protein preparation and 
detection of Nqo1 protein by Western blotting were performed as described in Materials and Methods. 
RL-34  
 
 
 
 
MEF  
  105 
After blotting for Nqo1, the membranes were stripped and re-probed with actin. The right hand panel 
of (A) and lower panel of (B) are the densitometry analysis of the immunoblots. The values of the 
treated cells were compared with untreated cells. For MEF cells all values were compared with that of 
untreated Nrf2
+/+ 
MEF cells.  
 
3.2.6 Treatment with flavonoids increases Nqo1 mRNA in RL-34 and 
MEF cells 
3.2.6.1 Change of mRNA of Nqo1 by quercetin or kaempferol over time  
After showing that quercetin and kaempferol can increase Nqo1 protein levels, we 
further investigated whether they regulated Nqo1 at the transcriptional level. Cells 
were exposed to quercetin, kaempferol or DMSO for various times as indicated in 
Figure 3.10. Total mRNA was extracted and that for Nqo1was measured by qT-PCR. 
The time course experiment showed that in RL-34 cells (figure 3.10 A), quercetin 
induced Nqo1 mRNA in a time dependent manner with the increase reaching a 
maximum of around 20-fold at 12 hours. Thereafter, the amount of Nqo1 mRNA 
decreased to around 13-fold at 24 hours. Though kaempferol also induced Nqo1 
mRNA over time, the increase appeared more gradual and sustained than was 
observed for quercetin.   
 
In Nrf2
+/+ 
MEF cells (figure 3.10 B), both quercetin and kaempferol increased Nqo1 
mRNA in a time dependent manner giving the highest induction at 12 hour of 
approximately 10-fold and 6-fold, respectively. Thereafter, the induction decreased 
gradually and was estimated to be 5-fold and 3-fold for quercetin and kaempferol, 
respectively, at 24 h. In Nrf2
-/- 
MEF cells (Figure 3.10 B), the basal level of Nqo1 
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mRNA was substantially lower than in wild-type fibroblasts. The induction level 
produced by quercetin and kaempferol in Nrf2
-/- 
MEF cells was around 3-fold and 
2.5-fold respectively. Collectively, these results show that both quercetin and 
kaempferol can increase Nqo1 enzyme activity, as well as its expression at both the 
protein and mRNA levels and these increases were principally Nrf2-dependent, but a 
small Nrf2-independent increase was also observed. In addition, quercetin was more 
potent than kaempferol as an Nqo1 inducting agent in both of the cell lines 
examined. 
A 
   
 
 
  107 
B 
 
 
Figure 3.10 Quercetin and kaempferol increase the mRNA level of Nqo1 in an Nrf2-dependent 
manner.  
RL-34 (A), Nrf2
+/+ 
and Nrf2
-/- 
MEF cells (B) were seeded in 60 mm dishes and left to recover for ~24 
h to reach ~80% confluence. Cells were then treated with vehicle DMSO (0.1%, v/v), quercetin (20 
μmol/l), kaempferol (20 μmol/l), for various time points and harvested simultaneously. RNA was then 
extracted and reverse transcribed to cDNA as described in Materials and Methods. cDNA was then 
used for Taq-man to detect the amount of Nqo1 mRNA. At least three independent experiments were 
performed. Data represented the mean ± standard error. The lower panel in (A) and lower panel in (B) 
represent the data at 12 time point. Treated cells were compared with DMSO treated cell (DMSO 
treated Nrf2
+/+
 MEF cells for MEF cells). Statistical analysis was carried out and student‟s t-test was 
carried out for the 12 time point value. (**/ξξ, P< 0.01; */ξP<0.05; * indicates postivite change while 
ξ indicates negative change ) 
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3.2.6.2 Consecutive treatments with quercetin or kaempferol  
After showing that both quercetin and kaempferol can induce the Nqo1 mRNA level, 
we wished to know whether re-treatment of RL-34 and MEF cells with quercetin or 
kaempferol could maintain elevation of the oxidoreductase over an extended period 
of time. As the time course showed that quercetin elicits the highest induction at 12 h 
in both RL-34 and MEF cells, whereas kaempferol showed highest induction at 24 h 
or 12 h in RL-34 or MEF cells respectively, RL-34 and Nrf2
+/+
 MEF cells were 
treated with quercetin or kaempferol every 12 h for 12, 24, 36 or 48 h to determine 
whether repeated treatment with polyphenols caused a sustained increase in Nqo1. To 
ensure that all cells for the polyphenol repeated treatment experiment were harvested 
at the same time, they were first exposed to the flavonoids at different time points. 
Thereafter, mRNA was extracted, reverse transcribed to cDNA and measured by 
Taq-man. The analysis in figure 3.11 A showed that in RL-34 cells the increase in 
NQO1 mRNA by quercetin dropped gradually from 10-fold at 12 h to 5-fold and 
4-fold at 24 h and 36 h, respectively, while the induction went diminished to 9-fold at 
48 h. On the other hand, the increase in Nqo1 mRNA by kaempferol was more stable 
over time with moderate decrease from 7-fold at 12 h to 4.3-fold at 24 h, going back 
at 5.5-fold and slightly dropped down again at 48 h to 4.5-fold. However, the change 
from 12 h to 24 h and followed by that in 48 h was not significant.  
 
The pattern of induction of NQO1 mRNA by flavonoids in MEF cells (figure 3.11 B) 
differed from that observed in RL-34 cells. The increase of Nqo1 mRNA by 
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quercetin appeared similar at 12 h and 24 h, which was around 11-fold, but it 
decreased thereafter from 7-fold at 36 h to around 3-fold at 48 h. In the case of 
kaempferol, increase in Nqo1 mRNA dropped from 10.5-fold at 12 h to 3.7-fold at 24 
h and kept decreasing further over time, maintaining an induction of around 3-fold at 
36 and 48 h. It was interesting to notice that over time the basal level of NQO1 
mRNA increased in RL-34 cells but decreased in MEF cells.  
A 
RL-34 
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Figure 3.11 Consecutive treatment with quercetin and kaempferol affected the mRNA level 
differently in RL-34 and Nrf2
+/+
 MEF cells.  
RL-34 (A) and Nrf2
+/+
 MEF cells (B) were seeded in 60-mm dishes and left to recover for ~24 h. 
When cells were ~70% confluent, they were either treated for 12, 24, 36, or 48 h with polyphenol. For 
each length of treatment, cells were washed and re-cultured in growth media containing either vehicle 
DMSO (0.1, v/v), quercetin (20 μmol/l) or kaempferol (20 μmol/l). Cells were harvested for analysis 
at the same time. Measurement of Nqo1 mRNA was carried out as described in Figure 3.10. All values 
were compared with that observed when cells were treated with DMSO for 12 h.  
 
 
3.2.7 Introducing mutations to ARE or XRE in Nqo1-luciferase reporter 
constructs 
The upstream regulatory region of mammalian Nqo1 genes contains both ARE and 
XRE enhancer sequences (Nioi & Hayes, 2004). Although it has been well 
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documented that Nqo1 is induced by sulforaphane and tBHQ through an ARE 
sequence, in an Nrf2-dependent manner, it was not known whether quercetin and 
kaempferol induced NQO1 through the ARE or XRE, or through both cis-elements. 
To address this issue, a series of Nqo1-luciferase reporter constructs were made. As 
described in section 2.2.2.1, using P-1016/nqo1-Luc as a template, three constructs 
containing the transversion mutation in the ARE, XRE or ARE and XRE were made 
and named as mutARE-1016/nqo1-Luc, mutXRE-1016/nqo1-Luc or mutARE/mutXRE 
-1016/Nqo1-Luc. RL-34 cells or MEF cells were transfected with either of these 
constructs along with pcDNA4/HisMax/lacZ encoding β-galactosidase (β-gal). After 
transfection, cells were treated with various chemicals and luciferase activity was 
measured and normalized to β-gal activity. As shown in Figure 3.12, when RL-34 
cells, that had been transfected with P-1016/NQO1-Luc, were treated with 20 μmol/l 
quercetin or 20 μmol/l kaempferol, an induction of reporter gene activity of around 
4- or 3.8-fold, respectively, was observed. By comparison, Sul or ICZ at a 
concentration of 5 μmol/l or 1 μmol/l, respectively, gave an induction of around 4.5- 
and1.9-fold induction, respectively.  When the ARE in the P-1016/Nqo1-Luc reporter 
construct was mutated, both the basal level and induction level for all chemicals were 
dramatically decreased. When the XRE was mutated, basal reporter activity level 
decreased to 16% and the levels of induction produced by quercetin, kaempferol, Sul 
and ICZ were decreased to various degrees with ICZ showing the greatest reduction. 
Unexpectedly, when cells were transfected with mutARE/mutXRE -1016/nqo1-Luc, basal 
reporter activity was decreased to 25% compared with cells transfected with 
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P-1016/nqo1-Luc; however, it was higher than that from constructs containing mutation 
in just the ARE or XRE alone.   
 
The responsiveness of the Nqo1-lucifersase constructs to flavonoids was examined in 
Nrf2
+/+
, Nrf2
-/-
, and DBA/2
 
MEF cells (Figure 3.13). Treatment of mouse wild-type 
fibroblasts, which had been transfected with the wild-type reporter constructs, with 
quercetin or kaempferol for 24 h resulted in an increased luciferase activity of around 
2-fold. When cells were transfected with mutARE-1016/nqo1-Luc, both the basal and 
inducible luciferase activities were dramatically decreased. By contrast, when cells 
were transfected with mutXRE-1016/nqo1-Luc, no significant change was observed in the 
basal luciferase activity or induction of luciferase activity by quercetin; however the 
induction level by kaempferol was decreased to 1.4-fold. When cells were 
transfected with mutARE/mutXRE -1016/nqo1-Luc, basal luciferase and inducible activity 
were comparable with the results obtained when the ARE was mutated (Figure 3.13 
A).  
 
Taken together, the results from RL-34 and Nrf2
+/+
 MEF cells indicated that both the 
basal activity from the Nqo1-luciferase reporters and the level of induction produced 
by quercetin and kaempferol are dictated by the ARE. To determine whether the 
basal and inducible reporter activity was mediated by Nrf2, we performed the same 
experiment in Nrf2
-/-
 MEFs (Figure 3.13 B). This showed that the mutant fibroblasts 
transfected with P-1016/nqo1-Luc produced substantially lower basal and inducible 
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luciferase activity when treated with flavonoids, compared with wild-type fibroblasts. 
When cells were transfected with mutARE-1016nNqo1-Luc or mutXRE-1016/nqo1-Luc, both 
the basal expression flavonoids induced expression were decreased slightly 
compared with in Nrf2
-/-
 MEFs transfected with the P-1016/nqo1-Luc. When Nrf2
-/-
 
MEFs were transfected with mutARE/mutXRE -1016/nqo1-Luc, there was a small decrease 
in the basal level but this was not significant. These results suggested that Nrf2 plays 
an essential role in the basal expression of Nqo1 and its induction by quercetin and 
kaempferol.  
 
To investigate whether the XRE is involved in either basal or inducible Nqo1 
regulation, the same experiment was carried out using DBA2/O MEF cells in which 
AhR has very low ligand binding affinity. As Nrf2
+/+
 MEF (C57BL/6) and DBA2/O 
MEF cells were generated from mice with different genetic background, the basal 
levels of NQO1 were not comparable between these two cells lines. However, we 
wanted to see whether the loss of AhR function can affect the level of induction 
produced by flavonoids. When the DBA/2O fibroblasts were transfected with 
P-1016/nqo1-Luc, the induction of reporter gene activity by quercetin was lower than 
that observed in Nrf2
+/+
 MEF cell (Figure 3.13 C). However, in the case of 
kaempferol, higher luciferase activity was detected in DBA/2O MEF than in Nrf2
+/+
 
MEF. When the DBA2/O fibroblasts were transfected with mutARE-1016/nqo1-Luc, the 
situation was the same as that in Nrf2
+/+
 MEFs. When cells were transfected with 
mutXRE-1016/nqo1-Luc, basal luciferase activity was decreased by 30% and induction by 
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quercetin did not change significantly compared with that observed when they were 
transfected with P-1016/nqo1-Luc. By contrast, when cells were treated with kaempferol, 
luciferase activity was slightly decreased in cells transfected with 
mutXRE-1016/nqo1-Luc compared with cells transfected with P-1016/nqo1-Luc. As was in 
the case of Nrf2
+/+
 MEF, when DBA2/O fibroblasts were transfected with 
mutARE/mutXRE -1016/nqo1-Luc, the basal level were a slightly higher than cells 
transfected with construct containing a mutation only in ARE or XRE. 
                             RL-34  
 
 
Figure 3.12 The ARE is responsible for both basal and inducible Nqo1-driven luciferase 
reporter activity.  
RL-34 cells were seeded in 6-well dishes and left to recover for ~24 h to reach ~70% confluence 
before transfection was then carried out as described in Materials and Methods. RL-34 cells were 
co-transfected with 1.875 μg of each reporter for either P-1016/nqo1-Luc (Nqo1), AREmut-1016/nqo1-Luc 
(ARE-mut), XREmut -1016/nqo1-Luc (XRE-mut) or AREmut/XREmut-1016/nqo1-Luc (AX-mut), together with 
0.125 μg β-Gal plasmids for normalization. After transfection, cells were treated with vehicle DMSO 
(0.1%, v/v), quercetin (20 μmol/l), kaempferol (20 μmol/l), sulforaphane (5 μmol/l) or IC Z (1 μmol/l) 
for 24 h before luciferase activity was measured. Luciferase activity was normalized by β-Gal activity. 
(A) RL-34 cells. Values were presented as the fold induction by comparing all values with cells 
transfected with P-1016/nqo1-Luc and treated with DMSO. Experiments were performed on at least three 
independent occasions. Data represents mean ± standard error. Student‟s t test was carried out for 
statistical analysis.（* P<0.01; ** P<0.05; ***P<0.001）. 
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Figure 3.13 The ARE is responsible for both basal expression and induction of NQO1-driven 
luciferase activity.  
Nrf2+/+, Nrf2-/- and BDAO/2 MEF cells were seeded in 6-well dishes and left to recover for ~24 to 
reach ~70%concluence. Transfection and treatment was carried out as described in Figure 3.13. Values 
were presented as the relative luciferase activity. Experiments were performed for on least 
A 
B 
C 
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independent occasions. Data represent mean ± standard error. Student‟s t test was carried out for 
statistical analysis (* indicates a positive change while ξindicates a negative change. */ξP<0.01; 
**/ξξP<0.05) 
 
3.2.8 Generation of Deletion mutation constructs 
When transversion mutations were introduced into both the ARE and XRE 
cis-elements, the basal level was higher than when either ARE or XRE was mutated 
alone. The reason for this finding is unclear. One possibility is that although the 
transversion mutation removed the ARE and XRE, it introduced another cis-element. 
To overcome this possible shortcoming, the ARE and XRE were eliminated by 
deletion mutagenesis.  As described in Materials and Methods, the P-1016/nqo1-Luc 
reporter construct was used as a template to generate three reporter constructs that 
lacked the ARE, the XRE or both of these elements, and were named as ∆ARE 
-1016/nqo1-Luc, ∆XRE-1016/nqo1-Luc or ∆ARE/XRE-1016/nqo1-Luc, respectively. The 
deleted sequence for each construct is shown in Figure 3.14. Following transfection 
of RL-34 cells with the P-1016/nqo1-Luc plasmid, treatment with quercetin and 
kaempferol induced luciferase activity between 3- and 4-fold (Figure 3.15). In MEF 
cells, quercetin and kaempferol also induced luciferase activity, though the fold 
increase was lower than that observed in RL-34 cells (Figure 3.16).  
 
As shown in Figure 3.15 and 3.16 A, when cells were transfected with ∆ARE 
-1016/nqo1-Luc, both the basal and inducible reporter activities were dramatically 
decreased in RL-34 cells and also Nrf2
+/+ 
MEF cells. Interestingly, when Rl-34 cells 
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were transfected with ∆XRE -1016/nqo1-Luc, the basal level of luciferase activity was 
decreased to about 50% of that obtained from cells transfected with the wild-type 
reporter plasmid (Figure 3.15). However, the magnitude of induction produced by 
quercetin and kaempferol from ∆XRE -1016/nqo1-Luc did not change significantly when 
compared with the fold increase observed from cells transfected with the wild-type 
plasmid. Furthermore, in Nrf2
+/+ 
MEF cells, deletion of the XRE sequence increased 
basal luciferase activity and had no effect on induction (Figure 3.16A). When cells 
were transfected with ∆ARE/∆XRE-1016/nqo1-Luc, basal and inducible luciferase 
activities were decreased to similar levels of that observed in the case of when cells 
were transfected with ∆ARE-1016/nqo1-Luc. Collectively, these results indicate that the 
ARE is indispensible for both basal and inducible expression of Nqo1 whereas the 
XRE may contribute to repression of the basal expression of Nqo1.  
 
To investigate whether the changes in basal and inducible luciferase activities were 
dependent on Nrf2, we performed the same reporter gene experiment in Nrf2
-/- 
MEF 
cells using wild-type and mutated P-1016/nqo1-Luc as had been performed in Nrf2
+/+
 
fibroblasts. It is already known that Nqo1 is regulated by Nrf2 and our data showed 
consistently that the basal luciferase reporter activity was much lower in the mutant 
fibroblasts than in the WT MEF cells and that quercetin or kaempferol did not induce 
reporter gene activity in the mutant fibroblasts (Figure 3.16B).  
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Figure 3.14 Sequences deleted in the mutant reporter constructs 
Deletion mutagenesis was carried out as described in Materials and Methods. Bold letters in the 
wild-type construct indicate the sequence to be deleted in each of the mutant construct.  
 
 
 
  
Figure 3.15 The ARE and XRE sequence exert different effects on induction of NQO1 by 
quercetin and kaempferol in RL-34 cells 
RL-34 cells were seeded in 6-well dishes and left to recover for ~24 h to reach ~70% confluence 
before transfection was carried out as described in material and method. RL-34 cells were 
co-transfected with 1.875 μg of each reporter for either P-1016/nqo1-Luc (Nqo1), ∆AREp-1016/nqo1-Luc 
(∆ARE), ∆XRE p-1016/nqo1-Luc (∆XRE) or ∆ARE/∆XREp-1016/nqo1-Luc (∆ARE/∆XRE), together with 
0.125 μg β-Gal plasmids for normalization. After transfection, cells were treated with vehicle DMSO 
(0.1%, v/v), quercetin (20 μmol/l), kaempferol (20 μmol/l), sulforaphane (5 μmol/l) or 3-MC (1 
μmol/l) for 24 h before luciferase activity was measured. Luciferase activity was normalized by β-Gal 
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activity. (A) RL-34 cells. Values are presented as the fold induction by comparing all values with cells 
transfected with P-1016/nqo1-Luc and treated with DMSO. Data represent mean ± standard error. 
Student‟s t-test was carried out and p value was obtained by comparing all data set with cells 
transfected with P-1016/nqo1-Luc and treated with DMSO. Student‟s t test was carried out for statistical 
analysis (* indicates a positive change while ξindicates a negative change. */ξP<0.01; **/ξξ
P<0.05) 
 
 
 
 
Figure 3.16 ARE and XRE exert different effects in the induction of NQO1 by quercetin and 
kaempferol in MEF cells  
A 
B 
C 
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Nrf2+/+, Nrf2-/- and BDAO/2 MEF cells were seeded in 6-well dishes and left to recover for ~24 to 
reach ~70%concluence. Transfection and treatment was carried out as described in Figure 3.15. Values 
were presented as the relative luciferase activity. Experiments were performed for on least 
independent occasions. Data represent mean ± standard error. Student‟s t test was carried out for 
statistical analysis (* indicates a positive change while ξindicates a negative change. */ξP<0.01; 
**/ξξP<0.05) 
 
3.2.9  The effect of quercetin and kaempferol on the level of GSH  
RL-34 cells were seeded in 60 mm dishes at a density of 10
6
 cells per well, and left 
to recover for 24 h to reach ~90% confluence. Cells were then washed with PBS 
once and FBS-free medium was used to culture the cells for another 24 h. Chemicals 
were spiked into the medium at different time points and the cells were finally 
harvested simultaneously.  Measurement of GSH was carried out as described in 
2.4.9. The results in Figure 3.17 show that neither quercetin nor kaempferol affected 
the level of GSH significantly. By contrast, it was found that treatment with 5 μM 
Sulforaphane caused a depletion of intracellular GSH between 2-8 h of ~20 % and 
stimulated the synthesis of GSH causing a 1.5-fold increase. 
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Figure 3.17 Changes in intracellular GSH upon treatment with phytochemicals  
RL-34 cells were treated with quercetin or kaempferol at the final concentration of 20 μmol/l or 
sulforaphane at 5 μmol/l. The glutathione assay was carried out as described in Materials and Methods. 
For each sample, triplicate reaction was carried out. Total GSH was measured and normalized to the 
amount of protein and presented as nmol of GSH per mg of protein.  
 
 
3.2.10 Biological consequence of treatment with quercetin and kaempferol 
As our data have demonstrated that quercetin and kaempferol can induce ARE-driven 
gene expression, we tested the hypothesis that they could provide protection against 
electrophiles in an Nrf2-dependent fashion. For this purpose, we chose the reactive 
α,β-unsaturated aldehyde acrolein as the electrophile, the toxicity of which have been 
shown to be decreased by isothiocyanate sulforaphane (Higgins et al., 2009). To this 
end, we pretreated RL-34 cells, Nrf2
+/+ 
MEF and Nrf2
-/- 
MEF cells with a flavonoid 
for 24 h prior to challenge with acrolein for a further 24 hours. Cell viability was 
then measured by MTT. Statistical analysis was carried out by GraphPad Prism 
(GraphPad Software, 2236 Avendia La Playa La Jolla, CA 92037, USA). 95% 
confidence intervals are shown in the bracket following the EC50 values. It showed 
that in RL-34 cells treatment with quercetin or kaempferol can increase the EC50 
from 66.5 (60.4-73.3) μmol/l to 92.5 (65.5-130.7) μmol/l or 96.2 (85.1-108.7) μmol/l 
respectively (Figure 3.18A). In MEF Nrf2
+/+
 cells, EC50 was significantly increased 
by quercetin or kaempferol from 65 (63.5-66.6) μmol/l to 117 (106.9-128.6) μmol/l 
or 81 (75.8-85.8) μmol/l respectively (Figure 3.18 B).  On the other hand, in Nrf2-/- 
MEF cells, the mutant fibroblasts treated with the vehicle had an EC50 of 16 
(15.7-16.9) μmol/l (Figure 3.18 B), significantly lower than that of Nrf2+/+ MEF. In 
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addition, the protection by quercetin and kaempferol was totally abolished. These 
results suggest that quercetin and kaempferol can provide protection against acrolein 
and this occurs in an Nrf2-dependent manner.  
A  RL-34 
 
B  MEF 
 
Figure 3.18 Quercetin and kaempferol protect against acrolein toxicity in an Nrf2-dependent 
manner.  
RL-34 (A), Nrf2
+/+
 or Nrf2
-/- 
MEF cells were seeded in 96-well plates and left to recover for ~24 h to 
reach ~80% confluence. Cells were then pretreated with vehicle DMSO (0.1%, v/v), quercetin (20 
μmol/l) or kaempferol (20 μmol/l) for 24 h. Afterwards, cells were treated for another 24 h with 
acrolein at various concentrations which are expressed as Log2[C(μM)] in the figure. Experiments 
were performed on at least three independent occasions. Data represent the mean ± standard error. 
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Statistical analysis and student‟s t test were carried out and EC50 was calculated. (A) P<0.05; (B) 
P<0.05.  
 
3.2.11 Induction of Cyp1a1 mRNA by quercetin and kaempferol in RL-34 
cells  
The results shown above have demonstrated that the XRE in Nqo1 contributes to its 
basal expression and induction of Nqo1 by quercetin and kaempferol. This in turn 
suggests that quercetin or kaempferol may influence the expression of other 
XRE-driven genes, such as CYP1A1. To test this hypothesis, we examined whether 
quercetin and kaempferol increased mRNA level of CYP1a1 in RL-34 cells. The 
result showed that both flavonoids could increase the mRNA level of CYP1A1 and 
the induction reached to a maximum at 6 h of 5.5-fold by quercetin and 3-fold by 
kaempferol (Figure 3.19).  
 
Figure 3.19 Quercetin and kaempferol can increase the mRNA level of CYP1A1 
Experiment was performed in the same way in RL-34 cells as that described in Figure 3.10 and the 
level of CYP1A1 mRNA was measured by Taq-man and normalized to the mRNA level of actin. 
Experiments were performed for three separate occasions and the data is presented as mean ± standard 
error.   
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3.3 Discussion 
3.3.1 Identificaiton of quercetin and kaempferol as inducers of 
ARE-driven genes  
The ability of flavonoids from the sub-class of flavonol, flavanone, catechin tannin 
and anthocyan to induce ARE-drive genes was screened using AREc32 cells. The 
assay revealed that quercetin and kaempferol gave higher induction of ARE-driven 
luciferase activity than did other flavonoids. By contrast, their glycosides did not 
show comparative induction, indicating the aglycone form exerted more biological 
function. Narigenin from the flavonone family, caynidin, keracyanin chloride and 
oenin chloride from the anthocyan family give inductions less than 50%. For the 
catechin-tannins family, no induction was observed by any of the chemicals tested. 
The difference of the ability to induce ARE-driven gene presented between different 
flavonoids family is possibly structure-related. However, such a relationship needs 
further investment.  
 
3.3.2 Induction of Nqo1 by flavonoids requires Nrf2 
By Western blotting, it has been shown that both quercetin and kaempferol stimulate 
induction of Nqo1 protein. By contrast, they had no effect on the expression of 
GSTP1. Though the gene encoding GSTP1 contains a functional ARE sequence in its 
promoter region, it can be regulated in an Nrf2-independent pathway. These result 
suggested that the induction of ARE-driven gene by flavonoids is probably in an 
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Nrf2-dependent manner. To confirm the induction of Nqo1 by flavonoids is in an 
Nrf2-dependent manner, Nrf2
+/+ 
and Nrf2
-/- 
fibroblasts were employed. This showed 
that compared with Nrf2
+/+ 
MEF, both the basal level and induction level of Nqo1 by 
quercetin and kaempferol were substantially lower in Nrf2
-/- 
MEF. Taken together, the 
induction of ARE-driven gene expression by flavonoids occurs through an 
Nrf2-dependent pathway.  
 
3.3.3 Flavonoids did not alter the level of GSH 
It has been reported that quercetin and kaempferol have antioxidant activity which is 
due to the presence of a phenolic hydroxyl group, and that quercetin exhibits a higher 
free radical scavenging activity than kaempferol (Akira et al., 2008). In addition, 
studies on quercetin showed that during its antioxidative activities, it becomes 
oxidized into various products. The two electron oxidation of quercetin yields the 
oxidation product quercetin-quinone, denoted as QQ. An in-vitro study has shown 
that QQ is very reactive towards thiols and can instantaneously form an adduct with 
GSH and called GSQ, (Figure 3.18) (Galati et al., 2001). This product is not stable 
and rapidly dissociates into GSH and QQ with a half life of 2 min. However, these 
studies are all in vitro and the in vivo formation and possible toxicity of QQ has not 
been demonstrated yet. In this theory, the possibility that quercetin and kaempferol 
can affect the level of endogenous GSH has been examined. This showed that the 
flavonoids exert no significant effect on the level of GSH. There are several 
possibilities that GSH was not depleted by either of the flavonoids. First, in the 
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absence of excessive [O] which was one of the conditions from previous studies 
examing the antioxidant property of quercetin and kaempferol, the flavonoids 
probably did not undergo oxidation, thus no reactive products were present to 
conjugate with GSH. Secondly, our study showed that the basal level of GSH is 
much higher in RL-34 cells than other cell lines (e.g. MEFs) (Higgins et al., 2009) 
which may contribute to the low level of depletion of GSH by sulforaphane; even the 
flavonoids become oxidized in cells and conjugated to GSH, the change of GSH was 
not significant based on the high basal level. Such result suggested that the induction 
of NQO1 by quercetin and kaempferol is not due to their antioxidant property. 
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Figure 3.20 Schematic presentation of the peroxidative metabolism of quercetin.  
The 3-hydroxy group on the C ring in quercetin can be oxidized to different products by the 
peroxidase-catalyzed one-electron oxidation. In the presence of GSH, quercetin forms a quercetin-SG 
conjugate with glutathione binding onto the A ring (Galati et al., 2001).  
 
3.3.4 The ARE but not the XRE is necessity for the induction of Nqo1 by 
flavonoids.  
It was known that Nqo1 is regulated by Nrf2 through the ARE. However, recent 
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studies showed that Nqo1 can also be induced by the ligands of AhR (Ma et al., 
2004). In view of the facts that the promoter region of Nqo1 contains an XRE, and 
quercetin and kaempferol share structural similarities with typical AhR ligands, it 
seemed possible that these two flavonoids induce oxidoreductase through the 
AhR-XRE pathway. Our experiments have shown that these two flavonoids induce 
Nqo1 at both protein and mRNA level in an Nrf2-dependent manner. We have also 
examined whether Nrf2-dependent induction of Nqo1 requires a functional ARE 
and/or XRE. For this purpose, we carried out mutagenesis analyses. At first, 
transversion mutations were introduced to the core sequence of the ARE and/or XRE 
in the mouse Nqo1 promoter. This showed that the ARE is required for induction of 
Nqo1 gene expression. However, the introduction of transversion mutations into the 
XRE exerted different effects on basal Nqo1 expression and induction of Nqo1 by 
quercetin. In RL-34 cells, in the absence of a functional XRE, both the basal and 
inducible level of NQO1 decreased substantially though not to such a great degree as 
when the ARE was mutated. However, in Nrf2
+/+
 MEF cells, it did not have 
significant effect on neither the basal nor induction level of Nqo1. Results from the 
DBA/2O MEFs also showed that the ARE but not XRE was required for basal and 
inducible expression of Nqo1 by flavonoids. Taken together, these results indicate 
that the ARE is necessity for both basal and inducible expression of Nqo1. However, 
there was a discrepancy in that when both ARE and XRE were mutated, in both 
RL-34 and MEF cells, the luciferase activity was higher than when only ARE was 
mutated.  
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We also examined the functional significance of the ARE and XRE sequence in the 
promoter of Nqo1 by deletion mutagenesis. Results from RL-34 cells and MEF cells 
showed that loss of the ARE abolished both basal and inducible expression of a 
reporter gene driven by the Nqo1 promoter. Again, the absence of the functional XRE 
exerted distinct effects on Nqo1-driven luciferase activity in different cell lines. In 
RL-34 cells, it caused around 50% reduction in the basal and inducible level. By 
contrast, the absence of XRE stimulated an increase in NQO1-driven luciferase 
activity in both Nrf2
+/+
 and DBA/2O MEFs. In the absence of both of these two 
response elements, the luciferase activity was lower than when either of them was 
deleted.  
 
Collectively, the results in this chapter suggest that the ARE in Nqo1 is responsible 
for both its basal expression and its induction upon treatment with quercetin and 
kaempferol. As Nrf2
+/+
 and DBA/2O MEFs are derived from two different mouse 
strains, the basal level of the luciferase activity is not comparable. The result from 
the DBA/2O fibroblasts suggests that lack of a functional AhR receptor did not affect 
the ability of quercetin or kaempferol to induce the Nqo1-driven luciferase activity; 
however, we could not draw the conclusion that AhR is not involved in the induction 
of NQO1 by the flavonoids, thus further investigation need to be carried out.  The 
function of XRE for the induction of Nqo1 is different for different cell lines. What 
caused such difference is still not clear.  
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3.4 Conclusion  
The first part of my study showed that quercetin and kaempferol exhibit substantial 
ARE-inducing ability. They increased Nqo1 enzyme activity, induced Nqo1 protein 
levels, and stimulated the mRNA level of Nqo1 in both RL-34 and MEF cells. 
Besides, the drug-metabolizing enzyme Cyp1a1 was positively regulated by the 
flavonoid at the transcriptional level. Quercetin showed itself to be a better inducer 
of Nqo1 than kaempferol, which may be due to their different structures or their 
conversion to different metabolites in the cells. This point still needs further study.  
 
Furthermore, it was found that induction of Nqo1 by the flavonoids occurs through 
an Nrf2-ARE dependent pathway. The XRE present in the promoter region of Nqo1 
appears to be involved in the induction of the oxidoreductase by the flavonoids in a 
cell-specific manner. Although previous studies showed that quercetin and 
kaempferol can act as pro-oxidants and be metabolized by conjugation with GSH, 
our study showed that in the cell culture system, the flavonoids did not alter the level 
of GSH. Finally, the induction of NQO1 by the flavonoids provides protection for 
cells against the toxicity cause by the electrophile acrolein.  
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4 Stimulation of Nrf2 and AhR activity by quercetin 
and kaempferol  
 
4.1 Introduction  
4.1.1 Nrf2 
Nrf2 is a CNC-bZIP transcription factor that is responsible for the regulation of a 
battery of ARE-driven genes, mostly encoding drug-metabolizing enzymes and 
antioxidant enzymes such as glutathione S-transferases, glutamate-cysteine ligase, 
NQO1, UDP:glucoronosyl transferases (UGTs), heme-oxygenase-1 (HO-1) and 
peroxiredoxin-1 (Prx1) (Hayes & McMahon, 2001; Ishii et al., 2000). These 
enzymes play a crucial role in protecting cells from electrophiles and oxidative stress, 
and prevent carcinogenesis. Under homeostatic conditions, Nrf2 is negatively 
regulated by Kelch-like ECH-associated protein 1 (Keap1), which facilitates 
degradation of Nrf2 through the proteasome (Itoh et al., 2003). Some dietary 
flavonoids are thought to exert their beneficial effect by up-regulating ARE-driven 
genes in an Nrf2-dependent pathway. 
 
More is known about the effect of quercetin on gene expression than is known about 
kaempferol. Tanigawa et al. (2007) investigated the mechanism by which quercetin 
increases the expression of NQO1 in human HepG2 cells. These workers found that 
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quercetin increased the binding activity of nuclear proteins to an ARE sequence and 
increased Nrf2-mediated gene transcription. The same study showed that quercetin 
increased the level of NQO1 mRNA and the abundance of NRF2 protein, by 
inhibiting the ubiquitination and extending the half-life of Nrf2. Furthermore, 
quercetin also reduced the level of Keap1 protein through the modification of the 
BTB-Kelch protein, without affecting the association between Keap1 and Nrf2. A 
study by Kimura et al. (2009) showed that quercetin can increase NRF2 protein 
levels in human HaCaT keratinocytes and induce the expression of HO-1 and GCLM, 
thus preventing oxidative damage caused by UVA (Kimura et al., 2009). A recent 
study of neuronal cells in culture has shown that quercetin is available intracellular 
just 1 min after treatment and it can increase the level of GSH around 40% but there 
is no effect on the protein level of thioredoxin (Trx2) (Arredondo et al., 2010). In 
addition, these researchers showed that quercetin increased the mRNA level of 
GCLC and stimulated the nuclear translocation of Nrf2. Another research group has 
reported that treatment with quercetin can increase the expression of HO-1 and also 
its mRNA in rat basophilic leukemia 2H3 (RBL-2H3) cells and this was found to be 
associated with nuclear translocation of Nrf2 protein (Matsushima et al., 2009). Also, 
Yao et al. (2009) have found that quercetin can protect human hepatocytes from 
ethanol damage by inducing HO-1. Moreover, this research group provided evidence 
that quercetin can modestly increase nuclear translocation of Nrf2 protein and this 
may be mediated by p38 and ERK (Yao et al., 2007). Furthermore, investigation of 
age-related macular degeneration found that in human retinal pigment epithelial 
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APRE-19 cells, quercetin, and other flavonoids including fisetin and eriodictyol, 
could increase Nrf2 protein levels and induce expression of HO-1 and Nrf2 
(Hanneken et al., 2006). 
 
Many studies have shown that kaempferol possesses antioxidant, anti-apoptosis and 
anti-inflammatory properties. In the case of kaempferol, though substantial studies 
have been reported for the broad effect of kaempferol on transcription factors such as 
NF-kB (Park et al., 2009) and HIF-1 activity (Mylonis et al., 2010) and also Src 
kinase activity (Lee et al., 2010), only a small amount of studies were about its effect 
on Nrf2. To date, only one paper was found on Pubmed showing modulation of Nrf2 
and its target gene by kaempferol. In this study, experiments carried out in House Ear 
Institute-Organ of Corti 1 HEI-OC1 cells showed that kaempferol prevented the 
ototoxic effects of cisplatin by stimulating nuclear accumulation of Nrf2 and 
inducing HO-1 and GCLC mRNA (Gao et al., 2010).  
 
4.1.2 AhR 
AhR is a ligand-activated transcription factor of the PAS superfamily. Ligand free 
AhR is located in the cytosol as a complex associated with Hsp90, p23 and XAP2. 
Ligand binding releases AhR from the complex and is followed by the translocation 
of AhR to the nucleus where it heterodimerizes with Arnt and binds to XRE 
sequences in the 5´ upstream region of target genes. Activation of AhR has been 
implicated in multiple physiological functions and dioxin-induced toxicology. 
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Ligands for the AhR, are structurally diverse. Many studies have investigated the role 
of flavonoids as the agonists/antagonists of AhR. Here, we will focus on studies 
describing such role for quercetin and kaempferol. In 1999, Ciolino et al. reported 
that quercetin served as an agonist of AhR whereas kaempferol acted as antagonist of 
AhR in MCF-7 cells (Ciolino et al., 1999). In a later study in HepG2 cells, Ahsida et 
al. (2000) reported that quercetin and kaempferol exhibited antagonist activity for the 
nuclear translocation of AhR at a concentration range of 1-10 μmol/l, but no agonist 
activity was observed. (Ashida et al., 2000). In 2003, Zhang et al. showed that 
quercetin and kaempferol were weak agonists of  AhR-mediated gene expression in 
MCF-7 cells (Zhang et al., 2003). The study by Zhang et al. also showed that the 
ability of quercetin and kaempferol to antagonize AhR was dependent on the cell 
context, as they did not exhibit such activity in HepG2 cells. In porcine vascular 
endothelial cells, quercetin inhibited induced oxidative stress produced by the 
PCB-77, induction of CYP1A1 mRNA caused by PCB-77 and AhR-DNA binding 
stimulated by PCB-77 at concentration range of 10-100 μmol/l (Ramadass et al., 
2003). In Caco-2 cells, quercetin served as a weak inducer of CYP1A1 protein and 
mRNA; on the other hand, quercetin was found to be highly effective in suppressing 
CYP1A1 induction by 1nM TCDD (Pohl et al., 2006). Kaempferol inhibited the 
formation of AhR/Arnt/DNA binding complex induced by β-NF and TCDD in vitro 
and in vivo, respectively (Puppala et al., 2007). Using a cell-based reporter assay in 
HepG2 cells and human hepatocytes, Li et al. found that quercetin and kaempferol 
activate AhR (Li et al., 2009). In human MCF-10A mammary epithelial cells, 
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quercetin increased CYP1B1 and CYP1A1 gene expression and activated AhR, 
whereas kaempferol suppressed constitutive CYP1B1 expression and antagonized 
AhR activation by benzo[α]pyrene (Rajaraman et al., 2009). Taken together, these 
studies showed that quercetin and kaempferol can either serve as agonists or 
antagonists of AhR, possibly depending on the concentration of the flavonoids and 
cell context.  
 
4.1.3 Possible interaction between Nrf2 and AhR 
The AhR has been extensively studied for its role in the induction CYP1 enzymes 
and mediating the toxicity of dioxin-like chemicals. More recently, with the 
availability of AhR-null mice, it has been revealed that the receptor is involved in 
numerous physiological processes such as cell cycle, and embryonic development. 
The mechanisms underlying those functions are the cross talk between AhR and 
various signalling pathway. One of the signalling pathways is the Nrf2-ARE axis.  
 
A few studies have investigated crosstalk between Nrf2 and AhR. Using Nrf2-null 
cells, Ma et al. (2004) showed that Nrf2 in involved in the activation of NQO1 by 
TCDD, but the underlying mechanism was not established. Subsequently, Batist and 
his colleagues reported the Nrf2 mRNA in Hepa-1c1c7 cells was significantly 
induced by TCDD in an AhR-dependent way (Miao et al., 2005). Further, these 
researchers also found that the promoter region of Nrf2 contains three XREs, and by 
chromatin immunoprecipitation assay, they showed AhR can bind to these XREs. In 
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another study, Kalthoff et al. (2010) showed that UGT1A10, one of the 
drug-metabolizing enzymes, can be regulated by both Nrf2 and AhR. The mRNA of 
UGT1A10 was showed to be induced by TCDD in KYSE70 human oesophageal 
squamous cell carcinoma cells. The promoter region of UGT1A10 contains two 
functional XRE sequences and one ARE sequence, through which TCDD or tBHQ 
elicit induction of UGT1A10. In addition, the UGT1A10 gene is coordinately 
regulated by Nrf2 and AhR. However, activation of AhR did not affect the mRNA 
level of Nrf2. The most interesting finding from this study was that Nrf2 and AhR 
can both bind the XRE and the ARE sequences, which explains the coordinate 
regulation of UGT1A10 by Nrf2 and AhR (Kalthoff et al., 2010). A second possible 
mechanism is a direct interaction between AhR and Nrf2 proteins; however, no 
evidence has been presented so far to demonstrate that the two transcription factors 
can physically interact. A third possibility is that an interaction can occur between 
Nrf2 and AhR-associated proteins or an interaction between AhR and 
Nrf2-associated proteins.  
 
4.1.4 Aims 
Previous results using Nrf2
+/+
 and Nrf2
-/-
 MEF cells suggested that Nrf2 is required 
for the induction of Nqo1 by quercetin and kaempferol. Overexpression of Nrf2 
further increased the transactivation of Nqo1 by phytochemicals.. We therefore 
wished to know whether these two flavonoids can increase Nrf2 activity. In addition, 
as quercetin and kaempferol can induce Cyp1a1 mRNA, we wished to know whether 
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they could activate the AhR.  
 
4.2 Results  
 
4.2.1 Overexpression of Nrf2 or AhR can upregulate NQO1  
Firstly, to confirm that Nrf2 and AhR are involved in the induction of NQO1 by 
quercetin or kaempferol, either or both of these two proteins were overexpressed in 
RL-34 cells that were co-transfected with P-1016/nqo1-Luc. RL-34 cells were seeded in 
6-well plates and allowed to reach ~80% confluence before they were transfected 
with various combinations of plasmid. After transfection, the cells were treated with 
phytochemicals for 24 h before luciferase activity was measured. A control group, 
comprising cells transfected with P-1016/nqo1-Luc and the empty pcDNA3.1/A plasmid, 
demonstrated that the empty expression vector had no effect on luciferase activity. 
The results showed that forced expression of either Nrf2 or AhR elevated basal Nqo1 
luciferase expression as well as induction of reporter gene activity by quercetin 
kaempferol. When both of these transcription factors were co-transfected, the 
increase in Nqo1-luciferase expression was moderate and indicated that these two 
proteins had an additive effect on induction rather than a synergistic effect.  
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Figure 4.4 Enhanced induction of NQO1 luciferase activity upon over expression of Nrf2 and/or 
AhR.  
RL-34 cells were seeded in 6-well plates. RL-34 Cells were co- transfected with 0.9375 μg 
P-1016/nqo1-Luc along with 0.9375 μg empty pcDNA3 plasmid, Nrf2, AhR or both Nrf2 and AhR protein 
expressing vector and together with 0.125 μg β-Gal plasmids for normalization. After transfection, 
cells were allowed to recover for 16 h before they were treated with DMSO, quercetin or kaempferol. 
Experiments were carried out on at least 3 separate occasions. Global normalization was carried out 
for the average value of each occasions and data are presented here as the mean value plus ± standard 
error. All values were normalized to the value of samples which were transfected with P-1016/nqo1-Luc 
and pcDNA3 and treated with DMSO. Student‟s t test was carried out by either comparing all the data 
sets with the DMSO group in the pcDNA3 data set, or comparing each treatment group in all data set 
with the same treatment group in the pcDNA3 data set. (. *P<0.01; ** P<0.05; *** P<0.001) 
 
4.2.2 Nrf2 protein levels are increased by quercetin and kaempferol  
Previous work has shown that under normal homeostatic conditions Nrf2 is 
negatively controlled by Keap1, which serves as a substrate adaptor for Cul3/Rbx1 
and therefore targets the CNC-bZIP factor for ubiquitination. However, under stress 
conditions, Keap1 is inactivated and Nrf2 protein is stabilized resulting in induction 
of ARE-driven genes. To check whether quercetin and kaempferol induce NQO1 
expression by stabilizing Nrf2 protein, endogenous levels of the CNC-bZIP factor in 
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RL-34 and MEF cells were examined after they had been treated with polyphenols 
for 2 h. Sulforaphane and 3-MC were included as positive controls. Immunoblotting 
showed that in both cell lines, the endogenous level of Nrf2 protein was increased by 
the polyphenols. In RL-34 cells, 20 μM quercetin and 20 μM kaempferol increased 
Nrf2 protein levels by ~9-fold and 5-fold, respectively; by comparison, sulforaphane 
(5 μmol/l) elicited an increase of ~ 9-fold as well, but 3-MC, a typical ligand of the 
AhR had no effect on the amount of Nrf2 protein. In Nrf2
+/+
 MEF cells, all 
xenobiotics tested had a more modest effect on Nrf2 protein compared with their 
effects in RL-34 cells. Quercetin and kaempferol caused ~3.5-fold and 3-fold 
increases in Nrf2 protein, respectively; sulforaphane gave ~3-fold increase whereas 
3-MC decreased the level of Nrf2 protein in MEFs to 50% compared with that of 
fibroblasts treated with DMSO.  
A  RL-34 
 
B 
 
Figure 4.5 The level of Nrf2 protein is increased by quercetin and kaempferol  
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(A) RL-34 cell were treated with vehicle DMSO (0.1 %, v/v), quercetin (20 μmol/l), kaempferol (20 
μmol/l), sulforaphane (5 μmol/l) and 3-MC (1μmol/l) for 2 h. Nrf2 protein level was monitored by 
Western blotting (left panel). Densitometry analysis of the immunoblot using quantity one software is 
presented in the right-hand panel. Analysis was performed by comparing treated cell with untreated 
cells. Density of the band corresponding to Nrf2 was normalized to that of actin before analysis. (B) 
Nrf2
+/+
 and Nrf2
-/-
 MEF cells were exposed to same treatment as that for RL-34 cells for 2 h and Nrf2 
protein level was monitored by Western blotting (left panel). Densitometry analysis of the immunoblot 
was presented on the right-hand panel. Analysis was performed by comparing treated Nrf2
+/+
 MEF 
cells and both treated and untreated Nrf2
-/-
 MEF cells with untreated Nrf2
+/+
 MEF cells. 
 
4.2.3 Transcription of Nrf2 is not affected by quercetin and kaempferol 
Having shown that the level of Nrf2 protein can be increased by quercetin and 
kaempferol, we examined whether the elevation was due to increased transcription of 
the Nrf2 gene. As the increase in Nrf2 protein occurred within 2 h, we treated cells 
with quercetin or kaempferol for either 1.5 or 3 h. Cells were then harvested and total 
mRNA was extracted and Nrf2 mRNA was quantified as described previously. This 
showed that the mRNA for Nrf2 did not change significantly over these time points 
in either RL-34 or MEF cells. This result indicated that the increased abundance of 
Nrf2 protein in RL-34 and MEF cells was not due to the increased transcription of 
Nrf2.   
A 
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Figure 4.6 The mRNA level of Nrf2 is not regulated by quercetin or kaempferol  
RL-34 (A) or MEF (B) cells were treated with vehicle DMSO (0.1%) or quercetin (20 μmol/l) or 
kaempferol (20 μmol/l) for either 1.5 or 3 h. Taq-man was performed as described in Materials and 
Methods. CT value of Nrf2 was normalized to that of actin. Values represent the mean ± S.E. of three 
independent measurements.   
 
4.2.4 Stabilization of Nrf2 protein by quercetin and kaempferol 
4.2.4.1 The half-life of Nrf2 protein is increased by quercetin and kaempferol 
Nrf2 can be regulated through post-translational mechanisms; we were interested to 
know whether quercetin or kaempferol could stabilize the CNC-bZIP protein. For 
this purpose, a cycloheximide-chase experiment was carried out as described in 
section 2.4.5. The data showed that the half-life of Nrf2 protein in RL-34 cells 
pre-treated with DMSO was around 30 min while it increased to 56 and 60 min in 
cells pre-treated with quercetin or kaempferol, respectively. 
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Figure 4.7 The half-life of Nrf2 protein is increased by quercetin and kaempferol  
(A) RL-34 cells were treated for 2h with DMSO (0.1%, v/v), quercetin (20 μmol/l), or kaempferol (20 
μmol/l) before CHX (10 μmol/l) were spiked into the medium at different time points. Cells were then 
harvested simultaneously with exposure to the chemicals for various time intervals. Nrf2 protein was 
detected by Western blotting. (B) Densitometry analysis was carried out using Quantity one software 
and the calculation of half-life of Nrf2 protein is described in Materials and Methods.  
4.2.4.2 Effect on the ubiquitylation of Nrf2 by quercetin and kaempferol 
The cycloheximide-chase experiment showed that quercetin and kaempferol both 
stabilize the Nrf2 protein in RL-34 cells. However, it is not clear through what 
mechanisms such stabilization occurred. McMahon, et al. (2003) has shown that 
Nrf2 is subject to ubiquitination in a Keap1-dependent manner. Thus one hypothesis 
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was that the half-life of Nrf2 protein increased as a consequence of its 
Keap1-mediated ubiquitination being inhibited. To test this idea, we examined the 
stability of ectopic Nrf2 when expressed in COS-1 cells in the presence or absence of 
ectopic mKeap1. To normalize the transfection efficiency, an expression construct for 
β-Gal was cotransfected with plasmids for mNrf2-V5 and mKeap1. After transfection, 
the COS-1 cells were treated with various phytochemicals for 2 h to see whether they 
could stabilize mNrf2-V5 protein in the presence of mKeap1. As anticipated, the 
level of ectopic Nrf2 protein in COS-1 cells that had been co-transfected with 
mKeap1 was much lower than when mKeap1 was absent. When cells were 
transfected with both mNrf2-V5 and mKeap1 expression plasmids, quercetin and 
kaempferol increased the level of Nrf2 ~4-fold and 2-fold, respectively.  
 
After showing that quercetin and kaempferol could stabilize Nrf2 protein, we carried 
out the ubiquitin assay as described in 2.4.7. The COS-1 cells were transfected with 
various combinations of mNrf2-V5, mKeap1 and Ub-his. After transfection, cells 
were treated for 2 h with various phytochemicals. Subsequently, His-tagged proteins 
were affinity-purified and subjected to Western blotting. A smear of high molecular 
mass V5-tagged protein was detected in the “pull-down” fraction contransfected with 
mNrf2-V5 and Ub-His (Figure 4.5 lanes 1-5) but not when either mNrf2-V5 or 
Ub-His was present. This result suggested that the high molecular weight fraction in 
the smeared band represents the polyubiquitinated mNrf2-V5. Densitometry analysis 
was carried out and the ratio of ubiquitinated Nrf2 protein to the amount of total Nrf2 
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protein was calculated. All the values were divided by the ratio when cells were 
treated with DMSO and the result obtained is presented as the fold inhibition of 
ubiquitination of Nrf2 protein. This experiment showed that both quercetin and 
kaempferol can inhibit the ubiquitination of Nrf2 by 50%.  
 
 
 
 
 
 
C 
 
A 
B 
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Figure 4.8 Quercetin and kaempferol can inhibit the ubiquitination of Nrf2 protein. 
(A) COS-1 cells were transfected with mNrf2-V5 either in the presence or absence of mKeap1. After 
transfection, cells were treated for 2 h with vehicle DMSO (0.1%, v/v), quercetin (20 μmol/l), 
kaempferol (20 μmol/l) or sulforaphane (5 μmol/l). The amount of protein used for analysis of each 
sample was normalized by the activity of β-Gal.  
(B) COS-1 cells were transfected with expression constructs for mNrf2-V5 and Ub-his in the presence 
(lane 2-5) or absence of mKeap1 (lane 1). In the presence of mKeap1, cells transfected with only 
mNrf2-V5 (lane 6) or Ub-his (lane 7) were included as negative control to prove the smear high 
molecular weight band represent ubiquitinated Nrf2 protein was measured. After transfection, the cells 
were treated as described in (A) for 2 h before the ubiquitination assay was carried out as described in 
Materials and Methods. The amount of V5-tagged protein in the samples from both “IP” and “input” 
was measured using Western blotting. For the input blot, it was stripped and re-probed with anti-actin 
antibody.  
(C) Densitometry analysis was carried out using quantity one software. The ratio of the band density 
of the ubiquitinated Nrf2 to that of the corresponding intact Nrf2 protein was calculated. The ratio of 
treated cell was compared with the untreated cells.  
 
4.2.5 Quercetin and kaempferol change the cellular localization of Nrf2 
The cyclohexamide-chase experiment showed that quercetin and kaempferol can 
stabilize Nrf2 protein. As we wished to know where such stabilization occurred, we 
examined whether the phytochemicals change the subcellular distribution of Nrf2 
protein. Cellular fractionation and immunocytochemistry were employed to address 
this question.  
 
4.2.6 Cellular fractionation  
RL-34 and MEF cells were treated for 2 h with various chemicals before being 
harvested and subjected to subcellular fractionation as described in 2.3.5. 
Immediately prior to fractionation, a small portion of total lysate (T) was withdrawn 
for immunoblot analyses along with protein from different subcellular fractions. In 
the case of RL-34 cells, three fractionations were purified (i.e. cytosol (C), 
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membranes (M) and nuclei (N)), whereas in the case of MEF cells, only two 
fractions were purified (i.e. the 3000× g (S) supernatant, containing both cytosol and 
membranes, and the nuclei (N)). Lamin A was used as a control to allow the purity of 
each fraction to be monitored. Western blotting showed that in both cell lines, 
quercetin and kaempferol increased the amount of Nrf2 protein in both the cytosol 
(i.e. 3000× g fraction in MEF cells) and the nuclear fractions. However, the blots 
suggested Nrf2 protein was present predominantly in the nuclear fraction rather than 
the cytoplasm under both basal and stressed conditions. 
A 
 
B 
 
Figure 4.9 Nrf2 protein is present predominantly in the nucleus both under basal and stressed 
condition. 
RL-34 (A) and Nrf2 
+/+
 MEF cells (B) were treated for 2 h with vehicle DMSO (0.1%, v/v), quercetin 
(20 μmol/l), or kaempferol (20 μmol/l), after which time the cells were subjected to subcellular 
fractionation as described in Materials and Methods. For RL-34 cells, three fractions were isolated 
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including cytosol (C), nucleus (N) and membrane (M). For MEF cells, two fractions were isolated 
including a 3000 × g fraction which included both cytosol and membranes (S) and nucleus (N). Total 
lysates (T) were also loaded as a positive control along with other fractions. The level of Nrf2 protein 
from each fraction was monitored by Western blotting. The same blot was stripped and re-probed with 
lamin A to evaluate the purity of nuclear fractions.    
 
 
4.2.6.1 Immunocytochemistry 
To further investigate the effect of quercetin and kaempferol on the cellular 
localization of Nrf2 protein, RL-34 cells were treated with each flavonoid for either 
30 min or 60 min before immunocytochemistry was carried out as described in 2.3.4. 
Consistent with the subcellular fractionation data, immunocytochemistry revealed 
that in both the untreated cells and those that had been treated with flavonoid, Nrf2 
was observed predominantly in the nucleus. However, upon treatment with quercetin 
or kaempferol, the amount of Nrf2 protein present in the nucleus, relative to that in 
the cytoplasm, was increased at both the 30 and 60 min time points. Thus these 
results also indicate that quercetin and kaempferol can stabilize Nrf2 protein and 
increase its abundance in the nucleus. Furthermore, it was noteworthy that in cells 
which were not exposed to xenobiotics, about 5% of them had more Nrf2 in 
cytoplasm than in the nucleus. The reason for this requires further investigation.  
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Figure 4.10 Nrf2 protein accumulates in the nucleus upon treatment with polyphenols.  
RL-34 cells were seeded onto coverslips in 60-mm dish and allowed to recovered for ~16 h by which 
time they had reached ~40-60% confluence. Afterwards, the cells were treated with vehicle DMSO 
(0.1%, v/v), quercetin (20 μmol/l) (A, B and C)) and kaempferol (20 μmol/l) (C & D) for various 
periods of time. As stated in Materials and Methods, location of endogenous Nrf2 protein was 
examined by immunocytochemistry followed by confocal imaging. FITC-labelled secondary antibody 
was used to locate Nrf2 protein. Nuclear DNA was stained by DAPI. DIC indicates images from 
normal light microscopy. The merge signal reprsents the results obtained when the three images were 
superimposed.  
(A) Confocal images of the localization of Nrf2 proteins. (B) The profiling of the distribution of the 
Nrf2 protein. (C) 5% of cell having Nrf2 predominantly accumulated in the cytoplasm only when 
treated with DMSO.   
 
 
4.2.7 AhR protein level was not affected by quercetin 
Due to the low affinity of the AhR antibody, it was not possible to detect signal by 
Western blotting. Therefore, immunoprecipitation was carried out as described 
earlier.  
To confirm the authenticity of the band believed to correspond to AhR, the mRNA 
for the receptor was also knocked down using siRNA. Prior to immunoblotting, cells 
were transfected with AhR siRNA or scrambled siRNA, and allowed to recover for 
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16 h before being subjected to immunoprecipitation. A comparison was made 
between cells transfected with AhR siRNA and those transfected with scrambled 
siRNA; and comparing cells pulled down with goat anti AhR antibody and cells 
pulled down with anti-goat IgG, the band indicated by an arrow corresponded to the 
AhR protein (Figure 4.8). A time course experiment was carried out for the 
immunoprecipitation and this method provided no evidence that the level of AhR 
protein was changed by quercetin  
 
 
 
Figure 4.11 Immunoprecipitation suggested there was no change of the level of AhR protein. 
(A) Two 100 mm dishes of RL-34 cells were seeded and left to reach ~80% confluence. They were 
then treated with vehicle DMSO (0.1%, v/v) or quercetin (20 μmol/l) for various times, as indicated, 
and harvested simultaneously. Immunoprecipitation was then carried out as described in Materials and 
Methods.   
(B) “Mock siAhR” or siAhR represents samples obtained from cells that were first transfected with 
either mock siRNA or AhR siRNA, respectively. After transfection, they were allowed to recover for 
24 h before they were subjected for immunoprecipitation as stated in (A). 
Arrow in (A) indicated the AhR standard in (B) indicated the actual band corresponding to AhR 
protein. “-C” represent the sample that were not pulled down by anti-AhR antibody but goat IgG.  
 
 
4.2.8 Quercetin and kaempferol up-regulate the AhR mRNA level   
RL-34 cells were treated with quercetin or kaempferol for different periods before 
A B 
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being harvested at the same time. RNA was extracted and measured as described 
earlier. This showed that quercetin and kaempferol gave the highest increase of 
3.5-fold and 1.8-fold in the amount of AhR mRNA , respectively, at 12 h.  
 
 
Figure 4.12 Quercetin and kaempferol increase the level of AhR mRNA.  
Taq-man was performed as described in Figure 3.10 and the mRNA was measured using a primer and 
probe set for rat AhR.  
 
4.2.9 Quercetin and kaempferol act as agonists of AhR 
As AhR is a ligand-activated receptor which is controlled by regulating its 
subcellular localization, immunocytochemistry was carried out to examine whether 
quercetin and kaempferol could change the localization of AhR in RL-34 cells. These 
liver epithelial cells were treated for either 30 or 60 min with polyphenols and 
immunocytochemistry was carried out as described in 2.3.4. The data obtained 
showed that the portion of AhR protein in cytoplasm of RL-34 cells was relatively 
higher than that observed in the nucleus. However, upon treatment for 30 min with 
quercetin, the portion of AhR protein in the nucleus was much higher than that in the 
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cytoplasm, and when the treatment was extended to 60 min, the portion of AhR 
protein in the nucleus became even more pronounced. These results suggested that 
quercetin at 20 μmol/l could stimulate the translocation of AhR from the cytoplasm 
of RL-34 cell to the nucleus.   
A 
 
B 
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Figure 4.13 Quercetin and kaempferol stimulate translocation of AhR from the cytoplasm to 
nucleus  
Sample preparation, immunocytochemistry and confocal imaging were the same as that described in 
Figure 4.7 to examine the cellular localization of AhR protein. RFP-labelled secondary antibody was 
used to locate AhR protein. Nuclear DNA was stained by DAPI. (A) Confocal images of the 
localization of AhR proteins. (B) Profiling of the distribution of the AhR protein.   
 
4.2.10  Co-IP did not detect physical interaction between Nrf2 and AhR 
in RL-34 cells upon exposure to quercetin or kaempferol  
To investigate whether Nrf2 and AhR physically interact upon exposure to quercetin 
or kaempferol, immunoprecipitation was carried out. Cells were treated with 
quercetin or kaempferol for 2 h and immunoprecipitation was carried out as 
described in 2.4.6. When proteins were pulled-down with anti-Nrf2 antibody, the 
immunoprecipitated material was probed with AhR antibody. A negative control 
denoted in the SDS-PAGE gel as “-C” represents material pulled down with rabbit 
IgG. In the IP sample, the band corresponding to the Nrf2 protein band was identified 
by comigration with an Nrf2 protein standard and appeared in the sample pulled 
down by anti-Nrf2 antibody, but was absent in the “-C” lane; this result suggested 
that the anti-Nrf2 antibody was relatively specific. When samples were blotted with 
AhR antibody, no band corresponding to the AhR protein appeared in the IP sample. 
In addition, samples pulled down by anti-Nrf2 antibody did not have any band that 
was absent from the “-C”.  Therefore, by immunoprecipitation using the stated Nrf2 
and AhR antibodies, we could not detect a physical interaction between Nrf2 and 
AhR under either basal conditions or upon exposure to quercetin or kaempferol. 
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Figure 4.14 Immunoprecipitation indicated there was no physical interaction between Nrf2 and 
AhR protein either under basal condition or when challenged with quercetin or kaempferol. 
RL-34 cells were seeded in duplicate in 100 mm dishes and left to recover and reach to 100% 
confluence. Cells were then exposed to vehicle DMSO (0.1%, v/v), quercetin (20 μmol/l) or 
kaempferol (20 μmol/l) for 2 h. Afterwards, cells were subjected for immunoprecipitation as described 
in material and methods. (A) Proteins were pulled down and probed with Nrf2 antibody. “–C” 
represented the sample that was pulled down with rabbit IgG. (B) The membrane used for A was 
stripped and probed with anti-AhR antibody raised in goat (M-20, Santa Cruz). (C) Proteins were 
pulled down with AhR antibody (M-20, Santa Cruz) and probed with monoclonal anti-AhR antibody 
(Abcam). “–C” represented the sample that pulled down with goat IgG. (D) The membrane used for (C) 
was stripped and probed with anti-Nrf2 antibody. Arrow in figure D in the “Input” part indicated the 
bands corresponding to Nrf2 protein.   
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4.3 Discussion 
4.3.1 Stabilization of Nrf2 protein by quercetin and kaempferol  
From the literature, it is known that Nrf2 is subject to rapid degradation under normal 
homeostatic conditions and its half-life is only around 15 mins in HepG2 cells. 
Results from our previous experiments suggested that induction of NQO1 by 
quercetin and kaempferol is mediated through the CNC-bZIP transcription factor 
Nrf2. Therefore, we hypothesized that quercetin and kaempferol exert a positive 
effect on Nrf2. To test this hypothesis, we examined Nrf2 protein levels in both 
RL-34 and MEF cells after exposure to quercetin and kaempferol. This showed that 
the flavonoids increased the Nrf2 protein levels. Subsequently, we investigated 
whether this elevation at protein level was due to increased transcription of its gene. 
It turned out that neither of the flavonoids had any effect on the mRNA level of Nrf2. 
Thus, it appears the elevation in Nrf2 protein is due to increased stabilization of the 
protein itself. Using the CHX assay, it was found that quercetin and kaempferol 
increased the half-life of Nrf2 protein in RL-34 cells from ~30 min to 56 and 60 mins, 
respectively. However, other study showed that the half life of Nrf2 is 15 min in 
HepG2 (Nguyen et al., 2003) and Hepa cells (Stewart et al., 2003), indicating that 
quercetin and kaempferol both stabilized the CNC-bZIP protein. Meanwhile, this 
result also suggested that the half-life of Nrf2 may vary between different cell lines. 
To further investigate how quercetin and kaempferol stabilized Nrf2, two pathways 
were examined. Firstly, we checked whether quercetin can inhibit the ubiquitination 
of Nrf2 which is one of the main mechanisms by which Nrf2 is degraded. 
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Transfection experiments were carried out in COS-1 cells using cDNAs encoding 
Nrf2, ubiquitin and Keap1, mimicking the homeostatic condition in cells. The results 
from these experiments showed that quercetin and kaempferol inhibited the 
ubiquitination of Nrf2 by ~50%. 
 
Furthermore, it has been proposed from previous experiment involving transient 
transfection of Keap1 that the BTB-Kelch protein binds and tethers Nrf2 in the 
cytoplasm where it targets the CNC-bZIP factor for ubiquitination. However other 
studies have shown that Nrf2 controls the basal expression of its target genes 
indicating it exhibits a constitutive function and is presumably present in the nucleus 
under homeostatic conditions. To confirm the cellular localization of Nrf2 protein 
under homeostatic condition and examine whether quercetin and kaempferol can 
change such localization, subcelluar fractionation and immunocytochemistry were 
carried out. Both methods showed that the Nrf2 protein resides predominantly in the 
nucleus under both homeostatic and stress conditions. In addition, quercetin and 
kaempferol caused Nrf2 protein to accumulate in the cell.  
 
Taken together, the experiments described in this chapter show that the increase of 
Nrf2 protein level stimulated by quercetin and kaempferol is through increase in its 
stability, which results from inhibition of its ubiquitination. Moreover, the flavonoids 
induced accumulation of Nrf2 proteins principally in the nucleus of cells rather than 
in the cytoplasm.  
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4.3.2 Quercetin and kaempferol as agonist of AhR 
Overexpression of AhR in RL-34 cells can further increase luciferase activity driven 
by the mouse Nqo1 gene promoter under both basal and stress conditions, indicating 
that this transcription factor is constitutively active and can be further activated by 
quercetin and kaempferol. In addition, our earlier experiment showed that quercetin 
and kaempferol can increase the mRNA level of CYP1A1 which is a major target of 
the AhR, again indicating that the activation of AhR can be induced by these two 
flavonoids. Although our results showed that mRNA of AhR can be increased by 
quercetin and kaempferol, Western blotting showed there was no change in the 
protein level of AhR, but such a lack of consistency may be due to the poor 
sensitivity of the AhR antibody. Activation of AhR can be induced by ligand binding, 
leading to its translocation from cytosol to nucleus. To examine whether quercetin 
and kaempferol may act as agonists of the AhR, immunocytochemistry was carried 
out and this showed that both flavonoids stimulated the nuclear translocation of AhR 
just after 30 min of exposure to the phytochemicals. As previous studies have shown 
different effect of quercetin and kaempferol on AhR either as agonists or antagonists 
indicating their agonist/antagonistic activity is dose- and cell context-dependent. Our 
result showed these two chemicals both posses agonist activity in RL-34 cells at a 
concentration of 20 μmol/l. 
 
4.3.3 Interaction between AhR and Nrf2 transcription factor  
Cross talk between Nrf2 and AhR has been suggested from previous studies. One of 
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the possible mechanisms for cross talk between these two transcription factors is 
through a physical interaction, which has not been reported in previous studies. In 
our study, compared with over-expression of one transcription factor alone, the over 
expression of both Nrf2 and AhR did not produce a synergistic effect on the 
luciferase activity driven by the Nqo1 upstream region after treatment by flavonoids, 
but rather an additive effect was observed, indicating that neither quercetin nor 
kaempferol stimulated cross talk between the two factors. Subsequently, we 
examined whether these two transcription factors interact by immunoprecipitation 
under normal homeostatic conditions or upon exposure to the flavonoid. The results 
showed that under either condition, no physical interaction between the AhR and 
Nrf2 was observed.   
 
4.4 Conclusion  
In this chapter, we confirmed the involvement of Nrf2 and AhR protein in the 
induction of NQO1 by the flavonoids quercetin and kaempferol. Subsequently, we 
examined the effect that quercetin and kaempferol exerted on transcription factors 
Nrf2 and AhR. This showed that both flavonoids can increase the stability of Nrf2 
and at the same time inhibit its ubiquitination leading to the nuclear accumulation of 
Nrf2 protein in the cell. The two flavonoids appeared to increase the mRNA level for 
AhR and could also act as agonists of the receptor at concentration of 20 μmol/l. 
However, no physical interaction between the two transcription factors was observed 
neither under homeostatic conditions nor after cells were exposed to the flavonoids 
  159 
in RL-34 cells.  
 
4.5 Supplementary data: Optimisation of AhR siRNA 
The data show that at the final concentration of 40 nM, AhR siRNA knocked down 
AhR mRNA to 25% while scrambled siRNR did not affect the mRNA level of AhR 
significantly at this concentration. Thus, 40 nM AhR siRNA was used to knock down 
AhR.  
 
Figure 4.15 Optimization of knocking down AhR using siRNA 
RL-34 cells were seeded in 60 mm dish and recovered for ~16 h to reach the confluence of 70%. Cells 
were then transfected with a range of concentration of siRNA as indicated on the figure. After 16 h 
transfection, medium was replaced with normal growth medium and cells were recovered for another 
24 h before mRNA was extracted. mRNA was measured and analysed as described in figure 3.10. 
Data represent mean ± standard error.  
 
  160 
5 Regulation of antioxidant and detoxification 
enzymes in mouse by quercetin and kaempferol  
 
5.1 Introduction 
Figure 4.16 Safe side of quercetin  
Early studies of the safety of flavonoids using Salmonella typhimurium TA98 with 
S9 mix, demonstrated that quercetin was mutagenic in bacteria (Bjeldanes & Chang, 
1977). Subsequently, quercetin was shown to serve as a carcinogen in rat intestine 
and bladder (Pamukcu et al., 1980). By contrast, a later study using golden hamsters 
found that treatment with up to 10% quercetin in the diet for ~700 days did not 
produce an increase in tumours, suggesting it is not carcinogenicity (Morino et al., 
1982). In a recent study, Swiss mice were fed quercetin for 28 days at dose of 0, 30, 
300, and 3000 mg/kg body weight/ day. No toxicity effect was observed for the 
treated group compared with control group (Ruiz et al., 2009).  
 
In addition, several studies have examined the safety of quercetin in humans. In 1975, 
it was reported that a single oral dose of up to 4 g of quercetin had no adverse effects 
in humans. A phase I clinical trial of quercetin suggested that a bolus of 1400 mg/m
2
 
(approximately 2.5 grams in a 70 kg adult) weekly dose of quercetin was safe (Ferry 
et al., 1996). Therefore, it appeared that treatment of quercetin at low concentrations 
to animals is not toxic. 
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5.1.1 Bioavailability and metabolism of quercetin 
There is more detailed information on quercetin than there is for kaempferol. In this 
thesis, I will present the information provided by previous studies on the 
bioavailability and metabolism of quercetin.  
 
Early studies reported that quercetin disappears rapidly from the plasma when 
administered intravenously to rodents indicating that it does not accumulate in tissues 
and biological fluids. Besides, it was proposed previously that quercetin is excreted 
into the faeces without intestinal absorption (Akira et al., 2008). A study by Kuhnau 
in 1976 and an investigation by Griffths in 1982 suggested quercetin, the aglycone 
form, but not its glycosides, was taken up in the gastro-intestinal tract by passive 
diffusion (Griffiths, 1982; Kühnau, 1976). A later study with human volunteers 
showed that quercetin glycosides can be absorbed in the small intestine, but also that 
this absorption greatly surpasses that of the aglycone, i.e. 52% of the glycosides was 
absorbed versus 24% of the aglycone (Hollman et al., 1995). Subsequently, it was 
confirmed by other studies that the absorption of quercetin is considerably enhanced 
by its conjugation with a sugar group (Erlund et al., 2000; Hollman et al., 1997). 
Two possible mechanisms could account for the increased absorption, resulting in a 
higher plasma peak concentration and in increased bio-availability. Firstly, it is the 
deglycosylation by β-glucosidases which are capable of liberating free quercetin for 
passive diffusion (Day et al., 1998; Németh et al., 2003). Secondly, quercetin is 
obsorbed through the facilitation of carrier-mediated transport. The transporter 
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responsible for quercetin uptake might be the sodium-dependent glucose 
transporter-1 (Gee et al., 1998; Walgren et al., 2000) or the multi-drug-resistance 
protein 2 (Walgren et al., 2000). After absorption, quercetin is metabolized in various 
organs including the small intestine, colon, liver and kidney. Methylated, sulphated 
and glucuronidated quercetin are the main metabolites in the small intestine and liver 
that arise as a result of the actions of drug-metabolizing enzymes (Hollman & Katan, 
1997). In addition, a study in a cell model using Caco-2 cells demonstrated that 
quercetin can be absorbed from the digestive tract and undergo subsequent metabolic 
conversion (Murota et al., 2000). 
 
Regarding the plasma concentration of quercetin, it is usually in the low nanomolar 
range, but upon supplementation it may increase to high nanomolar or low 
micromolar range (Hollman et al., 1996). A study examining its distribution in 
tissues in rat and pigs showed that, upon quercetin supplementation, the highest 
accumulation of the flavonoid and its metabolites was found in rat lungs and pig liver 
and kidney (de Boer et al., 2005). Compared with quercetin aglycone, the plasma 
concentrations of quercetin metabolites are rather high, ranging from 0-4 μmol/l, 
indicating that, upon repeated quercetin supplementation, they could attain a 
considerable plasma level (Hollman et al., 1997; Manach et al., 2005). 
 
5.1.2  NQO1 in animal  
Nqo1, regarded as a prototypical Nrf2-target gene, is a cytosolic flavoprotein 
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catalyzing the two-electron reductive metabolism and detoxification of endogenous 
and exogenous chemicals. NQO1 and GST were greatly elevated in cytosol from 
liver and extrahepatic tissues of rodents that were fed the anticarcinogenic dietary 
antioxidants butylated hydroxyanisole and ethoxyquin. Such cytosols also eliminated 
the mutagenic activities of urine of mice treated with benzo[α]pyrene. These findings 
led to the explicit suggestion that induction of drug-metabolizing enzymes could play 
a major role in protection against neoplasia and toxicity (Itoh et al., 1997; 
Ramos-Gomez et al., 2001). Double knockout mice deficient for Nqo1 and Nqo2 
showed a significantly higher skin tumour frequency and multiplicity compared with 
control wild-type or single knockout mice (Shen et al., 2010). Nqo1 is widely 
distributed in various tissues in human. By IHC, Nqo1 has been detected in the 
respiratory epithelial cells, epithelium of other tissues including breast duct, thyroid 
follicle, colon, and in the eye in corneal and lens epithelia. In addition, Nqo1 is 
highly expressed in hepatic tissue and gastrointestinal tract (Siegel & Ross, 2000).  
 
5.1.3 Aims 
Earlier studies during this project showed that quercetin and kaempferol could induce 
ARE-driven and XRE-driven genes expression in RL-34 cells. Therefore, it was 
important to know whether these flavonoids could act the same way in animals. Thus 
quercetin or kaempferol were administered to mice for four consecutive days and 
liver, stomach and intestine were harvested, and the changes in gene expression 
analysed.  
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5.2 Results 
5.2.1 Effects of quercetin and kaempferol on Nqo1 expression in the small 
intestine 
5.2.1.1 Western blotting  
Protein from the small intestine of C57BL/6 mice was extracted as described in 
2.4.3.2 and 2.2.6.2 and the level of Nqo1 protein and Nrf2 proteins measured by 
Western blotting. Densitometry analysis showed that Nqo1 protein level was 
increased 1.5-fold and 1.8-fold, respectively, by quercetin at a concentration of 10 
mg/kg or 100 mg/kg induced Nqo1 (Figure 5.1 A). In the case of kaempferol, the 
protein level of Nqo1 was increased to 1.2-fold and 1.3-fold, respectively, at the 
concentration of 10 and 100 mg/kg (Figure 5.1 B). Regarding the protein level of 
Nrf2, 4-, and 1.5-fold was observed, respectively for the treatment with quercetin at 
concentration of 10 and 100 mg/kg (Figure 5.1 C). Kaempferol gave an increase of 
the Nrf2 protein level of 2.2- and 1.8-fold, respectively at the concentration of 10 and 
100 mg/kg which is not consistent with the result observed for the change of Nqo1 
protein expression by the flavonoids (Figure 5.1 D).  
A 
 
  165 
 
B 
 
 
 
C 
 
 
 
  166 
 
D 
 
 
 
 
Figure 5.1 Level of Nqo1 and Nrf2 protein in the intestine of mouse. 
Mice were treated with 10 or 100 mg/kg quercetin (A&C) or kaempferol (B&D) as described in 
Materials and Methods. Protein from small intestine was extracted and subjected for the analysis of 
protein level of Nqo1 (A & B) and Nrf2 (C&D). Membranes were stripped and probed with Actin as 
well to ensure the equal loading of each sample. Densitometry analyses were carried out. The density 
of the band corresponding to target protein was normalized to actin and present as the “relative protein 
unit”. Data were then graphed using Graphpad Prism and represent the mean ± standard error.  
 
 
5.2.1.2  Flavonoids have no effect on the level of Nqo1 mRNA 
To further investigate whether quercetin can exert an effect on Nqo1 mRNA, 
Taq-Man was carried out. mRNA from small intestine was extracted as described in 
2.2.6.2 and measured by Taq-Man against Nqo1. This showed that quercetin with the 
concentration of 10 mg/kg or 100 mg/kg did not give any significant induction of 
Nqo1. As quercetin behaved as a more potent inducer in cell culture experiment and 
it showed no effect on the mRNA level of Nqo1 in the small intestine of mice, the 
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same experiment was not carried out for kaempferol.  
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Figure 5.2 Relative mRNA level of NQO1 in the small intestine of mouse 
Mice were treated with 10 or 100 mg/kg quercetin and mRNA was extracted from the small intestine 
as described in Materials and Methods. Triplicate reactions were carried out for each sample and 
normalized to the value of actin. Data presented here are the mean value of the 5 sample of each group. 
Mean value of each group was compared to that of the PBS group which was set as one. Mean ± 
Standard deviation was also presented for each group.  
 
5.2.2 Quercetin can increase the mRNA level of Cyp1a1 in small intestine 
but has no effect on AhR 
mRNA samples from small intestine extracted earlier were also used to measure the 
mRNA level of Cyp1a1 by Taq-Man. This showed that quercetin at 10 mg/kg 
increased the mRNA level of Cyp1a1 about ~ 3-fold. However, when the mice were 
treated with 100 mg/kg quercetin, there was no change in mRNA level of Cyp1a1 
was observed (Figure 5.3 A). The level of AhR mRNA was also examined and it 
showed that the flavonoids have no effect (Figure 5.3 B). 
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Figure 5.3 Relative levels of Cyp1a1 and AhR mRNA in the small intestine of mouse 
Mice were treated with 10 or 100 mg/kg quercetin and mRNA was extracted from the small intestine 
as described in material and methods. Triplicate reactions were carried out for each sample and 
normalized to the value of actin. Data presented here are the mean value of the 5 sample of each group. 
Mean value of each group was compared to that of the PBS group which was set as one. Mean ± 
Standard deviation was also presented for each group.  
 
5.2.3 Quercetin had no effect on the mRNA level of Nqo1 or Nrf2 in liver  
mRNA from liver was extracted as described earlier and was measured by Taq-man 
against Nqo1 and Nrf2. It showed that quercetin at either 10 or 100 mg/kg had any 
effect on the mRNA level of Nqo1 (Figure 5.4 A). In the case of Nrf2, and at both 
concentrations quercetin decreased the mRNA level to ~75% (Figure 5.4 B). 
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Figure 5.4 Relative mRNA level of Nqo1 or Nrf2 in the liver of mouse 
Mice were treated with 10 or 100 mg/kg quercetin and mRNA was extracted from the liver as 
described in material and methods. Triplicate reactions were carried out for each sample and 
normalized to the value of actin. Data presented here are the mean value of the 5 sample of each group. 
Mean value of each group was compared to that of the PBS group which was set as one. Mean ± 
Standard deviation was also presented for each group.  
 
 
5.2.4 Quercetin can increase the mRNA level of CYP1A1 and AhR in liver 
The mRNA was extracted from livers of mice treated with either PBS, or 10 or 100 
mg/kg quercetin. As shown in Figure 5.5, quercetin at 10 mg/kg caused induction of 
Cyp1a1 gene of around 1.5-fold (Figure 5.5 A) but had no effect on AhR (Figure 5.5 
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B). When mice were treated with 100 mg/kg quercetin, there was a ~1.7 fold increase 
of the CYP1A1 mRNA and 1.5 fold for the mRNA of AhR.  
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Figure 5.5 Relative mRNA level of CYP1A1 and AhR in the liver of mouse treated with 
quercetin 
Mice were treated with 10 or 100 mg/kg quercetin and mRNA was extracted from the small intestine 
as described in Materials and Methods. Triplicate reactions were carried out for each sample and 
normalized to the value of actin. Data presented here are the mean value of the 5 sample of each group. 
Mean value of each group was compared to that of the PBS group which was set as one. Mean ± 
Standard deviation was also presented for each group.  
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5.3 Discussion  
 
5.3.1 Effect of the flavonoids on the expression of Nqo1 and Nrf2 in small 
intestine and liver 
Our previous studies showed that quercetin and kaempferol can increase the Nqo1 
and its transcription factor Nrf2 in cell culture experiments. Therefore experiments 
were carried out using an animal model to examine whether the flavonoids could 
exert similar effect in vivo. Four days of consecutive treatment of quercetin or 
kaempferol at non-toxic concentration to C57/BL6 male mice appeared to increase 
the amount of protein level of Nqo1 by 20-80% in the small intestine. Indeed a 
dose-response was observed with quercetin at 100 mg/kg giving the highest 
induction of 80%. Such increase was accompanied with the increase of Nrf2 protein. 
Unexpectedly, the increase in Nrf2 protein is much higher than that of its target 
protein Nqo1. In addition, it was found that a low dose of each treatment of 10 mg/kg 
gave higher induction than the higher dose which was not consistent with the 
induction of Nqo1 by quercetin and kaempferol. In addition, a large variation 
between individual mice was observed in levels of Nqo1 and Nrf2 protein. Other 
reasons for the inconsistencies in these results are that as the increase in the Nqo1 
protein is not large enough for the densitometry analysis to give accurate 
measurements. Subsequently, to confirm whether Nqo1 was induced, Nqo1 mRNA 
level was measured and this showed that there was no significant change. Two 
possibilities may explain such contradiction. Firstly, the tissues were harvested 24 h 
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after treatment, while our cell culture result showed that quercetin and kaempferol 
gave the highest induction of NQO1 mRNA at 12 h. This finding suggests that the 
induction of Nqo1 or Nrf2 by quercetin or kaempferol may be present in some 
individuals will need to be confirmed using a larger group of animals and a different 
time point.  Our cell culture study showed that quercetin and kaempferol gave the 
highest induction of NQO1 mRNA at 12 h, whilst the mRNA analyzed for animal 
study was extracted from tissues harvested after 24 h of treatment. Such a difference 
may account for failure to detect the induction of Nqo1 mRNA. Secondly, 
densitometry analysis used for Western blotting analysis is semi-quantitative and 
therefore may not be sufficiently accurate to represent the levels of protein 
expression, especially when the change is moderate. To overcome such quantifying 
problems, enzyme activity could be measured to indicate the chage more accurately. 
 
Taken together, to achieve a better assessment of whether flavonoids affect the 
expression of drug metabolizing enzymes, a larger group of animals maybe useful. In 
addition, synthetic diet which does not contain any antioxidant should be considered, 
as the diet itself may contain polyphenols that mask the effect of quercetin on gene 
expression. Another strategy to avoid the effect of diet is to try a synthetic one.   
 
5.3.2 Effect of quercetin on the mRNA level of Cyp1a1 
As all the previous study showed that quercetin exerted more potent effect than 
kaempferol on the expression of Nqo1 and Nrf2, we only carried on the experiment 
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to examine the effect of quercetin on Cyp1a1 and its transcription factor AhR. This 
showed that quercetin can increase the mRNA level of Cyp1a1 in small intestine at 
the low dose of 10 mg/kg but not at the higher dose 100mg/kg. In addition, the 
mRNA level of its transcription factor was not affected by quercetin. In liver, the 
mRNA levels of both Cyp1a1 and AhR were elevated by quercetin which is 
consistent with results achieved from the cell culture study. However, compared with 
the induction of Cyp1a1 in the small intestine, around 3-fold, the induction for 
CYP1A1 at the same dose 10 mg/kg is much lower 20%. Such low induction may 
not be significant to lead to any biological consequence. However, these need to be 
further studied. 
 
Previous literature have shown that activation of AhR and its target gene Cyp1a1 
leads to the biotransformation of polycyclic aromatic hydrocarbons into active 
genotoxic metabolites, resulting in the initiation of chemical carcinogenesis (Nebert 
& Dalton, 2006). However, cell culture experiments have shown that quercetin can 
compete with TCDD for binding to the AhR thereby decreasing Cyp1a1 induction by 
TCDD, and in turn resulting in decreased toxicity.  
 
In addition to its ability to act as a transcription factor, AhR also functions as a 
ligand-dependent E3 ubiquitin ligase of certain nuclear receptors. Kawajiri et al. 
(2010) have reported that activation of AhR by natural ligands such as indole 
derivatives suppresses intestinal tumour development in the APC
min/+
 mouse 
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(Fujii-Kuriyama & Kawajiri, 2010). Based on our observation that quercetin can 
stimulate an increase in Cyp1a1 mRNA, it is possible that flavonoids can prevent 
intestinal carcinogenesis by activating AhR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  175 
6 Discussion and future perspectives 
6.1 Flavonols’ effect on the Keap1/Nrf2/ ARE gene battery  
Previous studies on flavonoids focus on their effect on the progress of various 
diseases such as cancer, cardiovascular disease and neurodegenerative diseases. Our 
work firstly examined whether and how they could provide protective effect to 
normal cells, RL-34 and MEF cells, by studying their effect on the Keap1/Nrf2/ARE 
gene battery, which are involved in antioxidant and detoxification system of the 
human body. Quercetin and kaempferol, the flavonols, were found the most potent 
ARE-inducers compared with the other flavonoids tested in the study. Further data in 
the Chapter 3 and 4 of this thesis provided evidence of the effect that quercetin and 
kaempferol exerted on the Keap1/Nrf2/ARE gene battery. The results showed that 
these two flavonols can regulate Nrf2 at its protein level by increasing its stability 
and inducing cellular translocation from cytosol to nucleus, but not on its mRNA 
level. Such changes of Nrf2 protein ultimately lead to increased transcription, 
translation activity of one of its target gene, Nqo1. In addition, our result showed the 
increased level of Nrf2 protein is due to the inhibition of ubiquitination of Nrf2 by 
quercetin and kaempferol. How such inhibition was achieved is still unclear. One of 
the possibilities is that quercetin and kaempferol or their metabolites can modify 
Keap1, the inhibitor of Nrf2, which in turn weakens the activity of Keap1, leading to 
the increased stability of Nrf2.  
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Furthermore, mutagenesis experiments revealed that the ARE in the promoter region 
of Nqo1 was required for the basal level and induction of Nqo1 by quercetin and 
kaempferol.  
 
Although in RL-34 cells quercetin and kaempferol caused good inductions of Nqo1, 
it had no effect on the expression of Gstp1, a protein encoded by another target gene 
of Nrf2 (Ikeda et al., 2002; Suzuki et al., 2005). A recent study found that Nqo1 is 
more inducible than GSTP1 in either normal or immortalized human lung cells, and 
neither of them were induced in adenocarcinoma A549 cells which have high level of 
constitutive expression of Nqo1 and GSTP1 (Tan et al., 2010). Another study showed 
that GSTP1 can be induced by sulforphane in rat clone 9 cells (Lii et al., 2010). 
Therefore, it is possible that quercetin and kaempferol induce specific cytoprotective 
genes in a cell specific manner.  
 
6.2 Quercetin and kaempferol’s effect on the AhR/XRE gene 
battery  
Previous studies showed that quercetin and kaempferol could act as either agonist or 
antagonist of AhR depending on concentration and cell context. In our study, we 
examined quercetin and kaempferol at 20 μmol/l in RL-34 cells and proved that they 
can act as AhR agonist by immunofloresence. This finding is further supported by 
the results showing that they can increase the mRNA level of Cyp1a1, a target gene 
of AhR. Such regulation of Cyp1a1 was also observed in the small intestine of male 
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mice which has been fed with quercetin and kaempferol (10 mg/kg body weight) for 
four days. Previous study by Kawarjiri, et al (2009) suggested the natural AhR ligand 
may be used to prevent intestinal cancer (Kawajiri et al., 2009). Therefore, the 
quercetin and kaempferol may be able to exert similar effect. However, this needs 
further investigations. 
 
In addition, our study also showed that induction of Nqo1 by quercetin and 
kaempferol is partly through XRE. By using WT MEF and DBA2/O MEF, we 
showed that the lack of functional AhR did not alter the transactivation of Nqo1 by 
quercetin or kaempferol either in the presence or absence of XRE. However, by 
overexpressing AhR in RL-34 cells, we do find that overexpression of AhR can 
increase the transactivation of Nqo1 by quercetin and kaempferol. Therefore, it is 
hard to conclude whether AhR is not involved in the regulation of Nqo1. Further 
experiments need to be carried out to investigate this question, such as using 
Hepa1c1c7 and AhR deficient Hepa1c1c7 cells or knocking down AhR in RL-34 or 
WT MEF cells.   
 
6.3 Co-ordinate regulation of Nqo1 by Nrf2 and AhR 
Previous studies have suggested several genes encoding drug metabolizing enzymes 
can be induced by TCDD, a typical AhR activator in an Nrf2 dependent manner such 
as UGT1A6, UGT1A10, Nqo1 and Gsta1 (Yeager et al., 2009). The underlying  
mechanism is probably due to the presence of both ARE and XRE in the promoter 
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region in these genes (Nioi & Hayes, 2004). The study of regulation of UGTs have 
identified the presence of XRE and ARE in the promoter region of UGT1A10 and 
revealed it can be regulated by both Nrf2 and AhR. They also showed that the 
coordinated regulation of UGT1A10 is not the result of cross reactivity but their 
simultaneously binding to both the XRE and ARE in the promoter region in 
UGT1A10 (Kalthoff et al., 2010). I also studied whether Nrf2 and AhR can 
coordinately regulate Nqo1. Over expression of either Nrf2 or AhR can up-regulate 
the transactivation of Nqo1, while the over expression of both transcription factors 
further increased both the basal level and induction of Nqo1 by quercetin and 
kaempferol, additively but not synergistically. Furthermore, by immunoprecipitation 
we did not observe any interactions between these two transcription factors. Taken 
together, ARE but not XRE plays predominated role in the regulation of Nqo1 by 
quercetin and kaempferol. Whether Nqo1 is regulated by Nrf2 and AhR in the way 
UGT1A10 is regulated needs further investigation. 
 
6.4 Chemoprevention and up-regulation of Nrf2 and AhR  
In this thesis, evidences have been provided that quercetin and kaempferol could 
increase the activity of Nrf2 and AhR protein. As we discussed in the introduction 
chapter, constitutive inactivation of Nrf2 can increase the sensitivity to toxicant and 
carcinogens while constitutive activation of Nrf2 are observed in the developing 
adenocarcinoma cells. In addition, increased activation of Nrf2 also contributes to 
chemoresistance of cancerous cells. Such contradictory roles of Nrf2 are probably 
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due to its ability to protect both normal cells and cancerous cells. The activation of 
Nrf2 by quercetin and kaempferol in normal cells can increase the capacity of cells 
defensive system and therefore can prevent cells from the attack by toxicants. As 
AhR is involved in many cellular physiological activities, whether the activation of 
AhR is good or bad still needs more studies.  
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